tag,mod,text,freq
timex3,age,70-year-old,3
timex3,age,64-year-old,2
timex3,age,in his 60s,3
timex3,age,in her 70s,1
timex3,age,83-year-old,1
timex3,age,74-year-old,5
timex3,age,53 year old,1
timex3,age,26 year old,1
timex3,age,age of 20,1
timex3,age,68 year old,1
timex3,age,82 year old,1
timex3,age,80 year old,1
timex3,age,in his 70s,2
timex3,age,her late 60s,1
timex3,age,70 year old,1
timex3,age,81 year old,2
timex3,age,87 year old,1
timex3,age,45,1
timex3,age,60,1
timex3,age,over the age of 65,1
timex3,age,over the age of 75,1
timex3,age,over the age of 70,1
timex3,age,15 year old,1
timex3,age,68 years,2
timex3,age,range: 52-81,1
timex3,age,56 year old,1
timex3,age,52 year old,1
timex3,age,61-year-old,2
timex3,age,38-year-old,3
timex3,age,42-year-old,3
timex3,age,24-year-old,1
timex3,age,43-year-old,2
timex3,age,68-year-old,2
timex3,age,ranged from 10-55 years,1
timex3,age,45 years,1
timex3,age,in his 20s;,1
timex3,age,8 months,1
timex3,age,"14 years, 8 months",1
timex3,age,"4 years, 2 months",1
timex3,age,33-year-old,2
timex3,age,98 days of age,1
timex3,age,29,1
timex3,age,32,1
timex3,age,63 years old,1
timex3,age,in her 20s,1
timex3,age,6-year-old,2
timex3,age,8-year-old,2
timex3,age,12-month-old,3
timex3,age,15-year-old,1
timex3,age,age of 9,1
timex3,age,age of 10,1
timex3,age,age of 11,1
timex3,age,age of 14,1
timex3,age,5-year-old,1
timex3,age,17-year-old,1
timex3,age,6-month-old,1
timex3,age,2nd day,1
timex3,age,at 5 months,1
timex3,age,at 6 months,1
timex3,age,81-year-old,1
timex3,age,28-year-old,2
timex3,age,age of 2 years,1
timex3,age,age of 7 years,1
timex3,age,37-year-old,1
timex3,age,age of 17,1
timex3,age,58-year-old,3
timex3,age,69-year-old,2
timex3,age,59-year-old,4
timex3,age,41-year-old,2
timex3,age,60-year-old,3
timex3,age,age 5 years,1
timex3,age,under 10 years of age,1
timex3,age,56-year-old,1
timex3,age,53-year-old,1
timex3,age,47-year-old,2
timex3,age,35-year-old,1
timex3,age,19-year-old,1
timex3,age,58 years old,1
timex3,age,72-year-old,1
timex3,age,49-year-old,1
timex3,age,at 46 years old,1
timex3,age,48-year-old,2
timex3,age,25-year-old,1
timex3,age,54-year-old,2
timex3,age,55-year-old,3
timex3,age,65-year-old,2
timex3,age,71-year-old,1
timex3,age,80-year-old,1
timex3,age,32-year-old,1
timex3,age,8 to 85 years,1
timex3,age,49.7 years,1
timex3,age,78-year-old,1
timex3,age,3-year-old,1
timex3,age,at the age of 2 years and 4 months,1
timex3,age,51-year-old,1
timex3,age,At 51,1
timex3,age,18-year-old,1
timex3,age,around the age of 12,1
timex3,age,15,1
timex3,age,12 months old,1
timex3,age,age of 6,1
timex3,age,21-year-old,1
timex3,age,around the age of 15,1
timex3,age,48 year old,1
timex3,age,age of 41,1
timex3,age,52-year-old,2
timex3,age,14 year old,1
timex3,age,13 months,1
timex3,age,41.9 years,1
timex3,age,57-year-old,1
timex3,age,12-year-old,1
timex3,age,66-year-old,3
timex3,age,60 years old,1
timex3,age,67-year-old,1
timex3,age,in her 50s,1
timex3,age,in his 30s,1
timex3,age,85 years and older,1
timex3,age,88-year-old,1
timex3,age,78 years old,1
timex3,age,age of 19,1
timex3,age,34-year-old,1
timex3,age,54 years old,1
timex3,age,71 years old,1
timex3,age,in her 40s,1
timex3,age,75 years old,1
timex3,age,87-year-old,1
timex3,age,81 years old,1
timex3,age,70 years old,1
timex3,age,27 years old,1
timex3,age,53 years old,1
timex3,age,76-year-old,1
timex3,age,around 4 to 10 weeks of fetal life,1
timex3,age,83 years old,2
timex3,age,77-year-old,1
timex3,age,in her 60s,1
timex3,age,69 years old,1
timex3,age,14-year-old,1
timex3,age,62-year-old,1
timex3,age,27-year-old,1
timex3,age,64 years old,1
timex3,age,50-year-old,1
timex3,age,from 61 to 81,1
timex3,age,80 years,1
timex3,age,20-year-old,2
d,positive,hemoptysis,1
d,positive,non-small cell lung cancer,3
d,positive,fever and increased inflammatory response,1
d,positive,hepatic dysfunction,3
d,positive,inflammatory response,2
d,positive,"small, poorly contrast enhanced masses",1
d,positive,lung cancer,8
d,positive,"hepatocellular necrosis, which was thought to be coagulation necrosis",1
d,positive,multiple hepatic masses due to inflammation,1
d,positive,multiple liver masses,1
d,positive,hepatic mass,1
d,positive,necrotizing multiple hepatic masses,2
d,positive,multiple hepatic masses,2
d,positive,necrotic multiple hepatic masses,1
d,positive,cholangitis involving nivolumab,2
d,positive,histopathological findings,1
d,positive,gastric cancer,8
d,positive,peritoneal and left supraclavicular lymph node recurrence,1
d,positive,psoriasis type drug eruption,1
d,positive,inflammatory cell infiltration and endotheliitis,1
d,positive,"damage to the bile duct epithelium, along with lymphocytic infiltration",1
d,positive,noncaseating epithelial cell granulomas containing Langhans-type multinucleated giant cells,1
d,positive,lymphocytes,1
d,positive,CD8-positive and CD4-positive,2
d,positive,relapse,1
d,positive,inflammatory cell infiltration,5
d,positive,plasma cells,1
d,positive,Inter-face hepatitis,1
d,positive,lymphoid infiltration,1
d,positive,lymphocyte aggregation,1
d,positive,infiltrating lymphocytes,2
d,positive,granuloma formation,1
d,positive,plasma cell infiltration and interface hepatitis,1
d,positive,laryngeal cancer,1
d,positive,liver damage,3
d,positive,fever,9
d,positive,enlarged gallbladder and thickened gallbladder wall,1
d,positive,diffuse dilatation and wall thickening,1
d,positive,inflammatory cell infiltrates,1
d,positive,chronic nonsuppurative destructive cholangitis,1
d,positive,further exacerbation of the cholangitis,1
d,positive,cholangitis,5
d,positive,tumor,17
d,positive,"Hypertension, hyperlipidemia",1
d,positive,vulvar malignant melanoma and lung metastasis,1
d,positive,lung metastases,1
d,positive,metastatic lesions,1
d,positive,lung metastatic lesions,1
d,positive,liver dysfunction with an inflammatory reaction,1
d,positive,"increased collagen fibers and inflammatory cell infiltration, mainly lymphocytes",1
d,positive,drug-induced hepatic impairment,1
d,positive,bile stasis liver failure,1
d,positive,recurrent pleural metastasis,1
d,positive,renal cell carcinoma,1
d,positive,jaundice and liver failure,1
d,positive,jaundice,3
d,positive,"chronic non-pyogenic destructive cholangitis, marked bile stasis",1
d,positive,irAE,1
d,positive,general condition deteriorated,1
d,positive,pulmonary and splenic metastasis of uterine leiomyosarcoma,1
d,positive,elevated liver enzymes,1
d,positive,liver function had tended to worsen,1
d,positive,cholestasis,1
d,positive,hepatocellular necrosis,1
d,positive,drug-induced hepatic impairment with impaired bile transport and hepatitis,1
d,positive,liver function abnormalities,2
d,positive,drug-induced hepatotoxicity,1
d,positive,acute hepatic impairment,1
d,positive,bone metastasis,2
d,positive,PD-L1,1
d,positive,liver dysfunction,3
d,positive,decreased appetite,3
d,positive,"hepatocyte shedding, hemorrhage, and infiltration of macrophages, lymphocytes, and plasma cells",1
d,positive,spotty necrosis,1
d,positive,lymphoplasmacytic infiltration,1
d,positive,liver enzymes level,1
d,positive,Fever,3
d,positive,skin rash,29
d,positive,bullous pemphigoid,1
d,positive,malaise,1
d,positive,elevated bilirubin levels,1
d,positive,erythema,10
d,positive,pemphigus,2
d,positive,eosinophilia,2
d,positive,the fever,1
d,positive,"prolongation of coagulation, hematopenia and the progression of jaundice",1
d,positive,non-comatose acute liver failure,1
d,positive,acute liver failure,2
d,positive,reduced level of neutrophils,1
d,positive,blood cell reduction,1
d,positive,"infiltrates, mainly eosinophils",1
d,positive,secondary changes,1
d,positive,Acute hepatic failure with eosinophilia,1
d,positive,"Jaundice, lower limb edema and dysbasia",1
d,positive,alcoholic cirrhosis of the liver,2
d,positive,edema in his lower legs and yellowish staining of urine,1
d,positive,difficult to climb stairs,1
d,positive,hard to maintain a standing position,1
d,positive,"manifest jaundice, pruritus, and leg edema",1
d,positive,"chronic liver injury, splenomegaly, worsening of the subcutaneous edema",1
d,positive,"bilateral pleural effusions, pulmonary edema and right upper lobe infiltration",1
d,positive,crushed erythrocytes and spur cells reflecting hemolysis,1
d,positive,ballooning of hepatocytes and Mallory body,1
d,positive,"fibrosis, and inflammatory cell infiltration",1
d,positive,alcoholic cirrhosis and associated spur cell anemia,1
d,positive,liver cirrhosis,2
d,positive,anemia,11
d,positive,poor oxygenation,1
d,positive,juvenile alcoholic cirrhosis complicated by spur cell anemia,1
d,positive,hepatic encephalopathy ,1
d,positive,intrahepatic portal hepatic vein shunt,1
d,positive,myocardial infarction,1
d,positive,somnolence,1
d,positive,hyperammonemia,3
d,positive,high signal intensity,1
d,positive,impaired consciousness caused by hepatic encephalopathy,1
d,positive,dilated,2
d,positive,intrahepatic shunt,1
d,positive,shunts,1
d,positive,shunt,5
d,positive,aneurysmal portal hepatic venous shunt,1
d,positive,hepatic encephalopathy,4
d,positive,portal venous shunts without liver disease,1
d,positive,acute myocardial infarction,1
d,positive,hepatic encephalopathy caused by an intrahepatic portal vein-hepatic vein shunt,1
d,positive,Impaired consciousness,2
d,positive,chronic hepatitis C,1
d,positive,cirrhosis C,1
d,positive,aortic valve stenosis,2
d,positive,"cirrhosis of the liver, type C",1
d,positive,impaired consciousness and hyperammonemia,2
d,positive,edema and dyspnea,1
d,positive,acute exacerbation of chronic heart failure,1
d,positive,heart failure,4
d,positive,portosystemic shunt,1
d,positive,cirrhosis,3
d,positive,encephalopathy,2
d,positive,dehydration,2
d,positive,C-type cirrhosis,1
d,positive,hepatic coma,4
d,positive,splenic-renal shunt,4
d,positive,Esophageal varices,2
d,positive,hepatic cirrhosis type C,1
d,positive,less controllable,1
d,positive,impaired consciousness,1
d,positive,"hepatic coma, Grade 3",1
d,positive,"hepatic coma, grade 1",1
d,positive,splenic renal shunt,2
d,positive,alcoholic cirrhosis complicated by gastric varices,1
d,positive,giant splenomegaly and thrombocytopenia,1
d,positive,gastric varices,7
d,positive,esophageal varices,5
d,positive,esophageal varicose veins,1
d,positive,"giant splenomegaly, a splenic renal shunt",1
d,positive,hypersplenism coupled with a low platelet count,1
d,positive,hypersplenism,1
d,positive,gastrorenal shunt,1
d,positive,gastric varices associated with cirrhosis with marked hypersplenism,1
d,positive,decompensated cirrhosis,3
d,positive,decompensated cirrhosis of the liver type C,1
d,positive,hepatic atrophy,1
d,positive,increase in portal pressure,1
d,positive,decompensated stage C cirrhosis,1
d,positive,hepatocellular carcinoma (HCC),1
d,positive,extrahepatic shunt,1
d,positive,intra-abdominal bleeding due to a splenic vein injury,1
d,positive,bleeding complications,1
d,positive,a pelvic fracture and ureteral injury due to traffic accident related trauma,1
d,positive,considerably elevated γ-GTP level,1
d,positive,right diaphragmatic hernia,2
d,positive,hernia portal,2
d,positive,excluded,1
d,positive,stenotic,3
d,positive,obstructed,2
d,positive,atrophic,3
d,positive,obscured,1
d,positive,slightly dilated,1
d,positive,development of a venous short circuit,1
d,positive,drained,1
d,positive,diaphragmatic hernia,1
d,positive,hemorrhagic shock,4
d,positive,portal hypertensive enteropathy induced by portal vein thrombosis,1
d,positive,cirrhosis and hepatocellular carcinoma,1
d,positive,decreased consciousness and a bloody bowel discharge,1
d,positive,low level of hematemesis,1
d,positive,dark red stool,1
d,positive,considerable quantity of tar feces was discharged,1
d,positive,respiratory arrest,1
d,positive,bloody stool,1
d,positive,lower gastrointestinal bleeding,1
d,positive,mild vasodilation and dilatation,1
d,positive,portal vein thrombus,1
d,positive,portal hypertensive enteropathy,1
d,positive,"General malaise, appetite loss",1
d,positive,general malaise and loss of appetite,1
d,positive,increase in hepatobiliary enzymes,1
d,positive,rapid increase in biliary enzymes,1
d,positive,blunted,1
d,positive,severe infiltration of inflammatory cells,1
d,positive,lymphocytic and histiocytic infiltrates,1
d,positive,ductular proliferation,1
d,positive,bridging fibrosis,1
d,positive,non-pyogenic destructive cholangitis,1
d,positive,symptomatic primary cholangitis,1
d,positive,primary biliary cholangitis,1
d,positive,Liver disorder,1
d,positive,liver disorder,1
d,positive,slightly obese,1
d,positive,fatty liver,3
d,positive,diffuse fatty liver,1
d,positive,increased level of urinary copper,1
d,positive,decompensated liver cirrhosis type C,1
d,positive,decompensated cirrhosis type C,1
d,positive,liver cancer,1
d,positive,ascites,9
d,positive,adverse outcome,1
d,positive,first degree atrioventricular block,1
d,positive,septicemia proximately caused by cellulitis,1
d,positive,sinus arrest,1
d,positive,chronic renal failure,1
d,positive,tendency to retain fluid,1
d,positive,atrial fibrillation,2
d,positive,liver failure,2
d,positive,death,1
d,positive,H. cinaedi bacteremia and cellulitis,1
d,positive,"decompensated cirrhosis, type C",1
d,positive,refractory hepatic ascites,1
d,positive,vomit,1
d,positive,reflux esophagitis,1
d,positive,decreased level of food intake,1
d,positive,hypoalbuminemia,1
d,positive,"bilateral lower leg pain, redness, warm sensations and swelling",1
d,positive,cellulitis,1
d,positive,positive blood culture,1
d,positive,bacteremia and cellulitis,1
d,positive,infections,1
d,positive,immunocompromised,1
d,positive,serum hepatitis,1
d,positive,"jaundice, edema, ascites, cachexia, bleeding daithesis and a disorder of consciousness",1
d,positive,"disorientated, remarkably emaciated, gave off an ammonia odor and presented hemorrhagic spots",1
d,positive,Hepatic coma,1
d,positive,obstructive jaundice,1
d,positive,Nagayo-Miyake's A' type hepatic cirrhosis and acute alcoholic hepatitis,1
d,positive,"lesions (multiple stones in the small pancreatic duct, fibrosis of the parenchyma and small necrotic foci)",1
d,positive,small abscess,1
d,positive,bile nephrosis,1
d,positive,hemorrhagic necrosis,1
d,positive,Edema,1
d,positive,aspergillosis and bronchopneumonia,1
d,positive,heartburn,1
d,positive,hepatoma,1
d,positive,pruritus,2
d,positive,swollen reddish-brown liver with a smooth surface,1
d,positive,markedly reduced,1
d,positive,greening and nodular elevation,1
d,positive,"enlargement, fibrosis, proliferation of bile ducts and the formation of intergubernaculum bridges",1
d,positive,jaundice gradually progressed,1
d,positive,pruritus persisted,1
d,positive,bleeding caused by an acute gastric ulcer,1
d,positive,large nodular cirrhosis,1
d,positive,anti-mitochondrial antibodies,2
d,positive,anti-smooth muscle antibodies,1
d,positive,post necrotizing cirrhosis,1
d,positive,abnormal liver function,1
d,positive,hepatosplenomegaly,1
d,positive,RA test,1
d,positive,anti-DNA antibody,1
d,positive,microsome test,1
d,positive,Liver found with post necrotic cirrhosis,1
d,positive,"marked reduction of fine bile ducts and interlobular bile ducts, papillary dilatation of the bile duct lumen of the size of a septal bile duct and aggregation of bile ducts in the vicinity",1
d,positive,swollen,1
d,positive,substance akin to a Mallory body,1
d,positive,common bile duct cysts,1
d,positive,dilatation,1
d,positive,congenital weakness,1
d,positive,partial obstruction,1
d,positive,idiopathic pregnancy jaundice,1
d,positive,gangrene and pruritus,1
d,positive,pregnancy,1
d,positive,palpated using one transverse finger,1
d,positive,hypertriglyceridemia,1
d,positive,bile stasis,2
d,positive,hepatocellular necrosis and inflammatory cell infiltration,1
d,positive,fatty infiltration,1
d,positive,chronic liver disease,1
d,positive,chronic hepatitis and cirrhosis,1
d,positive,cirrhosis of the liver,1
d,positive,chronic liver disorders,1
d,positive,persistently high levels,1
d,positive,alcoholic cirrhosis,1
d,positive,alcoholic hepatitis,1
d,positive,heavy consumption of alcohol,1
d,positive,parasternal lymph node metastasis,1
d,positive,metastasis of the parasternal lymph node,1
d,positive,Abnormal shadows,1
d,positive,enlarged parasternal lymph nodes,1
d,positive,FDG accumulation,1
d,positive,nodular shadows,1
d,positive,enlarged lymph nodes,3
d,positive,lymph nodes,5
d,positive,right parasternal lymph nodes,1
d,positive,metastases of breast cancer,1
d,positive,parasternal lymph node metastases,1
d,positive,torsion of the right middle lobe axis,1
d,positive,thoracic esophageal cancer,1
d,positive,"a right intrathoracic hematoma, bilateral pneumonia and atelectasis in the right middle lobe",1
d,positive,right pleural effusion,1
d,positive,thrombus,4
d,positive,right middle lobe atelectasis,2
d,positive,narrowing,1
d,positive,tortuosity,1
d,positive,torsion,1
d,positive,right middle lobe axial torsion,1
d,positive,adhesion,1
d,positive,adhesions,3
d,positive,adherent,4
d,positive,twisted,1
d,positive,DVT,3
d,positive,underdeveloped,1
d,positive,"elevated levels of antithrombin III, FDP, and D-dimer",1
d,positive,clots,1
d,positive,motor impairment,1
d,positive,sweating,1
d,positive,extreme muscle tension,1
d,positive,thrombus formation,1
d,positive,"is severely handicapped, both mentally and physically",1
d,positive,muscle tension,3
d,positive,worsening of his respiratory status,1
d,positive,tension,1
d,positive,cerebral palsy and mental disability,1
d,positive,worsening respiratory status,2
d,positive,increased muscle tension,1
d,positive,flexion,1
d,positive,considerable contortion due to muscle tension,1
d,positive,sputum,1
d,positive,gastrointestinal bleeding,3
d,positive,hemorrhage,2
d,positive,biliary atresia,5
d,positive,bleeding,4
d,positive,small bowel hemorrhage,3
d,positive,rupture of gastroesophageal varices,1
d,positive,bleeding from esophageal varices,1
d,positive,rebleeding,1
d,positive,portal hypertension,1
d,positive,in pre-shock,1
d,positive,poor QOL,1
d,positive,cholangitis and subileus,1
d,positive,atrophied,1
d,positive,bile lake,1
d,positive,extended,1
d,positive,intrahepatic stones,1
d,positive,fatigued,1
d,positive,QOL had been greatly compromised,1
d,positive,decreased hepatic artery blood flow,1
d,positive,depressed,2
d,positive,cutting her wrists,1
d,positive,stressful situations,1
d,positive,dependency and depression,1
d,positive,pathological dependency,1
d,positive,pathological dependency and depression,1
d,positive,flatulence and abdominal distension,2
d,positive,vomiting,4
d,positive,aerophagia,1
d,positive,abdominal distension,1
d,positive,flatulence,1
d,positive,gastric volvulus,1
d,positive,psychosomatic disorder,1
d,positive,gastrostomy complications,1
d,positive,cerebral palsy,1
d,positive,leaking,1
d,positive,esophageal atresia,1
d,positive,feeding disorder,1
d,positive,dumping syndrome,1
d,positive,immature teratoma of the right ovary,1
d,positive,peritoneal dissemination,2
d,positive,an ileus,1
d,positive,ileus associated with hypovolemia,1
d,positive,edema,6
d,positive,hypoproteinemia,1
d,positive,protein-losing enteropathy,1
d,positive,ileus symptoms,1
d,positive,partial stenosis,1
d,positive,ganglioneurosis and plexus hyperplasia,1
d,positive,lesions arose from abnormalities in the nerves of the gastrointestinal tract,1
d,positive,acquired chronic pseudo-intestinal obstruction,1
d,positive,diarrhea,4
d,positive,ulcerative colitis,1
d,positive,convulsions,2
d,positive,chronic constipation,1
d,positive,constipation,1
d,positive,cloacal exstropy,1
d,positive,ambiguous external genitalia,1
d,positive,"acting as if she were a boy, both physically and emotionally",1
d,positive,functional ileus,1
d,positive,psychomotor retardation,1
d,positive,duodenal atresia,2
d,positive,"high imperforate anus with a rectovaginal fistula, intestinal malrotation, and ventricular septal defect",1
d,positive,poor weight gain,1
d,positive,ventricular septal defect,1
d,positive,abdominal distension and vomiting,1
d,positive,adhesive ileus,1
d,positive,Liver dysfunction,1
d,positive,cerebral infarction,1
d,positive,"hypertension, and mild diabetes mellitus",1
d,positive,decreased consciousness,1
d,positive,pustules,2
d,positive,neutrophilic abscesses,1
d,positive,Kogoj's spongiform pustules,2
d,positive,"leukocytosis, strong positive CRP, elevated blood sedimentation, hypoproteinemia, and hypocalcemia",1
d,positive,pus,2
d,positive,generalized pustular psoriasis,2
d,positive,erythema and nail deformation,1
d,positive,"erythema, desquamation, and pustules",2
d,positive,fever developed,1
d,positive,elevated intraocular pressure due to glaucoma,1
d,positive,erythema and pustules,1
d,positive,diffuse erythema,1
d,positive,Munro's micro abscesses and Kogoj's spongy pustules,1
d,positive,pustular psoriasis,2
d,positive,bronchial asthma,2
d,positive,pruritic skin rash,1
d,positive,rash,2
d,positive,satellite swelling,2
d,positive,round monocyte infiltration,1
d,positive,"Leukocytosis, high serum IgE",1
d,positive,edematous erythema,4
d,positive,vesicles,2
d,positive,Keratinized erythema,1
d,positive,erythema and purpura,1
d,positive,purplish-red spots,1
d,positive,keratotic red plaques,1
d,positive,early stage skin rash,1
d,positive,dermatomyositis,3
d,positive,"right facial tic, renal cyst",1
d,positive,erythematous papules,3
d,positive,Erythema with desquamation,1
d,positive,lumbago,1
d,positive,muscle weakness in the extremities,1
d,positive,cyst-like lesions,1
d,positive,malignant tumor in the pelvic cavity,1
d,positive,dermatomyositis complicated by malignancy,1
d,positive,mass,13
d,positive,peritoneal pseudo-myxoma,1
d,positive,pruritic rash,1
d,positive,muscle weakness,2
d,positive,Heliotrope rash,1
d,positive,Erythema with keratosis,1
d,positive,Hashimoto's disease,2
d,positive,purpura,1
d,positive,pneumonia,1
d,positive,allergic vasculitis,1
d,positive,"purpura, and dyspnea",1
d,positive,pulmonary hemorrhage,1
d,positive,vasculitis,1
d,positive,Shermer test,1
d,positive,lymphocytic infiltration,2
d,positive,Sjogren's syndrome,3
d,positive,swelling,1
d,positive,Raynaud's phenomenon,2
d,positive,swelling and hardening,1
d,positive,edematous sclerosis,2
d,positive,erythematous scaly patches,1
d,positive,collagen fiber swelling and homogenization,1
d,positive,erythematous phase,1
d,positive,hyperkeratosis,1
d,positive,atrophy,1
d,positive,liquid degeneration,1
d,positive,infiltration,2
d,positive,lymphocyte-like cells,1
d,positive,IgM deposition,2
d,positive,anti-Scl70,1
d,positive,DLE,1
d,positive,generalized scleroderma associated with DLE,1
d,positive,hypertension,1
d,positive,"pedal edema, swelling of the fingers, dermal sclerosis, and diffused pigmentation",1
d,positive,generalized scleroderma,1
d,positive,Increased blood sedimentation,1
d,positive,lymphadenoma,1
d,positive,Swelling,1
d,positive,fever and dysphagia,1
d,positive,axillary lymph nodes on both sides,1
d,positive,pericardial fluid,1
d,positive,images showing metastasis of adenocarcinoma,1
d,positive,abscesses,3
d,positive,stomatitis,1
d,positive,small papules,1
d,positive,abdominal skin rash,1
d,positive,fissure formation and acanthosis,1
d,positive,deposits,1
d,positive,pemphigus vulgaris,2
d,positive,facial swelling,1
d,positive,pigmentation,1
d,positive,erythematous plaques,3
d,positive,Slightly atrophic scarring and pigmentation,1
d,positive,neutrophil infiltration,1
d,positive,nuclear fragmentation,1
d,positive,an increased erythrocyte sedimentation rate,1
d,positive,Bone marrow plasma cells,1
d,positive,punched-out image,1
d,positive,seborrheic eczema,1
d,positive,mildly pruritic skin rash,1
d,positive,Eosinophil count increased,1
d,positive,facial nerve paralysis,1
d,positive,amyctic erythema,1
d,positive,pruritic erythematous plaques,1
d,positive,telangiectasia,1
d,positive,benign lymphocytic infiltration,1
d,positive,"general malaise, fever and back pain",1
d,positive,tense blisters,1
d,positive,"high fever, enlarged lymph nodes, leukocytosis",1
d,positive,lymphocytes with nuclear abnormalities,1
d,positive,erythema multiforme,2
d,positive,atypical lymphocytes,1
d,positive,positive finding,1
d,positive,SLE,2
d,positive,tongue cancer,1
d,positive,hemorrhagic cystitis,2
d,positive,erythema annulare,1
d,positive,squamous cell carcinoma,2
d,positive,lupus nephritis,1
d,positive,anemia and hematuria,1
d,positive,collagen disease,1
d,positive,side effects,1
d,positive,pain and pruritus,1
d,positive,ulceration,1
d,positive,induration,5
d,positive,ulcerated,1
d,positive,granuloma with necrosis,1
d,positive,erythema induratum Bazin,1
d,positive,Antimicrobial staining,1
d,positive,pleural effusion,3
d,positive,Erythematous papules,2
d,positive,ovarian cyst,1
d,positive,papules,2
d,positive,Nodules surrounded by epithelioid cells and lymphocytes,1
d,positive,caseous necrosis,1
d,positive,Tuberculosis rash,1
d,positive,"Jaundice, pruritus, and xerostomia",1
d,positive,Jaundice,1
d,positive,"hepatosplenomegaly, eyelid xanthoma",1
d,positive,eruptive xanthoma,1
d,positive,linear xanthoma,1
d,positive,flat xanthoma,1
d,positive,parotid gland imaging was carried out and Schirmer test was positive,1
d,positive,primary biliary cirrhosis (PBC) stage 3,1
d,positive,xanthomas,2
d,positive,PBC and Sjogren's syndrome,1
d,positive,hyperlipidemia associated with PBC and xanthomatosis,1
d,positive,osteoporosis and esophageal varix associated with PBC,1
d,positive,PBC,2
d,positive,multiple cutaneous tumour,1
d,positive,HTLV-I provirus,2
d,positive,IL-2 receptor level was high,1
d,positive,HTLV-1 carrier,1
d,positive,T-cell receptor beta chain reconstitution (Tcβ ),1
d,positive,tumors,1
d,positive,fever and a cough,1
d,positive,acute exacerbation of diffuse panbronchiolitis,1
d,positive,giant cell arteritis,1
d,positive,cataracts,2
d,positive,arthralgia and a frostbite-like skin rash,1
d,positive,arthralgia,1
d,positive,facial erythema,1
d,positive,arthralgia and skin rash,1
d,positive,"cough, general malaise, low-grade fever, arthralgia, myalgia",1
d,positive,headaches and muscle weakness,1
d,positive,dyspnea,2
d,positive,general malaise,1
d,positive,low-grade fever and general malaise,1
d,positive,erythema exsudativum,1
d,positive,Erythema exsudativum,1
d,positive,lymph node,3
d,positive,enlarged intra-abdominal lymph nodes,1
d,positive,undifferentiated adenocarcinoma,1
d,positive,liquefaction degeneration,1
d,positive, edema,1
d,positive,dermatomyositis with gastric cancer as a complication,1
d,positive,Edematous sclerosis ,1
d,positive,generalized hyperpigmentation,1
d,positive,January 1987,1
d,positive,primary biliary cirrhosis,1
d,positive,small mass,1
d,positive,squamous cell carcinoma of the tongue,1
d,positive,scleroderma,1
d,positive,diffuse hyperpigmentation,1
d,positive,partial depigmentation,1
d,positive,excoriation,1
d,positive,RA,1
d,positive,collagen fibers,2
d,positive,perivascular cell infiltration,1
d,positive,immune abnormalities,1
d,positive,diabetes,1
d,positive,pruritis,1
d,positive,plethora and lichenification,2
d,positive,domed prurigo-like nodules,1
d,positive,Thick moss-like pus adhering,1
d,positive,cellular debris,1
d,positive,parakeratotic cells with keratotic plugs,1
d,positive,interpenetrating,2
d,positive, boring,1
d,positive,"inflammatory cell infiltration consisting of lymphocytes, histiocytes, eosinophils and neutrophils",1
d,positive,prurigo-like nodules,1
d,positive,erythema with scaling,1
d,positive,seborrheic dermatitis,1
d,positive,"pustules, crusts, and erosive plaques",1
d,positive,hair loss,1
d,positive,alopecia,1
d,positive,scaling,1
d,positive,pustular areas of the scalp,1
d,positive,staphylococcus epidermidis,1
d,positive,Erythema + Hair Loss (Alopecia),1
d,positive,Non-specific inflammation,1
d,positive,epidermal atrophy,1
d,positive,Pustular,1
d,positive,spongy pustules,1
d,positive,epidermoid carcinoma,1
d,positive,"erythema, bullae and erosions associated with pruritus",1
d,positive,eroded surface,1
d,positive,erosion,1
d,positive,spicule melting,1
d,positive,deposited,1
d,positive,insomnia,1
d,positive,Pruritus,1
d,positive,Erythema with scales,1
d,positive,sunburn cells,1
d,positive,pale red to pale reddish-brown papules with pruritus,1
d,positive,dermatitis,1
d,positive,pale red to pale reddish-brown papules,1
d,positive,dorsal eruption,1
d,positive,spongiform edema,1
d,positive,intraepidermal cell infiltration,1
d,positive,perivascular small round cell infiltration in the upper dermis,1
d,positive,contact dermatitis and photoallergic contact dermatitis,1
d,positive,psoriasis,2
d,positive,multiple basal cell epitheliomas,1
d,positive,psoriasis vulgaris,3
d,positive,PUVA lentigines,1
d,positive,black papules,1
d,positive,superficial basal cell epithelioma,1
d,positive,uveitis in the right eye,1
d,positive,Purpuric frostbite-like eruptions,1
d,positive,surface wound,1
d,positive,cutaneous sarcoidosis,1
d,positive,epithelioid cell granuloma,2
d,positive,transepithelial elimination of epithelioid cell granuloma,1
d,positive,BHL,1
d,positive,pulmonary lesions,1
d,positive,bone lesions,1
d,positive,chicken pox,1
d,positive,dark red spot infiltrates,1
d,positive,pain in the joints of the hands and feet,1
d,positive,"scars, brown in color",1
d,positive,light reddish-brown patches,1
d,positive, infiltration,1
d,positive,reddish-brown infiltrate,1
d,positive,epithelial nodules,1
d,positive,high ACE level,2
d,positive,bilateral uveitis,1
d,positive,posterior synechia,1
d,positive,swelling of the joints,1
d,positive,joints of the hands and feet,1
d,positive,"""hand motion"" (HM)",1
d,positive,scarring,1
d,positive,joint swelling and ocular symptoms,1
d,positive,subcutaneous nodules,3
d,positive,noncaseous granuloma made up of epithelioid histocytes,1
d,positive,Bilateral hilar lymphadenopathy,1
d,positive,interstitial changes,1
d,positive,elevated serum lysozyme,1
d,positive,sarcoidosis,5
d,positive,epithelioid cell granulomas,4
d,positive,membranocystic lesion (NASU)-like changes,1
d,positive,Membranous cystic lesions,1
d,positive,necrosis in conjunction with epithelioid cell granulomas,1
d,positive,lymph nodes which were swollen,1
d,positive,necrosis,4
d,positive,skin lesions,2
d,positive,Palpable erythema,1
d,positive,mildly infiltrated erythematous spots,1
d,positive,enlarged left hilar lymph nodes,1
d,positive,IgM elevation,1
d,positive,uveitis,1
d,positive,abnormal cellular immunity,1
d,positive,Rice-grain sized reddish brown papules,1
d,positive,type V hyperriboproteinemia,1
d,positive,"GOT, GPT, ChE, LAP, and γGTP levels were elevated",1
d,positive,foam cells,1
d,positive,hyperlipidemia,1
d,positive,cataract,1
d,positive,keratoconus,2
d,positive,bronchial asthma (asthma),1
d,positive,atopic dermatitis and asthma,1
d,positive,asthma,1
d,positive,atopic dermatitis,2
d,positive,vision loss,3
d,positive,torn retina,1
d,positive,opacity,1
d,positive,"atopic dermatitis, asthma",1
d,positive,itching sensation,1
d,positive,chronic conjunctivitis and cataracts in both eyes,1
d,positive,asthmatic,2
d,positive,bloodshot,1
d,positive,ocular diseases,1
d,positive,major asthma attack,1
d,positive,aspirin induced asthma,1
d,positive,anterior chest pain (ACP),1
d,positive,ACP,3
d,positive,asthma attack,2
d,positive,severe ACP,1
d,positive,bradycardia,1
d,positive,wheezing,1
d,positive,"ST elevation (II, III, aVF) and ST depression (V1-5)",1
d,positive,coronary spasm angina,1
d,positive,chest pain,1
d,positive,coronary spasm,1
d,positive,Fever and skin rash,1
d,positive,depression,1
d,positive,cervical lymph nodes,1
d,positive,dry rales,1
d,positive,desquamative erythema,1
d,positive,V25 low value,1
d,positive,thickening,3
d,positive,severe form of drug eruption with fever and lymphadenopathy,1
d,positive,"Increased white blood cell count (eosinophils), manifestation of atypical lymphocytes, elevated HHV-61gG, elevated HHV-71gG, and positive DLST",1
d,positive,hypersensitivity syndrome (HS),1
d,positive,Peripheral Airway Obstruction,1
d,positive,peripheral airway obstruction,1
d,positive,Hypersensitivity Syndrome and Organ Damage,1
d,positive,organ damage,1
d,positive,tissue damage,1
d,positive,HHV-6 DNA,1
d,positive,HS,4
d,positive,bronchial involvement,1
d,positive,HHV-6 reactivation,1
d,positive,transient hypogammaglobulinemia,2
d,positive,"Fever, generalized erythema",1
d,positive,Mild Intellectual Disability,1
d,positive,epileptic seizures,1
d,positive,fever and erythema,1
d,positive,liver dysfunction and thrombocytopenia,1
d,positive,"facial edema, lymphadenopathy",1
d,positive,fever and skin rash,1
d,positive,reactivation,1
d,positive,Micrognathia,1
d,positive,dysphagia,2
d,positive,developmental disability,1
d,positive,developmental delay,1
d,positive,gastroesophageal reflux disease,1
d,positive,recurrent bacterial infection,1
d,positive,eosinophils in stool,1
d,positive,GER,1
d,positive,milk allergy,1
d,positive,nausea,1
d,positive,eosinophilic infiltration,1
d,positive,eosinophilic gastroenteritis,3
d,positive,allergic reaction,1
d,positive,bronchial asthma attacks,4
d,positive,hypersensitivity pneumonitis,1
d,positive,aNO elevation,1
d,positive,dry cough and low-grade fever,1
d,positive,nodules,3
d,positive,"mixed ventilatory impairment, decreased diffusion capacity, and decreased SpO2",1
d,positive,alveolitis,1
d,positive,Candida albicans and Fusarium,1
d,positive,housing-related hypersensitivity pneumonitis,1
d,positive,exercise-induced stenosis,2
d,positive,cholinergic urticaria,2
d,positive,swelling rash with itching,1
d,positive,exercise-induced pruritus,1
d,positive,intradermal acetylcholine reaction,1
d,positive,exercise-induced airway stenosis,1
d,positive,Neurogenic inflammation,1
d,positive,Hay fever symptoms,1
d,positive,throat discomfort,2
d,positive,allergic to tofu,1
d,positive,OAS,1
d,positive,eruption,1
d,positive,swelling rash,2
d,positive,puffiness,2
d,positive,warm reed measles,1
d,positive,polymorphic erythematous drug eruption,1
d,positive,allergic rhinitis and hepatitis B,1
d,positive,arthritis,1
d,positive,erythematous plaques and papules,1
d,positive,joint pain,1
d,positive,erythema multiforme drug eruption,1
d,positive,right lower quadrant pain,1
d,positive,acute appendicitis,5
d,positive,enlargement,1
d,positive,inflammation,5
d,positive,peritoneal irritation symptoms,2
d,positive,thickened,1
d,positive,enlarged,5
d,positive,appendicitis,1
d,positive,adenocarcinoma,4
d,positive,catarrhal appendicitis,1
d,positive,appendiceal carcinoma,1
d,positive,simultaneous multiple colorectal carcinoma,1
d,positive,Positive fecal occult blood,1
d,positive,positive for occult blood in the stool,1
d,positive,0-IIa lesion,1
d,positive,type 1 lesion,1
d,positive,"Hypertension, hyperuricemia",1
d,positive,Erythema with scaling,1
d,positive,colorectal cancer,2
d,positive,status,1
d,positive,advanced rectal cancer,2
d,positive,dysgeusia and anorexia,1
d,positive,highly advanced rectal cancer,1
d,positive,prolapse of the colostomy,1
d,positive,peritonitis,1
d,positive,taste disorder and anorexia,1
d,positive,nutritional impairment,1
d,positive,watery stools,1
d,positive,dysgeusia,1
d,positive,chronic adhesive ileus and intractable diarrhea,1
d,positive,free air image,1
d,positive,generalized pyogenic peritonitis and perforation of the gastrointestinal tract,1
d,positive,intestinal adhesions,1
d,positive,increased back pain and decreased basic movement ability,1
d,positive,back pain,1
d,positive,excessive drainage,1
d,positive,advanced breast cancer,1
d,positive,"advanced breast cancer, multiple metastases, cervical cysts, and low nutrition",1
d,positive,severe periodontitis,1
d,positive,shaking,1
d,positive,Poor oral intake due to severe periodontitis,1
d,positive,side effect,1
d,positive,"bilateral breast cancer, right axillary lymph node metastasis, liver metastasis, and multiple bone metastasis",1
d,positive,"left axillary lymph node metastasis, uterine metastasis, and peritoneal dissemination",1
d,positive,pain,1
d,positive,postrenal renal failure,1
d,positive,ureteral stricture,1
d,positive,brachial plexus infiltration syndrome,1
d,positive,myoclonus,1
d,positive,ureteral stent obstruction,1
d,positive,emotional incontinence,1
d,positive,urinary tract obstruction,1
d,positive,adverse events,1
d,positive,myoclonus and emotional incontinence,1
d,positive,invasive ductal carcinoma of the breast,3
d,positive,uterine metastasis,1
d,positive,raised lesion,1
d,positive,poorly differentiated adenocarcinoma with signet ring cell carcinoma,1
d,positive,breast cancer,2
d,positive,cecal cancer,1
d,positive,cecal lesion,1
d,positive,elevated lesion,1
d,positive,GCDFP15,1
d,positive,CK7,3
d,positive,MUC1,1
d,positive,gastrointestinal metastasis of breast cancer,1
d,positive,Gastrointestinal metastasis of breast cancer,1
d,positive,invasive ductal carcinoma,1
d,positive,multiple metastases,1
d,positive,Uterine fibroid,1
d,positive,irregular hypoechoic mass,2
d,positive,isointense mass,1
d,positive,distortion,1
d,positive,invasive carcinoma,1
d,positive,hypoechoic areas with blood flow,1
d,positive,darkly stained mass,1
d,positive,contrast effect,1
d,positive,strong FDG accumulation on the nodule,1
d,positive,mass in the right breast,1
d,positive,ductal carcinoma en bloc,1
d,positive,ER,3
d,positive,PgR,1
d,positive,male breast cancer,1
d,positive,abdominal pain,6
d,positive,stenosis and dilatation due to thickening of the small intestine wall,1
d,positive,intestinal obstruction,1
d,positive,small bowel stenosis,2
d,positive,gastric IIC lesion,1
d,positive,gastric lesion,1
d,positive,adenocarcinoma (tub1-tub2 >muc),1
d,positive,SM to MP cancer,1
d,positive,non-neoplastic (inflammatory),1
d,positive,stenosis for small intestinal stenosis,1
d,positive,stenosis,4
d,positive,atypical cells,1
d,positive,poorly differentiated adenocarcinoma with invasive growth,1
d,positive,small bowel metastasis of lobular carcinoma of the mammary gland,1
d,positive,small intestine lesion,1
d,positive,invasive lobular carcinoma,2
d,positive,small bowel lesion,1
d,positive,small bowel metastatic recurrence,1
d,positive,small bowel metastatic recurrence of mammary invasive lobular carcinoma,1
d,positive,early gastric cancer.,1
d,positive,"Locally advanced rectal cancer, simultaneous liver metastasis",1
d,positive,main lesion and liver metastasis,1
d,positive,metastatic liver tumor,1
d,positive,type 2 advanced cancer,1
d,positive,heterogeneous colorectal cancer,1
d,positive,juvenile heterogeneous multiple colorectal cancer,1
d,positive,cancer of the rectum,1
d,positive,ileus,2
d,positive,lung metastasis tumor,1
d,positive,rectal cancer metastasis,1
d,positive,lymph node swelling,1
d,positive,swelling of the lymph nodes,1
d,positive,very elderly patient with ascending colon cancer with multiple liver metastases,1
d,positive,abdominal pain and anorexia,1
d,positive,mild dysphoria,1
d,positive,stroke,1
d,positive,liver function was impaired due to liver metastasis,1
d,positive,highly differentiated adenocarcinoma,1
d,positive,ascending colon cancer with multiple liver metastases,1
d,positive,lower rectal cancer,1
d,positive,Rectal cancer,1
d,positive,portal vein tumor embolization,1
d,positive,recurrence of multiple unresectable liver metastases,1
d,positive,metastatic lesion,2
d,positive,liver metastases,1
d,positive,multiple liver metastases,2
d,positive,ascending colon cancer with multiple liver and lung metastases,1
d,positive,abdominal pain and vomiting,2
d,positive,"dilatation of the small intestine, poor contrast of the wall, and a closed loop,",1
d,positive,strangulated ileus,2
d,positive,strangulation,1
d,positive,perianal abscess,1
d,positive,constipation and weight loss,1
d,positive,high inflammatory response,1
d,positive,abdominal mass,1
d,positive,contrast enhancement effect,1
d,positive,type 2 tumor lesion,1
d,positive,Japanese blood-sucking worm eggs with calcification,1
d,positive,stricture caused by the tumor,1
d,positive,tumor mass,1
d,positive,poorly differentiated adenocarcinoma,3
d,positive,nests of Japanese blood-sucking worm eggs,1
d,positive,ascending colon carcinoma,1
d,positive,Japanese blood-sucking worm eggs,1
d,positive,Japanese blood-sucking worm disease,1
d,positive,BRAF mutation,1
d,positive,MSI,1
d,positive,left supraclavicular lymph node,1
d,positive,simultaneous multiple lymphatic metastases of appendiceal cancer,1
d,positive,anaphylaxis,1
d,positive,liver metastasis,1
d,positive,interstitial pneumonia (IP),1
d,positive,small bowel perforation,2
d,positive,IP,2
d,positive,BRAF mutations,1
d,positive,allergic rhinitis,1
d,positive,right lower abdominal pain,1
d,positive,Tenderness and recoil pain,1
d,positive,wall thickening,5
d,positive,mass lesion,2
d,positive,ulcerative lesion,1
d,positive,inflammatory cell infiltrate,2
d,positive,increased fibrous connective tissue,1
d,positive,fibrous connective tissue,1
d,positive,neutrophil infiltrate,1
d,positive,eosinophilic colitis,1
d,positive,cellulitis acute appendicitis,1
d,positive,bloody stools,1
d,positive,lower abdominal pain,1
d,positive,tenderness and recurrent pain,1
d,positive,polymyositis,1
d,positive,inflammatory images and freeAir,1
d,positive,perforation of the sigmoid colon,1
d,positive,perforation,2
d,positive,sigmoid colon ulcer,1
d,positive,ulcers,1
d,positive,raised,1
d,positive,CMV inclusion bodies,1
d,positive,CMV enteritis,2
d,positive,gastrointestinal perforations,1
d,positive,alcoholic pancreatitis,1
d,positive,Severe alcoholic pancreatitis,1
d,positive,acute pancreatitis,1
d,positive,pancreatitis,4
d,positive,upper abdominal pain,2
d,positive,cystic mass,1
d,positive,debris,1
d,positive,pancreatic stone,3
d,positive,atrophy and tissue deterioration,1
d,positive,elevated amylase,1
d,positive,alcoholic chronic pancreatitis and pancreatic stones,1
d,positive,pancreatic duct fusion failure,1
d,positive,pancreatic cyst,1
d,positive,chronic pancreatitis,1
d,positive,cholecystocholedocholithiasis,1
d,positive,high confluence of pancreatic and bile ducts,1
d,positive,osteoarthritis of the knee,1
d,positive,common bile duct dilatation,1
d,positive,high level confluence of pancreatic and bile ducts,1
d,positive,stones,3
d,positive,common bile duct stones,1
d,positive,fibrosis-accompanied wall thickening,1
d,positive,chronic inflammatory changes,1
d,positive,cholecystitis,4
d,positive,deep vein thrombosis,2
d,positive,uterine cancer,1
d,positive,attack of cholelithiasis,1
d,positive,deep vein thrombosis and pulmonary embolism,1
d,positive,gallstones,1
d,positive,wall,1
d,positive,Abdominal distension,2
d,positive,a large mass and ascites,1
d,positive,"sigmoid colon cancer, peritoneal dissemination",1
d,positive,giant ovarian tumor,1
d,positive,respiratory distress,1
d,positive,ovarian tumor,1
d,positive,ascites and liver metastasis,1
d,positive,peritoneal disseminations,2
d,positive,huge right ovarian tumor,1
d,positive,sigmoid colon cancer,2
d,positive,invaded,2
d,positive,tubular adenocarcinoma,1
d,positive,invasion,3
d,positive,right ovarian fibroma,1
d,positive,thoracoabdominal effusion,1
d,positive,Meigs syndrome,1
d,positive,vomiting and upper abdominal pain,1
d,positive,hyperechoic,1
d,positive,cholelithiasis with cholangitis,1
d,positive,fresh blood,1
d,positive,adherent clots,1
d,positive,irregular defects,1
d,positive,hemorrhagic cholecystitis with cholangitis,1
d,positive,thrombosis in the left ventricle,1
d,positive,right costal pain,2
d,positive,extravascular leakage,1
d,positive,hemorrhage due to gallbladder necrosis,1
d,positive,stone,2
d,positive,ulcer,1
d,positive,disruption due to the spillover of inflammation,1
d,positive,Hemorrhagic cholecystitis,1
d,positive,Tenderness,1
d,positive,inflammatory reaction,1
d,positive,sigmoid colon diverticulitis,1
d,positive,enlarged gallbladder,1
d,positive,gallbladder stones and biliary sludge,1
d,positive,cholelithiasis,1
d,positive,severe inflammation,1
d,positive,bile mud,1
d,positive,acute hemorrhagic gangrenous cholecystitis,1
d,positive,emphysematous cholecystitis,3
d,positive,DIC,2
d,positive,Diabetes mellitus,1
d,positive,arteriosclerosis obliterans,1
d,positive,abscess cavity,1
d,positive,drainage,1
d,positive,necrotic,1
d,positive,fragile,1
d,positive,perforation of the common bile duct,1
d,positive,tender findings,1
d,positive,air density,1
d,positive,fluid accumulation appearing to be ascites,1
d,positive,gastrointestinal perforation,1
d,positive,neutrophilic infiltration,1
d,positive,bacilli,1
d,positive,acute cholecystitis,1
d,positive,intra-abdominal free gas,1
d,positive,gallstone cholecystitis,2
d,positive,hydrocephalus,1
d,positive,rectal cancer,3
d,positive,MDS,4
d,positive,positive fecal occult blood,1
d,positive,uterine fibroids,2
d,positive,myelodysplastic syndromes,1
d,positive,fecal occult blood,1
d,positive,HLA antibodies,1
d,positive,moderately differentiated adenocarcinoma,1
d,positive,pancytopenia,1
d,positive,cancer,1
d,positive,traumatic abdominal wall hernia caused by traffic trauma,1
d,positive,injured,1
d,positive,redness due to trauma,1
d,positive,tear,1
d,positive,defect in the abdominal wall,1
d,positive,traumatic abdominal wall hernia,1
d,positive,tears,1
d,positive,prolapsed,1
d,positive,abdominal wall injury,1
d,positive,pain due to the muscle tear,1
d,positive,traumatic ventral wall hernia,1
d,positive,type 2 EL,4
d,positive,AAA,1
d,positive,type 1b and type 2 EL,1
d,positive,EL,2
d,positive,sarcoidosis complicated by esophageal cancer,1
d,positive,pain after meals,1
d,positive,esophageal cancer,1
d,positive,hilar and mediastinal lymph nodes,2
d,positive,accumulation,2
d,positive,mediastinal hilar lymph nodes,1
d,positive,lower thoracic paraoesophageal lymph nodes (110),1
d,positive,abnormally hyperintense,1
d,positive,hypointense,1
d,positive,mediastinal lymph node,1
d,positive,esophageal cancer complicated with sarcoidosis,1
d,positive,paratracheal lymph nodes,1
d,positive,Lymph node,1
d,positive,metastasis,3
d,positive,110 lymph nodes,1
d,positive,non-cheese granulomas,1
d,positive,dyschezia and diarrhea,1
d,positive,Type 2,1
d,positive,isolated left adrenal metastasis after rectal cancer surgery,1
d,positive,left adrenal tumor,1
d,positive,left adrenal metastasis from rectal cancer,1
d,positive,postoperative isolated left adrenal metastasis from rectal cancer,1
d,positive,cardiac orbital pain,1
d,positive,elevated tumor,1
d,positive,gastric leiomyosarcoma,3
d,positive,tumor-induced dyspepsia,1
d,positive,desmin,1
d,positive,transit barrier,1
d,positive,travel abnormality,1
d,positive,Gastric cancer,1
d,positive,No. 8a lymph node,1
d,positive,advanced gastric cancer and cholecystolithiasis,1
d,positive,hematemesis and black stool,1
d,positive,type 3 advanced gastric cancer,1
d,positive,diabetes mellitus,1
d,positive,positive oral margins,1
d,positive,abscess formation,1
d,positive,extramural invasion,1
d,positive,tenderness and rebound pain,1
d,positive,fluid accumulation,1
d,positive,perforating the reticulum to form an abscess,1
d,positive,localized peritonitis,1
d,positive,gastric cancer type 2,1
d,positive,obstruction,1
d,positive,food mass,5
d,positive,early stage gastric cancer,1
d,positive,cardiac orbital pain and vomiting,1
d,positive,tenderness with muscular defense,1
d,positive,gastric dilatation and accumulation of food residue,1
d,positive,subjective symptoms,1
d,positive,abdominal findings,1
d,positive,gastric dilatation,1
d,positive,gastric tube cancer,1
d,positive,hotnode,1
d,positive,AFP-producing gastric duct cancer and multiple liver metastases,1
d,positive,hemorrhagic complications,1
d,positive,gastric tube carcinoma,1
d,positive,bilateral ovarian tumor (dermoid cyst),1
d,positive,Type3 poorly differentiated adenocarcinoma,1
d,positive,Rectal wall thickening,1
d,positive,rectal metastasis of gastric cancer,1
d,positive,frequent bowel movements,1
d,positive,rectal metastasis from gastric cancer,1
d,positive,cancerous peritonitis,1
d,positive,multiple skeletal muscle and skin metastases,1
d,positive,type 3 tumor,2
d,positive,malignancy,1
d,positive,anemic,1
d,positive,disseminated nodules,1
d,positive,undifferentiated carcinoma,1
d,positive,skin metastases,1
d,positive,Peritoneal dissemination,1
d,positive,advanced gastric cancer,1
d,positive,multiple gastric cancer,1
d,positive,enlarged mesenteric lymph nodes,1
d,positive,skin nodules,2
d,positive,consistent findings of metastasis of gastric cancer,1
d,positive,multiple skin metastases of gastric cancer,1
d,positive,multiple bone metastases and pathological fractures of the cervical spine,1
d,positive,lymph node metastasis,1
d,positive,Skin metastasis of visceral malignancies,1
d,positive,cutaneous metastases of gastric cancer,1
d,positive,dyspepsia,1
d,positive,esophageal lesions,1
d,positive,type III lesion,1
d,positive,multiple,1
d,positive,0-IIa+IIc lesions,1
d,positive,primary tumor and metastatic lymph nodes,1
d,positive,mouth lesion,1
d,positive,gastric carcinoma,1
d,positive,enlarged posterior pancreatic head lymph nodes and paraaortic lymph nodes,1
d,positive,unresectable advanced gastric cancer,2
d,positive,CN,1
d,positive,primary lesion,1
d,positive,paraaortic lymph nodes,1
d,positive,para-aortic lymph node,1
d,positive,bloody discharge,1
d,positive,type 2 tumor,1
d,positive,well-differentiated adenocarcinoma,1
d,positive,direct invasion,1
d,positive,metastasis to lymph node 253 and the left side,1
d,positive,lateral lymph node,1
d,positive,highly advanced sigmoid colon cancer,1
d,positive,moderately to poorly differentiated adenocarcinoma,1
d,positive,locally advanced rectal cancer,1
d,positive,"abdominal pain, nausea, and vomiting",1
d,positive,colonic gas with dilatation,1
d,positive,circumferential mass,1
d,positive,Adenocarcinoma,1
d,positive,primary tumor,1
d,positive,regional lymph nodes,1
d,positive,scar stenosis,1
d,positive,abnormal small bowel vessels,1
d,positive,rectal bleeding,1
d,positive,ruptured vessel,1
d,positive,abnormal vessels,1
d,positive,schizophrenia,1
d,positive,"fever, abdominal distension, and vomiting",1
d,positive,influenza A,1
d,positive,abdominal tenderness,1
d,positive,mobile appendix,1
d,positive,complete obstruction,1
d,positive,band,1
d,positive,strangulating,1
d,positive,complications of appendicitis,1
d,positive,strangulated ileus due to,1
d,positive,idiopathic retroperitoneal hematoma,1
d,positive,retroperitoneal mass,1
d,positive,gallbladder stones,2
d,positive,drain,1
d,positive,gallbladder stone disease and retroperitoneal tumor,1
d,positive,retroperitoneal tumor,1
d,positive,hematoma,2
d,positive,uric acid-containing stones,1
d,positive,calcium stone,1
d,positive,pure uric acid stones,1
d,positive,mixed uric acid and Ca stones,1
d,positive,Ca stone,2
d,positive,uric acid stone,1
d,positive,aggravated,1
d,positive,Ca stones,1
d,positive,hydronephrosis,2
d,positive,thinning,1
d,positive,benign prostatic hyperplasia (BPH),2
d,positive,BPH,1
d,positive,urinary retention,1
d,positive,benign prostatic hyperplasia,1
d,positive,Urinary retention,1
d,positive,bladder cancer and lung cancer,2
d,positive,primary tumors,1
d,positive,bladder cancer,3
d,positive,previous cancer,1
d,positive,bladder cancers,1
d,positive,urothelial carcinoma,1
d,positive,Bladder cancer,1
d,positive,late-stage cancer,1
d,positive,advanced cancer,1
d,positive,non-muscle invasive cancer,1
d,positive,lightheadedness and gross hematuria,1
d,positive,blood flow,1
d,positive,bladder tumor,1
d,positive,Gross hematuria,2
d,positive,superficial bladder cancer,1
t-test,executed,CT scan and bronchoscopy,1
t-test,executed,blood work,2
t-test,executed,contrast enhanced computed tomography (CECT),1
t-test,executed,liver tumor biopsy,1
t-test,executed,blood culture,1
t-test,executed,EOB-MRI,1
t-test,executed,CT scan,9
t-test,executed,CT and MRCP,1
t-test,executed,liver biopsy,13
t-test,executed,Blood biochemical tests,1
t-test,executed,MRCP and ERC,1
t-test,executed,immune checkpoint inhibitor,1
t-test,executed,blood test,9
t-test,executed,hepatitis virus and autoantibody tests,1
t-test,executed,Abdominal echography,1
t-test,executed,Contrast-enhanced computed tomography (CECT) of the abdomen,2
t-test,executed,blood sample taken,2
t-test,executed,Blood samples taken,1
t-test,executed,Echocardiography,1
t-test,executed,CT,13
t-test,executed,bone marrow biopsy,1
t-test,executed,"Various blood tests, imaging studies and histological examinations",1
t-test,executed,Contrast CT scan,1
t-test,executed,Blood test,2
t-test,executed,peripheral blood smear,1
t-test,executed,Percutaneous liver biopsy,1
t-test,executed,head MRI,1
t-test,executed,Abdominal echocardiography,1
t-test,executed,Doppler,1
t-test,executed,Contrast-enhanced CT scan,2
t-test,executed,Portal angiography,1
t-test,executed,abdominal echo and contrast CT scan,1
t-test,executed,Blood chemistry test,1
t-test,executed,Upper endoscopy,1
t-test,executed,upper endoscopy and abdominal imaging examinations,1
t-test,executed,Contrast-enhanced computed tomography (CECT),1
t-test,executed,upper endoscopy,1
t-test,executed,Biochemical Laboratory Blood Test,1
t-test,executed,Imaging,1
t-test,executed,dynamic CT scan,1
t-test,executed,Doppler ultrasonography,1
t-test,executed,FibroScan,1
t-test,executed,balloon occlusion test,1
t-test,executed,physical examination which included various blood tests,1
t-test,executed,dynamic computed tomography of the abdomen,1
t-test,executed,MRCP examination,1
t-test,executed,Transarterial portal venography (CT),1
t-test,executed,hepatic arteriographic CT scan,1
t-test,executed,measured,1
t-test,executed,Upper gastrointestinal endoscopy,2
t-test,executed,Chest X-rays and abdominal CT scans,1
t-test,executed,chest X-ray,2
t-test,executed,endoscopic examinations,1
t-test,executed,Blood tests,5
t-test,executed,Contrast-enhanced CT and abdominal ultrasonography,1
t-test,executed,imaging,1
t-test,executed,which,1
t-test,executed,Azan,1
t-test,executed,blood tests,3
t-test,executed,Abdominal US,1
t-test,executed,Penicillamine Challenge Test,1
t-test,executed,percutaneous liver biopsy,1
t-test,executed,ATP-7B gene test,1
t-test,executed,"Penicillamine Challenge Test, copper level measurement in the liver tissue",1
t-test,executed,HCV RNA PCR test,1
t-test,executed,echocardiograph,1
t-test,executed,HCV RNA PCR,1
t-test,executed,upper gastrointestinal endoscopy,5
t-test,executed,MRI of the lower leg,1
t-test,executed,Blood cultures,1
t-test,executed,autopsy,2
t-test,executed,laparoscopic liver biopsy,1
t-test,executed,laparoscopic direct cholangiography,1
t-test,executed,Liver Wedge Biopsy,1
t-test,executed,oral trans-static cholecysto-cholangiography,1
t-test,executed,liver biopsies,1
t-test,executed,cholecystogram and duodenal fluid levels,1
t-test,executed,E2 test,1
t-test,executed,the radioimmunosorbent test (Rharmacia),1
t-test,executed,chest MRI,2
t-test,executed,PET-CT,4
t-test,executed,CT angiogram of the chest,1
t-test,executed,contrast-enhanced CT scan of the chest,1
t-test,executed,thoracoscopic examination,1
t-test,executed,chest contrast CT,1
t-test,executed,Bronchoscopy,1
t-test,executed,Venous ultrasonography,1
t-test,executed,Blood coagulation tests,2
t-test,executed,angiography,2
t-test,executed,echo and CT,1
t-test,executed,Cholangiography,1
t-test,executed,endoscopy,3
t-test,executed,endoscopic,1
t-test,executed,fetal diagnosis,1
t-test,executed,FibroScan 502,3
t-test,executed,measures the elasticity,1
t-test,executed,histopathological examination,1
t-test,executed,general clinical examination,1
t-test,executed,drug-induced lymphocyte stimulation test and patch test,1
t-test,executed,Oral Provocation study,1
t-test,executed,Biopsy,3
t-test,executed,local cold tolerance test,1
t-test,executed,Passive transfer test,1
t-test,executed,muscle biopsy and electromyography,1
t-test,executed,abdominal CT,4
t-test,executed,biopsies,1
t-test,executed,2D immunoblotting,1
t-test,executed,RA test,1
t-test,executed,Parotid gland angiography,1
t-test,executed,minor salivary gland biopsy,1
t-test,executed,gum test,1
t-test,executed,Direct fluorescent antibody,1
t-test,executed,skin biopsy on the extensor side of the forearm,1
t-test,executed,biopsy of the lymph nodes,1
t-test,executed,needle biopsy,2
t-test,executed,biopsy,18
t-test,executed,direct fluorescent antibody test,2
t-test,executed,indirect fluorescent antibody test,1
t-test,executed,Direct Fluorescent Antibody test,1
t-test,executed,head X-ray,1
t-test,executed,general blood and urine,1
t-test,executed,"patch test, an intradermal test and a drug-induced lymphocyte stimulation test",1
t-test,executed,"as a trial, the same medication was administered again",1
t-test,executed,skin biopsy,2
t-test,executed,lymph node biopsy,1
t-test,executed,tested orally,1
t-test,executed,Tuberculin reaction,1
t-test,executed,simple chest X-ray,1
t-test,executed,Ts reaction,1
t-test,executed,Abdominal CT,2
t-test,executed,gastric biopsy,2
t-test,executed,blood work and a liver biopsy,1
t-test,executed,direct fluorescence antibody test,1
t-test,executed,Van Gieson's stain,1
t-test,executed,Closed patch test,1
t-test,executed,photo-patch test (UVA Toshiba FL-20S ),1
t-test,executed,the internal radiation test,1
t-test,executed,lymphocyte stimulation test,1
t-test,executed,patch test,1
t-test,executed,"same photopatch test (UVA 8.4 J/c㎡, MED or below)",1
t-test,executed,Biopsies,1
t-test,executed,tuberculin reaction test,6
t-test,executed,medical checkup,2
t-test,executed,DNCB sensitization test,1
t-test,executed,Riboprotein analysis,1
t-test,executed,EKG,1
t-test,executed,Chest CT Scan,1
t-test,executed,chest CT scan,1
t-test,executed,DLST,1
t-test,executed,RAST,2
t-test,executed,HRCT,1
t-test,executed,TBLB,1
t-test,executed,sedimentation antibody,1
t-test,executed,homecoming provocation test,1
t-test,executed,Exercise-induced tests,1
t-test,executed,prick test,1
t-test,executed,intradermal test,3
t-test,executed,ice cube test,2
t-test,executed,heat stress test,3
t-test,executed,biochemical tests,3
t-test,executed,Intradermal tests,1
t-test,executed,patch tests,1
t-test,executed,Contrast-enhanced computed tomography (CT) of the abdomen,3
t-test,executed,blood samples,2
t-test,executed,Lower gastrointestinal endoscopy,2
t-test,executed,Colonoscopy,2
t-test,executed,FIM,2
t-test,executed,PEM,2
t-test,executed,medical examination,2
t-test,executed,breast ultrasonography,1
t-test,executed,cytology,2
t-test,executed,MMG,1
t-test,executed,MUS,1
t-test,executed,Contrast-enhanced MRI,1
t-test,executed,Contrast-enhanced MMG,1
t-test,executed,puncture aspiration cytology,1
t-test,executed,sentinel lymph node biopsy (SN),1
t-test,executed,Double-balloon endoscopy,1
t-test,executed,lower gastrointestinal endoscopy,1
t-test,executed,CF,3
t-test,executed,enteroscopy,1
t-test,executed,PET and CT scans,1
t-test,executed,blood draw,1
t-test,executed,Biochemistry,1
t-test,executed,CT and abdominal Echo,1
t-test,executed,colonoscopy and biopsy,1
t-test,executed,follow-up CT scan,2
t-test,executed,Abdominal computed tomography (CT) scan,1
t-test,executed,Endoscopically,1
t-test,executed,Blood sampling,1
t-test,executed,CMV antigenemia,1
t-test,executed,75gOGTT,1
t-test,executed,Abdominal CT and US,1
t-test,executed,ERCP,1
t-test,executed,MRCP,1
t-test,executed,pancreatic ductography,1
t-test,executed,Abdominal ultrasonography,2
t-test,executed,ERC,1
t-test,executed,Contrast-enhanced radiography,1
t-test,executed,contrast-enhanced CT scan of the abdomen,2
t-test,executed,contrast-enhanced CT of the abdomen,1
t-test,executed,abdominal ultrasonography,1
t-test,executed,cardiac catheterization,1
t-test,executed,thorough gastrointestinal examination,1
t-test,executed,Computed tomography (CT) of the abdomen,1
t-test,executed,ultrasound (US) and CT,1
t-test,executed,US,1
t-test,executed,CT and PET scan of the thorax,1
t-test,executed,contrast-enhanced CT scan,2
t-test,executed,3D-CT,1
t-test,executed,coronary angiography,1
t-test,executed,Abdominal CT and emergency endoscopy,1
t-test,executed,simple abdominal CT,1
t-test,executed,abdominal contrast-enhanced CT,1
t-test,executed,Gastrointestinal endoscopy and fluoroscopy,1
t-test,executed,scintigraphy,1
t-test,executed,rapid,1
t-test,executed,ascites cytology,1
t-test,executed,imaging studies,1
t-test,executed,sigmoidoscopy,1
t-test,executed,Rectal biopsy,1
t-test,executed,Ascitic fluid cytology,1
t-test,executed,Simple abdominal computed tomography (CT),1
t-test,executed,CT scan of the abdomen,2
t-test,executed,vaginal speculum examination,1
t-test,executed,biopsied,1
t-test,executed,Bowel endoscopy,1
t-test,executed,MRI,2
t-test,executed,Abdominal radiography,1
t-test,executed,abdominal CT scan,1
t-test,executed,lower gastrointestinal endoscopy (CF),1
t-test,executed,contrast-enhanced CT abdomen,1
t-test,executed,physical examination,1
t-test,executed,transrectal prostate biopsy,1
t-test,executed,ultrasonography,1
t-test,executed,subjective symptom score,1
t-test,executed,urine flow rate and residual urine measurement,1
t-test,executed,PSA measurement,1
t-test,executed,Abdominal pelvic CT,1
t-test,executed,Doppler echocardiography,1
timex3,date,Then,2
timex3,date,same time,5
timex3,date,2 months later,3
timex3,date,3 months later,1
timex3,date,In recent years,2
timex3,date,in recent years,1
timex3,date,this study,17
timex3,date,1 year ago,1
timex3,date,After 3 weeks,1
timex3,date,4 weeks later,1
timex3,date,second,2
timex3,date,first,4
timex3,date,"Thereafter,",1
timex3,date,this report,4
timex3,date,2014,1
timex3,date,Here,10
timex3,date,"June, 1 year before 20XX",1
timex3,date,"Subsequently,",1
timex3,date,"November, 1 year before 20XX",1
timex3,date,January 20XX,2
timex3,date,"late February 20XX,",1
timex3,date,mid-March,1
timex3,date,In early April 20XX,1
timex3,date,3 days later,1
timex3,date,from the 4th day,1
timex3,date,49 days after her illness commenced,1
timex3,date,this,7
timex3,date,Later,4
timex3,date,future,3
timex3,date,"On December 19, 201X",1
timex3,date,"on January 22, one year after 201X",1
timex3,date,one week later,1
timex3,date,same day,10
timex3,date,After 1 week,1
timex3,date,November 201X,1
timex3,date,in December,1
timex3,date,afterwards,2
timex3,date,approximately 2 months time,1
timex3,date,2 years before 20XX,1
timex3,date,"August, 20XX",2
timex3,date,On September 9,1
timex3,date,on September 10 ,1
timex3,date,September 17,1
timex3,date,September 24,1
timex3,date,2 days later,1
timex3,date,October 1,1
timex3,date,on October 6,1
timex3,date,October 27,1
timex3,date,Since then,3
timex3,date,here,1
timex3,date,"in March, 20XX",1
timex3,date,At that time,2
timex3,date,"From that time forward,",1
timex3,date,"in October, 20XX",1
timex3,date,1964,1
timex3,date,and,4
timex3,date,11 years before 20XX,1
timex3,date,one year before 20XX,2
timex3,date,"December 11, one year before 20XX",1
timex3,date,Thereafter,5
timex3,date,"On December 11, one year before 20XX",1
timex3,date,"on January 8,  20XX",1
timex3,date,From then on,2
timex3,date,At this juncture,1
timex3,date,on March 1,1
timex3,date,Recently,1
timex3,date,approximately the past 5 years,1
timex3,date,Initially,3
timex3,date,While,1
timex3,date,following day,4
timex3,date,in 20XX,1
timex3,date,3 years after 20XX,1
timex3,date,approximately one month,1
timex3,date,then,6
timex3,date,5 years before 20XX,3
timex3,date,Every year,1
timex3,date,"December, 20XX",1
timex3,date,"May, 20XX",1
timex3,date,9 years before 20XX,1
timex3,date,subsequent,1
timex3,date,the future,1
timex3,date,in August 20XX,1
timex3,date,third day,1
timex3,date,followed by,1
timex3,date,earlier,1
timex3,date,at the time,1
timex3,date,July 20XX,1
timex3,date,recent years,5
timex3,date,Following,1
timex3,date,after one year,1
timex3,date,early 2019,1
timex3,date,previous,1
timex3,date,next day,3
timex3,date,Afterwards,1
timex3,date,third week,2
timex3,date,6th week,1
timex3,date,early stage,1
timex3,date,7th day,1
timex3,date,9th day,1
timex3,date,14th day,2
timex3,date,15th day,1
timex3,date,15th day of the illness,1
timex3,date,29th day of the illness,1
timex3,date,36th day of the illness,1
timex3,date,This time,3
timex3,date,2 years prior,1
timex3,date,Subsequently,10
timex3,date,S.44.3.27,1
timex3,date,second (S.45.2.8),1
timex3,date,third (S.47.6.8),1
timex3,date,S.48.11.28,1
timex3,date,1969,1
timex3,date,1974,1
timex3,date,next,2
timex3,date,1968,1
timex3,date,this time,2
timex3,date,4 years ago,1
timex3,date,3 years ago,4
timex3,date,2 years ago,1
timex3,date,present study,3
timex3,date,2012,2
timex3,date,June 1990,2
timex3,date,end of August 2010,1
timex3,date,foreseeable future,1
timex3,date,approximately 6 months later,1
timex3,date,thereafter,1
timex3,date,From 4 months ago,1
timex3,date,this ,1
timex3,date,subsequently,1
timex3,date,After 1 month,1
timex3,date,in 2005,1
timex3,date,"July 2, 1990",1
timex3,date,in September 1987,1
timex3,date,November 11,1
timex3,date,November 19 of the same year,1
timex3,date,Around the same time,1
timex3,date,winter,1
timex3,date,after that,2
timex3,date,every year around the end of September,1
timex3,date,the end of October,1
timex3,date,July,3
timex3,date,winter months,1
timex3,date,about 2 weeks before,1
timex3,date,this point,1
timex3,date,the first month,1
timex3,date,"February 2, 1990",1
timex3,date,summer of 1989,1
timex3,date,by the end of the year,1
timex3,date,"On April 4, 1990",1
timex3,date,mid-June,1
timex3,date,mid-July,1
timex3,date,August,1
timex3,date,13 years,1
timex3,date,previous seven years,1
timex3,date,At this time,2
timex3,date,September 26,1
timex3,date,about 2 years,1
timex3,date,Three months ago,2
timex3,date,1988,2
timex3,date,July 1991,2
timex3,date,January 1990,1
timex3,date,end of June,1
timex3,date,on July 2,1
timex3,date,on October 3,1
timex3,date,around September 1989,1
timex3,date,"on March 28, 1990",1
timex3,date,fifth day,2
timex3,date,after two months,1
timex3,date,"March 28, 1990",2
timex3,date,Around October 1985,1
timex3,date,around June of the following year,1
timex3,date,Every winter after that,1
timex3,date,In 1988,1
timex3,date,fall of 1989,1
timex3,date,Four years ago,1
timex3,date,previously,1
timex3,date,"August 2, 1989",1
timex3,date,July 21,1
timex3,date,August 1,1
timex3,date,August 2,2
timex3,date,"May 17th, 1990",1
timex3,date,At the beginning of June,1
timex3,date,June 8,1
timex3,date,12th,1
timex3,date,18th,1
timex3,date,after around 2 weeks,1
timex3,date,late July,1
timex3,date,Recent years,1
timex3,date,August 1985,2
timex3,date,September 1989,1
timex3,date,July of the following year,1
timex3,date,May 1979,1
timex3,date,1987,1
timex3,date,From around January 1990,1
timex3,date,two months prior,1
timex3,date,"January 20, 1990",1
timex3,date,Approximately 50 years ago,1
timex3,date,In June 1989,1
timex3,date,February 1989,1
timex3,date,at age 13,1
timex3,date,December 1988,1
timex3,date,In 1990,1
timex3,date,around 1965,1
timex3,date,around 1984,1
timex3,date,One week later,1
timex3,date,"January 29, 1988",1
timex3,date,"March 18, 1988",1
timex3,date,May 26,1
timex3,date,from about 2 months ago,1
timex3,date,September 1988,5
timex3,date,approx. the past 7 years,1
timex3,date,5 years ago,2
timex3,date,December of the same year,2
timex3,date,"July 9, 1960",1
timex3,date,From around 1955,1
timex3,date,After a few months,1
timex3,date,In 1959,1
timex3,date,November of the same year,1
timex3,date,August 1987,1
timex3,date,1960s,1
timex3,date,"the future,",1
timex3,date,1970,1
timex3,date,1986,1
timex3,date,1976,1
timex3,date,1978,2
timex3,date,"January 28, 1986",1
timex3,date,1973,1
timex3,date,1983,1
timex3,date,January 1986,1
timex3,date,"November 9, 1984",1
timex3,date,August 1983,1
timex3,date,Six months later,1
timex3,date,November 1984,1
timex3,date,July 1988,1
timex3,date,October 1988,1
timex3,date,"March 14, 1987",1
timex3,date,Two months prior,1
timex3,date,"July 20, 1988",1
timex3,date,March 1983,1
timex3,date,In March 1988,1
timex3,date,two months before,1
timex3,date,From some time ago,1
timex3,date,some time,1
timex3,date,Last year,1
timex3,date,long,1
timex3,date,March 1986,1
timex3,date,June of the same year,1
timex3,date,towards the end of November 1992,1
timex3,date,On December 7,1
timex3,date,the next day (December 8),1
timex3,date,following day (December 9),1
timex3,date,Later on,1
timex3,date,(December 29),1
timex3,date,our times,1
timex3,date,As of today,1
timex3,date,January 2001,1
timex3,date,On May 2,1
timex3,date,May 24,1
timex3,date,on June 4,1
timex3,date,On June 17,1
timex3,date,April 2001,1
timex3,date,on April 20,1
timex3,date,July 6,1
timex3,date,July 23,1
timex3,date,August 3,1
timex3,date,August 20,1
timex3,date,in 2007,1
timex3,date,2007,1
timex3,date,at the end of September,1
timex3,date,one month after,1
timex3,date,two months after,1
timex3,date,spring,1
timex3,date,early summer,1
timex3,date,used to,1
timex3,date,Five years ago,1
timex3,date,mid-December 2009,1
timex3,date,mid-January,1
timex3,date,day after,1
timex3,date,days later,1
timex3,date,"Later, in the first third of February",1
timex3,date,"following day,",1
timex3,date,2008,1
timex3,date,10th day,2
timex3,date,1991,1
timex3,date,5 years,2
timex3,date,September 2012,2
timex3,date,January 2013,1
timex3,date,further,1
timex3,date,always,1
timex3,date,2 years,1
timex3,date,2 months,1
timex3,date,5 days,1
timex3,date,on the 10th postoperative day,1
timex3,date,19th day,1
timex3,date,21st day,1
timex3,date,the 26th day of illness,1
timex3,date,the 33rd day of illness,1
timex3,date,on 53rd day of illness,1
timex3,date,75th day of sickness,1
timex3,date,44th day of sickness,1
timex3,date,65th day,1
timex3,date,85th day of illness,1
timex3,date,99th day,1
timex3,date,In this report,3
timex3,date,in the middle of May 201X,1
timex3,date,in early June,1
timex3,date,6th day of illness,1
timex3,date,October 2009,1
timex3,date,March 2012,1
timex3,date,May of the same year,1
timex3,date,after the first operation,1
timex3,date,initial,1
timex3,date,We,7
timex3,date,"In this report,",1
timex3,date,June 2012,1
timex3,date,14 years ago,2
timex3,date,report,1
timex3,date,"December, 2006",1
timex3,date,In May 2007,1
timex3,date,January 2008.,1
timex3,date,postoperative,2
timex3,date,December 2012,2
timex3,date,in January 2013,1
timex3,date,Two months later,1
timex3,date,A year and a half later,1
timex3,date,three years ago,1
timex3,date,November 2011,1
timex3,date,In this case,1
timex3,date,December 2010,1
timex3,date,eosinophilic colitis,1
timex3,date,two weeks,1
timex3,date,end of the year,1
timex3,date,January 2006,1
timex3,date,after,1
timex3,date,January 2011,1
timex3,date,on February 1 of the same year,1
timex3,date,"on May 28, 2012",1
timex3,date,on August 10,1
timex3,date,7 years ago,1
timex3,date,five years,1
timex3,date,6 years,1
timex3,date,Two years ago,1
timex3,date,"This time,",1
timex3,date,six months ago,1
timex3,date,May 2012,2
timex3,date,"Later,",1
timex3,date,11th day,1
timex3,date,Two days after,1
timex3,date,"this report,",1
timex3,date,July 2012,1
timex3,date,20 years ago,2
timex3,date,10 years ago,1
timex3,date,September 2011,1
timex3,date,the day before,1
timex3,date,the 1980s,1
timex3,date,27th day,1
timex3,date,In this article,1
timex3,date,ninth sick day,1
timex3,date,After that,2
timex3,date,since then,1
timex3,date,In 1998,1
timex3,date,15th day of the disease,1
timex3,date,1994,1
timex3,date,2006,1
timex3,date,"November 2012,",1
timex3,date,February of the same year,1
timex3,date,Thirty years ago,1
timex3,date,We report here,1
timex3,date,3 months,1
timex3,date,day 1),2
timex3,date,days 1-5,1
timex3,date,2010,1
timex3,date,have,1
timex3,date,third sick day,1
timex3,date,We report a case,1
timex3,date,May 1986,1
timex3,date,October 1990,1
timex3,date,March 2008,1
timex3,date,September 2008,1
timex3,date,initially,1
timex3,date,Previous,1
timex3,date,"On May 15, 2007",1
timex3,date,"On May 16,",1
timex3,date,May 17,1
timex3,date,June 29,1
timex3,date,this article,1
r,executed,durvalumab (anti-PD-L1 antibody),1
r,executed,maintenance therapy,1
r,executed,radiochemotherapy (S-1 + CDDP),1
r,executed,radiotherapy,1
r,executed,radiochemotherapy,6
r,executed,pylorus-preserving gastrectomy,1
r,executed,3rd line chemotherapy,1
r,executed,second-line,1
r,executed,Systematic chemotherapy,1
r,executed,resected,5
r,executed,up to 15 courses,1
r,executed,second course was administered,1
r,executed,steroid pulse therapy,1
r,executed,pulse therapy and steroids,1
r,executed,steroid pulse therapy (500 mg/day),1
r,executed,pulsed steroid therapy,1
r,executed,PSL pulse therapy,1
r,executed,nutritional therapy,1
r,executed,blood transfusion,4
r,executed,"Blood transfusions, plasma filtration with dialysis",1
r,executed,continuous intravenous,1
r,executed,ventilatory management,1
r,executed,percutaneous transhepatic obliteration (PTO),1
r,executed,PTO,1
r,executed,obliterate,1
r,executed,percutaneous transhepatic obliteration,1
r,executed,IFN treatment,1
r,executed,TAVI procedure,1
r,executed,TAVI,1
r,executed,conservative treatment,6
r,executed,Percutaneous transhepatic obliteration,1
r,executed,fluid management,1
r,executed,shunt obliteration,1
r,executed,obliteration,2
r,executed,AmplatzerTM Vascular Plug,1
r,executed,intravenous,3
r,executed,splenorenal shunt occlusion,1
r,executed,obliterated with an AmplatzerTM Vascular Plug,1
r,executed,Obliteration using a vascular plug,1
r,executed,vascular plug,1
r,executed,PSE,3
r,executed,BRTO,5
r,executed,Endoscopic sclerotherapy for varicose veins,1
r,executed,embolism,1
r,executed,emergency splenectomy and umbilical vein ligation,1
r,executed,Percutaneous microwave ablation,1
r,executed,sofosbuvir and regipasvir,1
r,executed,extrahepatic shunt ligation and splenectomy,1
r,executed,laparotomy,7
r,executed,percutaneous localized therapy,1
r,executed,antiviral therapy,1
r,executed,surgical treatment,1
r,executed,EIS,1
r,executed,resuscitation,1
r,executed,Hemostatsis therapy,1
r,executed,fluid replacement,1
r,executed,thoracoscopic excisional biopsy,3
r,executed,breast reconstruction implant,1
r,executed,reconstruction,1
r,executed,papilloplasty,1
r,executed,right mastectomy,1
r,executed,implant,1
r,executed,surgery,16
r,executed,Thoracoscopic,1
r,executed,combined resection,2
r,executed,thoracoscopic resection,1
r,executed,breast implant reconstruction,1
r,executed,thoracoscopic surgery,1
r,executed,"right thoracic esophageal subtotal resection, two-region dissection and gastric tube reconstruction with posterior mediastinal and cervical anastomosis",1
r,executed,operative,3
r,executed,chest operation,1
r,executed,Antibiotics were administered and the level of physical therapy was increased,1
r,executed,Manual insufflation,1
r,executed,IVC filter,1
r,executed,emergency surgery,6
r,executed,chest was opened,1
r,executed,detached,3
r,executed,dissected,4
r,executed,dissect the lung parenchyma,1
r,executed,lung ventilation,1
r,executed,ventilator,1
r,executed,assist sputum expectoration,1
r,executed,ventilator (Trilogy 100),1
r,executed,voice and physical touch,2
r,executed,postural drainage,1
r,executed,assisted cough physiotherapy to improve sputum expectoration,1
r,executed,thorax expansion exercises and squeezing physiotherapy,1
r,executed,transplant,7
r,executed,"Endoscopic treatment, e.g. sclerotherapy and ligation",1
r,executed,S-B tubes,1
r,executed,"conservative treatment, e.g. fasting and blood transfusion",1
r,executed,shut off,1
r,executed,dissecting,1
r,executed,living donor liver transplant,2
r,executed,hepatoportoenterostomy,1
r,executed,hospitalized,1
r,executed,reanastomosis,1
r,executed,psychiatric treatment,1
r,executed,Psychiatric treatment (pyschopharmacotherapy and psychotherapy),1
r,executed,psychological counseling,1
r,executed,psychotherapy,1
r,executed,radical esophagectomy,1
r,executed,gastrostomy tube infusion,1
r,executed,one-shot injection,1
r,executed,gastrostomy tube,1
r,executed,one-shot infusion,1
r,executed,resection,9
r,executed,chemotherapy,13
r,executed,steroids,1
r,executed,another laparotomy,1
r,executed,surgically removed,1
r,executed,intravenous CsA therapy,1
r,executed,intravenous FK506 therapy,1
r,executed,Intravenous,1
r,executed,continuous intravenous infusion,2
r,executed,oral,1
r,executed,nutritional guidance,1
r,executed,Nutritional Counseling,2
r,executed,ostomy pouch,2
r,executed,bowel resection and stoma construction,1
r,executed,Fluid intake level and stoma management,1
r,executed,nursing care/support for when the patient was out of doors,1
r,executed,radical surgery,3
r,executed,colostomy,4
r,executed,intragastric decompression via a nasogastric tube,1
r,executed,reduced jaundice,1
r,executed,take oral,1
r,executed,surgical,1
r,executed,FAMT therapy,1
r,executed,excision,2
r,executed,surgery and chemotherapy,1
r,executed,high-dose steroid therapy,1
r,executed,Pericardiocentesis,1
r,executed,pulse therapy,3
r,executed,re-administration,1
r,executed,intravenously,1
r,executed,PUVA therapy,1
r,executed,cobalt irradiation,1
r,executed,VEPA therapy,1
r,executed,electron beam irradiation,1
r,executed,systemic administration,2
r,executed,insulin,1
r,executed,pneumonectomy,1
r,executed,topical therapy,1
r,executed,topical PUVA therapy,2
r,executed,PUVA,1
r,executed,irradiation,1
r,executed,full-thickness transplant,1
r,executed,BD inhaler,1
r,executed,emergency cardiac catheterization,1
r,executed,IV infusion,1
r,executed,mPSL pulse therapy,1
r,executed,gastric tube,1
r,executed,central venous feeding,1
r,executed,tube feeding,1
r,executed,with oral therapy,1
r,executed,treated conservatively,1
r,executed,laparoscopic ileal resection,1
r,executed,laparoscopy-assisted ileocecal resection,2
r,executed,Surgery,4
r,executed,FEEA,1
r,executed,DST,1
r,executed,anti-TNF-α antibody treatment,1
r,executed,Hartmann operation,1
r,executed,TPN management,1
r,executed,NST intervention,2
r,executed,nasogastric tube,1
r,executed,continuously administered to,1
r,executed,rehabilitation,2
r,executed,drains,3
r,executed,catheters,1
r,executed,TPN,2
r,executed,insertion of drains and catheters,1
r,executed,EN management,1
r,executed,EN + TPN,1
r,executed,oral surgical approach,1
r,executed,bilateral ureteral stents,1
r,executed,right nephrostomy,1
r,executed,hysterectomy,1
r,executed,hemicolectomy,2
r,executed,excised,1
r,executed,mastectomy,1
r,executed,partial,4
r,executed,Bp,1
r,executed,adjuvant therapy,2
r,executed,radiation,2
r,executed,breast-conserving surgery,1
r,executed,LADG,1
r,executed,partial resection,3
r,executed,colorectal,1
r,executed,mFOLFOX6,4
r,executed,total,7
r,executed,rectus abdominis skin-fat valve formation,1
r,executed,ileal conduit construction,1
r,executed,"mFOLFOX6 + Bev,",1
r,executed,partial hepatectomy,1
r,executed,FOLFIRI plus Bev,1
r,executed,hemijejunostomy,1
r,executed,D3 dissection,2
r,executed,low anterior resection,1
r,executed,LV + 5FU,1
r,executed,thoracoscopic partial resection of the right upper lobe of the lung,1
r,executed,SOX,1
r,executed,panitumumab plus CPT-11 combination therapy,1
r,executed,bevacizumab based XELOX,1
r,executed,Bevacizumab based XELOX,2
r,executed,chemotherapy for cancer,1
r,executed,amputation,1
r,executed,UFT/LV therapy,1
r,executed,bevacizumab plus FOLFIRI,1
r,executed,panitumumab plus FOLFIRI,1
r,executed,emergency surgical,1
r,executed,resection and anastomosis,1
r,executed,D2 dissection,3
r,executed,end-to-end anastomosis,1
r,executed,closed,1
r,executed,subtotal colectomy,1
r,executed,anticancer drug therapy,1
r,executed,steroid therapy,1
r,executed,anticancer therapy,1
r,executed,PpPD,1
r,executed,perform,1
r,executed,Total,1
r,executed,autologous pancreas transplantation,1
r,executed,treated with intravenous therapy,1
r,executed,Endoscopic treatment,1
r,executed,ERCP,2
r,executed,ENPD implantation,1
r,executed,ENPD,1
r,executed,EUS,1
r,executed,rendezvous technique,1
r,executed,Frey's operation,1
r,executed,anastomosis lateral to the of the pancreatic duct jejunum,1
r,executed,4-OPDS continuous 1-layer suture,1
r,executed,3-0 bicryl node 2-layer suture,1
r,executed,Roux-en Y anastomosis,1
r,executed,Frey operation,1
r,executed,diversion surgery,2
r,executed,transpapillary lithotripsy of the common bile duct,1
r,executed,cholecystectomy and extrahepatic biliary resection and reconstruction,1
r,executed,removal,10
r,executed,temporary inferior vena cava filter,3
r,executed,radiation therapy,1
r,executed,heparin replacement,1
r,executed,laparoscopic cholecystectomy,3
r,executed,operation,3
r,executed,temporary inferior vena cava filtering,1
r,executed,removed,4
r,executed,Laparoscopic cholecystectomy,2
r,executed,ascites drainage,1
r,executed,underwent,1
r,executed,oophorectomy,1
r,executed,anticoagulation,1
r,executed,ERBD tube,1
r,executed,anticoagulant,1
r,executed,operated,1
r,executed,laparoscopically,4
r,executed,detachment of the adhesions,2
r,executed,ligation and dissection,1
r,executed,covering,1
r,executed,drain,2
r,executed,metallisolar stent,1
r,executed,internal slimming,1
r,executed,lavage drainage,1
r,executed,a ventriculoperitoneal shunt,1
r,executed,ventriculoperitoneal shunt,1
r,executed,shunt tube,1
r,executed,Penrose drain,1
r,executed,laparoscopic anterior resection,1
r,executed,simple total hysterectomy,1
r,executed,transfused,1
r,executed,laparoscopic anterior,1
r,executed,curative surgery,1
r,executed,speculum surgery,1
r,executed,tomy,2
r,executed,suture repair,1
r,executed,additional treatment,2
r,executed,EVAR,1
r,executed,US and CT-guided percutaneous abdominal aortic aneurysm puncture and embolization,1
r,executed,stent graft insertion,1
r,executed,thoracoscopy-assisted subtotal esophagectomy,1
r,executed,Miles' operation,1
r,executed,adjuvant chemotherapy,1
r,executed,open cholecystectomy,1
r,executed,EMR,1
r,executed,"splenectomy, D2 dissection, and Roux-Y reconstruction",1
r,executed,dissection,2
r,executed,after CABG,1
r,executed,CABG,1
r,executed,total removal,2
r,executed,dissection D1,1
r,executed,Roux-en-Y reconstruction,1
r,executed,surgical manipulation,1
r,executed,cured,1
r,executed,elective surgery,1
r,executed,Surgical,1
r,executed,Roux-Y reconstruction,1
r,executed,removing,1
r,executed,gastrectomy,3
r,executed,Billroth-1 gastrectomy,1
r,executed,fasting and intravenous fluids,1
r,executed,crushed,1
r,executed,endoscopic,1
r,executed,radical,1
r,executed,anterior sternal pathway gastric tube reconstruction,1
r,executed,sentinel node navigation,1
r,executed,segmental resection,1
r,executed,PR,1
r,executed,systemic chemotherapy,2
r,executed,arterial reservoir,1
r,executed,Total ,1
r,executed,APR,1
r,executed,palliative operation,1
r,executed,DO dissection,1
r,executed,combined,2
r,executed,surgery with right thoracotomy-opening esophagectomy for gastric tube reconstruction,1
r,executed,D3 resection,1
r,executed,adjuvant surgery,1
r,executed,S-1/CDDP therapy,1
r,executed,transverse colon twin-hole colostomy,1
r,executed,curative resection,1
r,executed,curatively,1
r,executed,given,1
r,executed,fixed,1
r,executed,chemoradiation,1
r,executed,low anterior rectal resection,1
r,executed,upper D3 and left lateral dissection,1
r,executed,transanal ileus tube,1
r,executed,ileal colostomy,1
r,executed,mFOLFOX6 therapy,1
r,executed,laparoscopic low anterior resection,1
r,executed,IVR,3
r,executed,small,1
r,executed,embolized,1
r,executed,microcoils,1
r,executed,Hemostasis and marking,1
r,executed,small laparotomy,1
r,executed,conservative treatment with insertion of an ileus tube,1
r,executed,opening the abdomen,1
r,executed,laparoscopic removal,1
r,executed,single-hole,1
r,executed,Nephrectomy,1
r,executed,endoscope,1
r,executed,nephrectomy,1
r,executed,Ligation and amputation,1
r,executed,neraton catheter,1
r,executed,aspirate and remove,1
r,executed,nephrectomized,1
r,executed,closed wound,1
r,executed,Transumbilical nephrectomy through a small specular incision,1
r,executed,transurethral enucleation with bipolar (TUEB) ,1
r,executed,bipolar system,1
r,executed,minimally invasive procedure,1
r,executed,TUEB,2
r,executed,permanent urethral stent,2
r,executed,Temporary urethral stents,1
r,executed,Prostacus,1
r,executed,Memokath,1
r,executed,temporary urethral stent,1
r,executed,Permanent urethral stent,1
r,executed,Memotherm,1
r,executed,local anesthesia,1
r,executed,stent,2
r,executed,balloon catheter,1
r,executed,changed and reimplantation,1
r,executed,TUL and cystoscopy,1
r,executed,double stent,1
r,executed,Permanent urethral stents,1
r,executed,TUR-Bt,2
r,executed,cystectomy,1
r,executed,embolization,1
r,executed,intravesical injections,1
timex3,med,two courses,1
timex3,med,5 days after,1
timex3,med,third dose,1
timex3,med,one week after starting dosage,1
timex3,med,following,2
timex3,med,postoperative,28
timex3,med,After 3 courses,1
timex3,med,2 weeks after reducing,1
timex3,med,After increasing,1
timex3,med,Four months after starting treatment,1
timex3,med,after the medication was stopped,1
timex3,med,after recovery,1
timex3,med,when the patient was admitted to the hospital's dermatology department,1
timex3,med,after the use,1
timex3,med,transferred to our department,1
timex3,med,after several days of being on the medication,1
timex3,med,receiving outpatient treatment,1
timex3,med,2 months later,1
timex3,med,4 courses,1
timex3,med,at the end of the fifth course,1
timex3,med,On admission,4
timex3,med,After treatment,2
timex3,med,no longer administered,1
timex3,med,after discontinuing,1
timex3,med,after discontinuing the medication,1
timex3,med,After readmission,1
timex3,med,After the start of,1
timex3,med,After tapering off,1
timex3,med,During treatment,1
timex3,med,"At the time of his transfer from the previous hospital,",1
timex3,med,After discontinuation,1
timex3,med,post-operative,3
timex3,med,course,1
timex3,med,after SVR,1
timex3,med,After the treatment,2
timex3,med,is undergoing treatment,1
timex3,med,at the time of consultation,1
timex3,med,intraoperative,5
timex3,med,post treatment,1
timex3,med,receiving treatment,1
timex3,med,prior to treatment,1
timex3,med,after sustaining a SVR,1
timex3,med,both during the surgery and postoperatively,1
timex3,med,7 months post surgery,1
timex3,med,preoperative,23
timex3,med,after BRTO,1
timex3,med,during the surgery,1
timex3,med,Post surgery,1
timex3,med,18 months have already elapsed since the operation,1
timex3,med,after the operation,1
timex3,med,time of admission,3
timex3,med,5 years after,1
timex3,med,hemostatis,1
timex3,med,once the diagnosis was made,1
timex3,med,after the start of oral medication,1
timex3,med,10 years after diagnosis,1
timex3,med,during treatment,1
timex3,med,Prior,1
timex3,med,being given the new medication,1
timex3,med,prior to being given,1
timex3,med,2 months before the start of treatment,1
timex3,med,4 weeks after starting the dosage,1
timex3,med,3 weeks after starting the dosage,1
timex3,med,6 weeks after the medication had been discontinued,1
timex3,med,the day she started taking,1
timex3,med,2 days after starting the medication,1
timex3,med,After one week of taking,1
timex3,med,course of treatment,1
timex3,med,10 days after discontinuing,1
timex3,med,16 days after the discontinuation,1
timex3,med,during the course of treatment,1
timex3,med,in the early stage of medication,1
timex3,med,day before admission,1
timex3,med,Upon Admission,1
timex3,med,9th month,1
timex3,med,38 weeks gestation,1
timex3,med,6th day after delivery,1
timex3,med,After remission,1
timex3,med,after insertion,1
timex3,med,After the insertion,1
timex3,med,postoperatively,3
timex3,med,post operative,1
timex3,med,after undergoing,1
timex3,med,five days after the surgery,1
timex3,med,after the surgery,1
timex3,med,After the surgery,4
timex3,med,after removal,2
timex3,med,After preoperative chemotherapy (FP2 course),1
timex3,med,9th postoperative day,2
timex3,med,16th postoperative day,2
timex3,med,After placement,1
timex3,med,post,2
timex3,med,after the second surgery,1
timex3,med,While on the ventilator,1
timex3,med,put on,1
timex3,med,After surgery,4
timex3,med,following surgery,1
timex3,med,second day after the transplant,1
timex3,med,post-transplant,1
timex3,med,in place as,1
timex3,med,After undergoing,1
timex3,med,Following the latest surgery,1
timex3,med,After being admitted,1
timex3,med,20th day after starting,1
timex3,med,After a month of treatment,1
timex3,med,5 months after being admitted,1
timex3,med,Three months have passed since this pediatric patient was discharged from the hospital,1
timex3,med,Immediately after delivery,1
timex3,med,One week after treatment started,1
timex3,med,soon after surgery,1
timex3,med,discontinued,1
timex3,med,3 hours after treatment,1
timex3,med,After 36 hours,1
timex3,med,At the initial examination,3
timex3,med,initial examination,1
timex3,med,Postoperative,6
timex3,med,During the course of the disease,1
timex3,med,throughout the entire disease course,1
timex3,med,treatment,2
timex3,med,At admission,1
timex3,med,About one month after the start,1
timex3,med,Upon initial examination,1
timex3,med,Following the resolution,1
timex3,med,during the treatment,1
timex3,med,during the administration,2
timex3,med,time of initial examination,1
timex3,med,at the initial examination,1
timex3,med,During the course,2
timex3,med,2 weeks prior to being examined for the first time,1
timex3,med,during the monitoring of the patient's progress,1
timex3,med,tapered,1
timex3,med,4.5 months had passed since her first examination,1
timex3,med,therapy,2
timex3,med,3 months before her first visit,1
timex3,med,course of a topical,1
timex3,med,throughout the period the patient's progress was kept under observation,1
timex3,med,currently taking,1
timex3,med,2 months after she started the oral medication,1
timex3,med,after irradiation,1
timex3,med,At the time of the initial examination,1
timex3,med,At the time of admission,1
timex3,med,After being hospitalized,1
timex3,med,her progress is being monitored,1
timex3,med,considering,2
timex3,med,"At the time of the first visit,",1
timex3,med,being treated,1
timex3,med,undergoing treatment,2
timex3,med,seen at the outpatient clinic,1
timex3,med,At the time he was admitted,1
timex3,med,during tapering,2
timex3,med,upon Admission,1
timex3,med,1 month after being discharged,1
timex3,med,during the course,1
timex3,med,When admitted,1
timex3,med,after treatment,1
timex3,med,before admission,1
timex3,med,time of discharge,1
timex3,med,after induction of homecoming,1
timex3,med,After hospitalization,2
timex3,med,x Three days after return to the hospital,1
timex3,med,on admission,3
timex3,med,before treatment,1
timex3,med,after the repeated inhalation,1
timex3,med,after the repeated,1
timex3,med,About one year before the initial diagnosis,1
timex3,med,"At the time of initial examination,",1
timex3,med,Twenty-five days after referral,1
timex3,med,in the,1
timex3,med,12 months after the surgery,1
timex3,med,at Admission,1
timex3,med,ninth postoperative day,1
timex3,med,after surgery,1
timex3,med,"At the time of intervention,",1
timex3,med,21st postoperative day,1
timex3,med,at the time of admission,3
timex3,med,after tooth extraction,2
timex3,med,1 week after extraction,1
timex3,med,After the denture was made,1
timex3,med,immediately after admission,1
timex3,med,after administration,1
timex3,med,After initiation,1
timex3,med,Nine days after the start,1
timex3,med,2 days after discontinuation,1
timex3,med,after the atomisation,1
timex3,med,Two years after surgery,1
timex3,med,6 years after surgery,1
timex3,med,under endocrine therapy,1
timex3,med,Seven years,1
timex3,med,8 months after surgery,2
timex3,med,7 years and 8 months after,1
timex3,med,undergoing chemotherapy,1
timex3,med,7 years after,1
timex3,med,Preoperative,4
timex3,med,Intraoperative,4
timex3,med,14-year postoperative,1
timex3,med,after 14 months,1
timex3,med,after the period,1
timex3,med,the 6th course,1
timex3,med,undergoing,1
timex3,med,6 months after surgery,1
timex3,med,After,1
timex3,med,after finishing,1
timex3,med,treatments,1
timex3,med,recurrence,1
timex3,med,during,2
timex3,med,post-op,1
timex3,med,postoperative day 17,1
timex3,med,Twenty days after the start,1
timex3,med,7th postoperative day,1
timex3,med,after starting,1
timex3,med,After 4 courses,1
timex3,med,after healing,1
timex3,med,When she came to the hospital,1
timex3,med,during long-term,1
timex3,med,fourth day of treatment,1
timex3,med,"At the time of admission,",2
timex3,med,after PpPD,1
timex3,med,Postoperatively,4
timex3,med,4-OPDS continuous suture,1
timex3,med,18th day after the surgery,1
timex3,med,under treatment,1
timex3,med,follow-up,1
timex3,med,after ERCP,1
timex3,med,after placement,1
timex3,med,While undergoing,1
timex3,med,perioperative period,1
timex3,med,After admission,3
timex3,med,on the,1
timex3,med,After observing,1
timex3,med,day after surgery,1
timex3,med,patient,1
timex3,med,During the hospitalization,1
timex3,med,22 POD,1
timex3,med,on postoperative day 7,2
timex3,med,fourth day of admission,1
timex3,med,after the examination,1
timex3,med,at the time of transfer to the new department,1
timex3,med,5th day after transfer,1
timex3,med,third postoperative day,1
timex3,med,on postoperative day 4,1
timex3,med,postoperative day 13,1
timex3,med,18th day after surgery,1
timex3,med,after,1
timex3,med,after conservative treatment,1
timex3,med,during port insertion,1
timex3,med,After removal,1
timex3,med,next day,1
timex3,med,fifth postoperative day,1
timex3,med,before surgery,2
timex3,med,day of surgery,1
timex3,med,intraoperatively,2
timex3,med,11th postoperative day,1
timex3,med,after stent graft endarterectomy (EVAR ),1
timex3,med,after EVAR,1
timex3,med,immediately after surgery,1
timex3,med,1 year after surgery,1
timex3,med,After the procedure,1
timex3,med,after the treatment,1
timex3,med,after preoperative chemotherapy,1
timex3,med,Intraoperatively,1
timex3,med,four months have passed since the surgery,1
timex3,med,preoperatively,2
timex3,med,perioperative,1
timex3,med,After giving,1
timex3,med,one year and nine months after surgery,1
timex3,med,after recurrence surgery,1
timex3,med,on arrival at the hospital,1
timex3,med,during dissection,1
timex3,med,after this surgery,1
timex3,med,During the postoperative follow-up,1
timex3,med,after CABG,2
timex3,med,intraoperative or postoperative,1
timex3,med,during opening,1
timex3,med,22nd day after surgery,1
timex3,med,As of 8 months after surgery,1
timex3,med,is,1
timex3,med,After the operation,1
timex3,med,18 years after,1
timex3,med,fourth day of hospitalization,1
timex3,med,at 1 year and 6 months after surgery,1
timex3,med,1 year and 7 months after surgery,1
timex3,med,After 5 courses,1
timex3,med,2 years after,1
timex3,med,time of surgery,1
timex3,med,six months after surgery,1
timex3,med,Three years and six months after surgery,1
timex3,med,After 2 courses,1
timex3,med,at the time of the first course,1
timex3,med,after the second course,1
timex3,med,after chemotherapy,1
timex3,med,More than one year has passed since the surgery,1
timex3,med,2 years after surgery,1
timex3,med,after 2 years,1
timex3,med,After executing,1
timex3,med,One year has passed since the surgery,1
timex3,med,after curative resection,1
timex3,med,urgently admitted to the hospital,1
timex3,med,After the surgery ,1
timex3,med,last dose,1
timex3,med,10th day after surgery,1
timex3,med,admitted,1
timex3,med,Upon admission,1
timex3,med,the seventh postoperative day,1
timex3,med,removal,1
timex3,med,one and a half months after the surgery,1
timex3,med,day after the surgery,1
timex3,med,postoperative days 2 to 5,1
timex3,med,3 months postoperatively,1
timex3,med,during catheterization,1
timex3,med,deployment,1
timex3,med,at the time of re-implantation of the change,1
timex3,med,catheter life duration,1
timex3,med,removed,1
timex3,med,After the self-drainage test,1
timex3,med,just before inspection with,1
timex3,med,one year and four months after surgery,1
m-key,executed,LVFX,2
m-key,executed,anti-PD-L1 antibody,3
m-key,executed,antibiotics,6
m-key,executed,immune checkpoint inhibitors,1
m-key,executed,anti-PD-LI antibody,1
m-key,executed,nivolumab,4
m-key,executed,PSL,19
m-key,executed,immune checkpoint inhibitor,1
m-key,executed,UDCA,3
m-key,executed,Nivolumab,4
m-key,executed,cytotoxic anticancer drug,1
m-key,executed,PSL and UDCA,1
m-key,executed,anti-PD-1 antibody,1
m-key,executed,anti-PD1 antibody,1
m-key,executed,Ipilimumab,1
m-key,executed,anti-CTLA-4 antibody,1
m-key,executed,ipilimumab,1
m-key,executed,ICI,1
m-key,executed,pazopanib,3
m-key,executed,Mycophenolate mofetil (MMF),1
m-key,executed,oral pazopanib,1
m-key,executed,steroid dose,1
m-key,executed,pembrolizumab,2
m-key,executed,methylprednisolone,1
m-key,executed,prednisolone,5
m-key,executed,Prednisolone (PSL),1
m-key,executed,immunomodulators,1
m-key,executed,CMZ,2
m-key,executed,diuretics,2
m-key,executed,Lactitol,1
m-key,executed,DCV + ASV,2
m-key,executed,diuretic,1
m-key,executed,lactulose and BCAAs,1
m-key,executed,Rifaximin and levocarnitine,1
m-key,executed,BCAAs,1
m-key,executed,BCAA infusion,1
m-key,executed,as rifaximin and lactulose,1
m-key,executed,5% EOI,1
m-key,executed,Ursodeoxycholic acid,1
m-key,executed,SOF/VEL,7
m-key,executed,furosemide and spironolactone,1
m-key,executed,tolvaptan,1
m-key,executed,Ceftriaxone,1
m-key,executed,minocycline,2
m-key,executed,CO2,2
m-key,executed,nutritional agent,2
m-key,executed,Gastrostomy tube,1
m-key,executed,gastrostomy tube,1
m-key,executed,nutritional supplement(s),1
m-key,executed,gelatinized nutritional,1
m-key,executed,albumin,1
m-key,executed,steroids,6
m-key,executed,prednisone,3
m-key,executed,CsA,1
m-key,executed,FK506,2
m-key,executed,"Daikenchuto (Chinese herbal medication, mfr. Tsumura",1
m-key,executed,Daikenchuto,1
m-key,executed,Chinese herbal medicine,1
m-key,executed,(ICKT),1
m-key,executed,Tigason,2
m-key,executed,Etretinate,1
m-key,executed,acetazolamide (Diamox®,1
m-key,executed,Acetazolamide,1
m-key,executed,acetazolamide,1
m-key,executed,Antihistamines,1
m-key,executed,steroid ointment,2
m-key,executed,Vitamin E,1
m-key,executed,Prednisolone,1
m-key,executed,potassium iodide,1
m-key,executed,DDS,1
m-key,executed,INH,1
m-key,executed,methylprednisolone sodium succinate,2
m-key,executed,salazopyrin,2
m-key,executed,Minalfen,1
m-key,executed,cyclophosphamide,3
m-key,executed,Cyclophosphamide,1
m-key,executed,immunosuppressants,1
m-key,executed,minomycin,1
m-key,executed,ACNU lotion,1
m-key,executed,IFN-alpha,1
m-key,executed,IFN-1α,2
m-key,executed,Predonin,1
m-key,executed,steroid,4
m-key,executed,betamethasone benzoate ointment,1
m-key,executed,promethazine hydrochloride,1
m-key,executed,promethazine hydrochloride (white vaseline base),1
m-key,executed,UVA,4
m-key,executed,termite insecticides,1
m-key,executed,40x diluted chlorpyrifos,1
m-key,executed,0.3% 8MOP ointment,1
m-key,executed,UVB,1
m-key,executed,corticosteroids,1
m-key,executed,painkillers,1
m-key,executed,nitroglycerin,1
m-key,executed,diltiazem,1
m-key,executed,nitroglycerin.,1
m-key,executed,bronchodilator medication (hydrocortisone),1
m-key,executed,intravenous injection of heparin,1
m-key,executed,"heparin, nitrates and PSL",1
m-key,executed,"amoxapine, carbamazepine and flunitrazepam",1
m-key,executed,carbamazepine,2
m-key,executed,carbamazepine (CBZ),1
m-key,executed,valproic acid (VPA),1
m-key,executed,CBZ,2
m-key,executed,VPA,1
m-key,executed,betamethasone,1
m-key,executed,PPIs,1
m-key,executed,highly hydrolyzed formula,1
m-key,executed,amino acid non-allergenic milk (Elental®P),1
m-key,executed,amino acid non-allergenic milk (Elemental Formula),1
m-key,executed,fat preparations,1
m-key,executed,inhaled steroids (ICS),1
m-key,executed,SABA,2
m-key,executed,ICS,3
m-key,executed,SABA abortive,1
m-key,executed,antihistamines,1
m-key,executed,epinastine + montelukast,1
m-key,executed,fluticasone,1
m-key,executed,anticholinergic drug,1
m-key,executed,"antihistamines, anti-LT and anticholinergics",1
m-key,executed,Ovisot,1
m-key,executed,noradrenaline,1
m-key,executed,celecoxib,3
m-key,executed,celecoxib and teprenone,1
m-key,executed,olopatadine hydrochloride,2
m-key,executed,diflucortrone herbate,1
m-key,executed,teprenone,2
m-key,executed,diflucortron herbate,1
m-key,executed,Celecoxib and teprenone,1
m-key,executed,celecoxib-induced,1
m-key,executed,adalimumab,1
m-key,executed,synbiotics (EN),1
m-key,executed,nutritional supplements,1
m-key,executed,synbiotics,1
m-key,executed,glutamine,1
m-key,executed,pregabalin,4
m-key,executed,Fentanyl patch,1
m-key,executed,tamoxifen,1
m-key,executed,AI drugs,1
m-key,executed,contrast medium,2
m-key,executed,TS1,1
m-key,executed,capecitabine,1
m-key,executed,oral,1
m-key,executed,panitumumab,1
m-key,executed,bevacizumab,2
m-key,executed,XELOX + bevacizumab,1
m-key,executed,Xeloda,1
m-key,executed,"mFOLFOX6, Bmab, and peptide vaccine",1
m-key,executed,L-OHP,1
m-key,executed,FOLFIRI,1
m-key,executed,Bmab,1
m-key,executed,warfarin,1
m-key,executed,ganciclovir,2
m-key,executed,HLA-compatible,1
m-key,executed,MAP,1
m-key,executed,platelets,1
m-key,executed,NBCA (n-butyl cyanoacrylate),1
m-key,executed,NBCA,1
m-key,executed,abdominal CT scan,1
m-key,executed,RI,1
m-key,executed,TS-1,1
m-key,executed,Taxol,1
m-key,executed,S-1 plus CDDP,1
m-key,executed,S-1,3
m-key,executed,CDDP,2
m-key,executed,Docetaxel,1
m-key,executed,5FU,1
m-key,executed,S-1/CDDP,1
m-key,executed,mFOLFOX6,1
m-key,executed,5-FU/OHP,1
m-key,executed,concentrated red blood cells,1
m-key,executed,"cyanoacrylate, and lipiodol",1
m-key,executed,Zelform,1
m-key,executed,BCG,1
c,,further increase,1
c,,improved,26
c,,presented,20
c,,decrease,3
c,,disappeared,22
c,,emergence,1
c,,development,2
c,,found to be elevated,1
c,,worsened,8
c,,identical,1
c,,decreased,12
c,,reducing,2
c,,discontinued,8
c,,showed no improvement,2
c,,reduced,4
c,,progressed,3
c,,further compromised,1
c,,shrink,2
c,,improvement,13
c,,tended to shrink,2
c,,tended to increase,2
c,,indicating,1
c,,no morphological changes,1
c,,gradually tapered off,3
c,,appear,1
c,,worsened condition,1
c,,had set in,1
c,,worsen,2
c,,worsening,2
c,,did not improve,5
c,,exacerbation,2
c,,signs of improving,1
c,,normalized,4
c,,expression,1
c,,greater level,1
c,,quick resolution,1
c,,a gradual decrease,1
c,,developed,10
c,,mildly decreased,1
c,,showed improvement,2
c,,increased,9
c,,broke out,3
c,,her fever abated,1
c,,fever dropped,1
c,,dropped,1
c,,persisting,2
c,,tapered off,1
c,,appeared,34
c,,seen,1
c,,acute onset,1
c,,higher,1
c,,immediately normalized,1
c,,remained stable,1
c,,suddenly,1
c,,SVR,3
c,,responding well,1
c,,observed,2
c,,quickly normalized,1
c,,clear cause,1
c,,did not present,1
c,,improve,7
c,,did not worsen,1
c,,increased (Fl→F2,1
c,,lack of blood flow,1
c,,"had shrunk (Lg-cf, Fl, RC0)",1
c,,improvement in hepatic function,1
c,,improve hepatic function,1
c,,dramatic improvement,1
c,,thrombus,1
c,,doubled,1
c,,restored,1
c,,without recurrence,1
c,,reduces,1
c,,improves liver function,1
c,,found,1
c,,opened,1
c,,without recovering,1
c,,internal pressure increased,1
c,,further increased internal pressure,1
c,,cases occurring,1
c,,incidence rate,1
c,,persisted,3
c,,below,1
c,,increase,6
c,,possibility,1
c,,experienced,5
c,,ruptured,1
c,,negative,4
c,,relapsed,2
c,,Medication was stopped,1
c,,less pronounced,1
c,,signs of improvement,1
c,,developing,1
c,,dropping,1
c,,terminate,1
c,,SVR4,1
c,,compromised,1
c,,again worsened,1
c,,not improve,1
c,,intermittently,1
c,,emerged,1
c,,shrunk,3
c,,death,1
c,,rapidly improved,1
c,,elevated,11
c,,had worsened,1
c,,no improvement,2
c,,modest improvement,1
c,,released,1
c,,present,1
c,,relieve,2
c,,reduce,2
c,,completely abated,1
c,,bleeding will not stop,1
c,,hemostasis does not occur,1
c,,PTC,1
c,,lowered,1
c,,stop,1
c,,shortened,1
c,,improvement in their QOL,1
c,,resolved,5
c,,symptoms became less pronounced,1
c,,between flares,1
c,,improve his QOL,1
c,,gain weight,1
c,,values were nearly normal,1
c,,increased rapidly,2
c,,did not respond,2
c,,gradually disappeared,2
c,,repeated remission and exacerbation,1
c,,stabilized,1
c,,subsided,1
c,,induce or exacerbate,1
c,,exacerbating,1
c,,subside,2
c,,disappear,1
c,,did not completely disappear,1
c,,induced,1
c,,appearance,5
c,,had,2
c,,changed,3
c,,typical rash,1
c,,grow,1
c,,No signs of recurrence or metastasis,1
c,,Improvement,2
c,,gradually reduced after changing,1
c,,life was prolonged,1
c,,alleviated,2
c,,ineffective,2
c,,only a temporary effect,1
c,,gradually worsened,1
c,,symptoms worsened,1
c,,no recurrence,3
c,,gradually reduced,1
c,,appeared and worsened,1
c,,the dose was reduced,1
c,,exacerbated,1
c,,discontinuation,1
c,,gradual tapering,1
c,,presented and began to spread,1
c,,spread all over the patient's body,1
c,,"increased to approx. 40,000",1
c,,appearance ,1
c,,appear and disappear,1
c,,gradually enlarged,1
c,,recovered,2
c,,was,1
c,,no remarkable,1
c,,remission,2
c,,falling,1
c,,spread,1
c,,gradually increased in size,1
c,,gradually spread,1
c,,dropped off,1
c,,went away,1
c,,"showed a tendency to erupt, and with the condition worsening",1
c,,improves,1
c,,grows back,1
c,,fade away,1
c,, presented,1
c,,relieved,2
c,,had developed,1
c,,Since the rash began to spread,1
c,,manifested,2
c,,faded,2
c,,tendency to gradually spread with the number of nodules increasing,1
c,,tended to spontaneously regress,1
c,,not changed in size,1
c,,quickly disappeared,1
c,,"spread, with the number of papules increasing",1
c,,disappearance,3
c,,got worse,1
c,,considerably improved,1
c,,nearly disappeared,1
c,,easily resolved,1
c,,repeat episode,1
c,,nearly subsided,1
c,,gradually increased,1
c,,discontinue,1
c,,onset and severity,1
c,,temporary relapse,1
c,,rapid tapering ,1
c,,Another relapse,2
c,,having,1
c,,downward trending,1
c,,fever resolved,1
c,,once again presented,1
c,,diminished,1
c,,lightened,1
c,,completed,1
c,,relapse has not been observed,1
c,,an increase,1
c,,presenting,1
c,,getting worse,1
c,,worse again,1
c,,mild,1
c,,persistent,1
c,,increased to the same level,1
c,,increased again,1
c,,that does not improve,1
c,,reappeared,1
c,,gradual decreased,1
c,,without any,1
c,,a case of,1
c,,no change,1
c,,significantly improved the nutritional,1
c,,restore intestinal function,1
c,,dose was increased,1
c,,almost disappeared,1
c,,completely discontinued,1
c,,intervention was terminated,1
c,,improvement in nutritional status and ADL,1
c,,improvement of the nutritional status and ADL,1
c,,drainage volume was reduced,1
c,,trend toward maintenance and improvement of nutritional status,1
c,,improving intestinal function,1
c,,maintain and improve,1
c,,stable increase,1
c,,shift,1
c,,changes,3
c,,improved temporarily,1
c,,deterioration,1
c,,fluctuated,1
c,,patency,1
c,,is alive and recurrence-free,1
c,,tendency to shrink further,1
c,,did not disappear,1
c,,became normal range,1
c,,CR,1
c,,slightly decreasing trend,1
c,,partial response,1
c,,with,2
c,,reduction,1
c,,markedly improved,1
c,,withdrawn,1
c,,ileum,1
c,,PD,1
c,,PR,2
c,,grew rapidly,1
c,,elevation,1
c,,flared up again,3
c,,glucose tolerance had improved,1
c,,improved once,1
c,,weight loss,1
c,,marked increase,1
c,,general condition deteriorated,1
c,,increase in,1
c,,rapid exacerbation,1
c,,improving,1
c,,mildly elevated,1
c,,tended to improve,1
c,,narrowed,1
c,,removed,4
c,,discolored,1
c,,progress,1
c,,progressive,2
c,,intensified,1
c,,enlarged,1
c,,loss of blood flow,1
c,,progression,1
c,,continued,1
c,,no longer progressive,1
c,,develops,1
c,,gradual improvement,1
c,,free of recurrence,1
c,,were not receding,1
c,,hepatic mobilization,1
c,,tended to rise,1
c,,terminated,1
c,,numerous,1
c,,gradually increased in size and number,1
c,,tended to disappear,1
c,,shrank,1
c,,reduction in size,1
c,,anally,1
c,,downstaging,2
c,,marked reduction,1
c,,remained,1
c,,down staging,1
c,,loss,1
c,,loss of fertility,1
c,,pCR,2
c,,occur,1
c,,lower,1
c,,reimplantation,1
c,,QOL and ADL were improved,1
c,,died,1
c,,cured,1
c,,complete cure,1
c,,remained unchanged,1
c,,unchanged,1
f,,multiple,15
f,,scattered,7
f,,obvious,5
f,,almost completely,1
f,,necrotic,2
f,,variety,3
f,,moderate,8
f,,small number,2
f,,AIH like,1
f,,various,3
f,,dominance,1
f,,37.6°C,1
f,,normal limits,1
f,,free,1
f,,some,6
f,,slowly,2
f,,mild,18
f,,minimal,2
f,,allergic or metabolic,1
f,,remarkable,9
f,,PBC-like,2
f,,CD8 positive,1
f,,refractory,1
f,,Steroid resistance,1
f,,steroid resistant,1
f,,mixed type,1
f,,markedly,2
f,,cholestasis,1
f,,small lymphocytes,1
f,,focal,1
f,,main findings,1
f,,Grade 4,1
f,,frequent,1
f,,approximately 10%,1
f,,Stage 4,1
f,,extensive,5
f,,baseline,1
f,,hepatocellular damage type,1
f,,increased rapidly,1
f,,38°C,3
f,,direct type predominance,1
f,,different,1
f,,clear,3
f,,gradually,9
f,,again,1
f,,sudden,3
f,,quickly,1
f,,permeability,1
f,,spike-like projections,1
f,,very serious,1
f,,poor prognostic factor,1
f,,numerous,7
f,,non-expandable,1
f,,acquired,1
f,,congenital,1
f,,non-cirrhotic liver,1
f,,another,1
f,,comparatively good,1
f,,major,1
f,,thick walled,1
f,,thick,2
f,,partially,1
f,,"Lm, F3, Cb, RC0",1
f,,"Lg-cf, F1, RC0",1
f,,protruding,1
f,,approximately 80%,1
f,,large,7
f,,severe,8
f,,434.7 cm³,1
f,,remarkedly developed,1
f,,hepatotropic,1
f,,distal hepatic,1
f,,875.6 g/cm³,1
f,,2 cm,1
f,,Not being appropriate for excision,1
f,,slightly,1
f,,protrusion,1
f,,considerably,1
f,,highly,3
f,,heterogeneous,1
f,,could not be identified,1
f,,prolapse,1
f,,enlarged,1
f,,mechanically,1
f,,similar to the Budd-Chiari syndrome (type IV),1
f,,similar to the Budd-Chiari syndrome,1
f,,considerable quantity,2
f,,intermittently,1
f,,dark purple,1
f,,dark red,2
f,,slight,1
f,,uneven and irregular,1
f,,margins,1
f,,mainly lymphocytes,1
f,,part,2
f,,some areas,3
f,,rapidly,5
f,,higher than the reference value,1
f,,higher,4
f,,not uniformly present,1
f,,unlikely,1
f,,beyond the normal range,1
f,,very unlikely,1
f,,Genotype 1b,1
f,,serious,3
f,,range: stage 3b,1
f,,grade IV,1
f,,brownish,1
f,,LA classification Grade C,1
f,,950 g,1
f,,surrounded,1
f,,many,5
f,,0.5 cm,1
f,,completely,2
f,,disorganization,1
f,,green,1
f,,history of hepatitis,1
f,,continuity,1
f,,spherical,1
f,,lobular center,1
f,,very low,1
f,,extremely high values,1
f,,3,1
f,,firmly attached,1
f,,three,1
f,,large and small alveolar-like and cord-like,1
f,,stage II,1
f,,37.7°C,1
f,,appeared to be extending,1
f,,about 90 degrees counterclockwise,1
f,,asymptomatic,1
f,,central ilium and femoral type,1
f,,peripheral type (crus type),1
f,,peripheral type,1
f,,central type,1
f,,very serious illnesses,1
f,,minimize,1
f,,intractable,4
f,,massive,1
f,,indeterminate hemorrhagic site,1
f,,common,1
f,,insufficient,1
f,,significantly,2
f,,has yet to prove fatal,1
f,,repeated,5
f,,repeatedly,2
f,,remarkably,3
f,,withered branching,1
f,,not felt to be in imminent danger,1
f,,easily,1
f,,chronic disease,1
f,,mild to moderate,1
f,,mental,1
f,,instability,1
f,,pathological,1
f,,very noticeable,1
f,,peculiar,1
f,,expression,1
f,,attenuated,1
f,,noticeably,1
f,,loud,1
f,,repeated ,1
f,,would simply not stop,1
f,,small,3
f,,narrow,1
f,,persistence,1
f,,recurred,1
f,,indeterminate cause,1
f,,steroid-resistant,1
f,,pancolitis type,1
f,,Matts' grade 4,1
f,,severe type,1
f,,fulminant,1
f,,grade 2,1
f,,sex chromosome XY,1
f,,remarkable behavior,1
f,,non-invasive,1
f,,invasive,1
f,,frequently occurred,1
f,,large and small,1
f,,appeared,1
f,,psoriasis-like,2
f,,repeat,1
f,,cholinergic urticaria-like,1
f,,very mild,1
f,,ineffective,1
f,,in some areas,1
f,,uniformly,1
f,,mildly elevated,1
f,,prominent,2
f,,erythema multiforme or eczema-like,1
f,,Elevated,1
f,,significant,2
f,,elevated,3
f,,attached,1
f,,originating in the appendix,1
f,,almost entirely around,1
f,,clearly,1
f,,Elevated values in the speckled pattern,1
f,,repeated recurrence,1
f,,Diffuse,2
f,,atrophic,1
f,,perivascular,1
f,,dense,2
f,,"extremely large, soybean-sized",1
f,,increasingly bloody,1
f,,painful,2
f,,widely,1
f,,two,2
f,,IgG and C3,1
f,,2-5 cm in diameter,1
f,,scattered or clustered,1
f,,large amount,2
f,,almost,1
f,,unusual dry type,1
f,,up to the size of a fingernail,1
f,,fused,1
f,,same,1
f,,up to 16%,1
f,,continued,1
f,,21 × 10 mm,1
f,,central depression,1
f,,milky white cauliflower-like elevation,1
f,,Multiple,2
f,,up to thumb size,1
f,,feverish sensation,1
f,,almost symmetrical,1
f,,Most,1
f,,degenerated,1
f,,similar,2
f,,Numerous,1
f,,ranging in size from pin head to that of a grain of rice,1
f,,Some,1
f,,yellow,1
f,,tendency to fuse,1
f,,clearly observed,1
f,,High levels,2
f,,small papules and striae,1
f,,unique,1
f,,widespread and diverse,1
f,,Tumor stage,1
f,,tumor stage,1
f,,clusters,1
f,,plate-like,1
f,,size of the first joint of the little finger,1
f,,moderate increase,1
f,,reticular layer,1
f,,Common,1
f,,3-5 mm in size,1
f,,cup-shaped,1
f,,basophilic,1
f,,flattened slightly,1
f,,"at first glance, scar-like",1
f,,high levels,2
f,,similarity,1
f,,diam. of 1.5 cm,1
f,,up to the size of the tip of the little finger,1
f,,looked like lichen planus,1
f,,phototoxic,1
f,,phototoxicity,1
f,,isolated,1
f,,millet-sized,1
f,,Nine,1
f,,flat-lying,1
f,,≤ 3 mm in diameter,1
f,,neither itchy nor painful,1
f,,an embankment-like pattern,1
f,,centrally atrophic,1
f,,red and raised,1
f,,which were congruent,1
f,,nearly ,1
f,,disseminated,1
f,,up to 7-8 mm in diameter,1
f,,nearly,1
f,,specific,2
f,,consistent,1
f,,pea-sized,2
f,,more than 20,1
f,,ranging in size from that of a pea to the first joint of a thumb,1
f,,A single,1
f,,size of a chicken egg,1
f,,2,1
f,,diffuse,1
f,,uniformly sized,1
f,,necrosis diameter is limited to about 300 μm,1
f,,several millimeters,1
f,,up to the size of half a grain of rice,1
f,,together,1
f,,mildly impaired,1
f,,relatively small,1
f,,diffusely or sporadically,1
f,,rapid,4
f,,characteristic,1
f,,severely,2
f,,steroid dependent,1
f,,the,1
f,,rapid onslaught,1
f,,fatal,1
f,,palpable (several the size of the first joint of a thumb),1
f,,Confluent,1
f,,diverse,1
f,,Intractable,1
f,,high,3
f,,acute,1
f,,persisting,1
f,,centrilobularbar,1
f,,neutrophil-dominant,1
f,,recurrent,1
f,,localized,4
f,,5-cm,1
f,,Group 4,1
f,,Stage I,1
f,,flat and soft,1
f,,hypersensitive,1
f,,remained,1
f,,protruded,1
f,,so much,1
f,,relatively common,1
f,,about 6 mm,1
f,,indistinct borders,1
f,,early stages of metastasis,1
f,,malignant,1
f,,partially indistinct margins,1
f,,with a maximum diameter of more than 30 mm,1
f,,malignancy,2
f,,benign,1
f,,25-mm-large,1
f,,heterogeneously,1
f,,mottled,1
f,,mainly,1
f,,other,1
f,,with a diameter of 1.2 x 1.2 cm,1
f,,mass-to-nipple distance of 1.5 cm,1
f,,Malignancy,1
f,,less,1
f,,occasionally,1
f,,approximately 3 cm,1
f,,1 m,1
f,,diffusely proliferating,1
f,,diffuse type,1
f,,non-resectable,1
f,,new,1
f,,apparent,1
f,,total circumference,1
f,,circumferential type 2,1
f,,75 x 45 mm,1
f,,55 x 40 mm,1
f,,approximately 60 cm,1
f,,marked,4
f,,huge,2
f,,10 cm,1
f,,circumferential,5
f,,strong,2
f,,several,2
f,,immunosuppressive state,1
f,,hard,1
f,,about 50 mm,1
f,,50 x 30 mm,1
f,,elastic hard,1
f,,eosinophilic,1
f,,as well,1
f,,consisting mainly of eosinophils,1
f,,diabetic pattern,1
f,,24 × 22 mm,1
f,,14 mm,1
f,,7 mm,1
f,,cast-shaped,1
f,,delicate,1
f,,reflux,1
f,,The common tube length was 7 mm,1
f,,5 kg,1
f,,15 cm in diameter,1
f,,about 1000 ml/day,1
f,,tightly,1
f,,two places,1
f,,bile-like,1
f,,2.5 cm in size,1
f,,same size,1
f,,muscular,1
f,,bilirubin,1
f,,distended,1
f,,purulent,1
f,,yellowish,1
f,,of,1
f,,about 5 mm,1
f,,black,1
f,,generalized,1
f,,gangrenous,1
f,,severe form,1
f,,RCMD-RS,1
f,,semicircular type 2,1
f,,while maintaining,1
f,,torn,1
f,,prolonged,1
f,,aneurysm diameter,1
f,,continuously,1
f,,diameter of the mass,1
f,,maximum short diameter,1
f,,about 65 mm,1
f,,full circumference,1
f,,strongly,1
f,,4 cm,2
f,,early pregnancy,1
f,,7-cm-long,1
f,,originating,1
f,,maximum longitudinal length,1
f,,120 mm,1
f,,type 5,1
f,,one unit,1
f,,inadequate,1
f,,high 38°C,1
f,,involving and perforating,1
f,,mainly papillary pattern,1
f,,10*8.3 cm,1
f,,"tub2, depth SM",1
f,,rice-grain-sized,1
f,,chemotherapy resistance,1
f,,AFP-producing,1
f,,55 x 50 mm,1
f,,at the depth of Se,1
f,,lumped,1
f,,"type 3,",1
f,,110 x 80 mm,1
f,,SD,1
f,,type 2,1
f,,Grade 3 or higher,1
f,,48 mm in diameter,1
f,,irregular,1
f,,76 mm in size,1
f,,fiber could not be passed,1
f,,more than 70%,1
f,,scarring,1
f,,smooth,1
f,,approximately 10 cm,1
f,,approximately 8 cm,1
f,,a few,1
f,,fibrously,1
f,,well-defined,1
f,,4 cm in diameter,1
f,,smooth-surfaced,1
f,,elastic-hard,1
f,,surrounded by a thick fibrous membrane,1
f,,blood and unstructured material,1
f,,the probability,1
f,,two lateral finger (4 cm),1
f,,two lateral finger,1
f,,prior,3
f,,non-muscle layer invasion,1
f,,invasion,1
f,,was in progress,1
f,,Two,1
f,,branched,1
f,,approximately 5 cm,1
a,,hepatic region inside the radiated area,1
a,,the irradiated liver,1
a,,liver,23
a,,common bile duct or intrahepatic bile duct,1
a,,portal region,2
a,,bile duct,4
a,,the lobules,1
a,,portal vein area,1
a,,in the portal region,2
a,,bile duct epithelium,3
a,,lobular,1
a,,"common bile duct, and right and left hepatic ducts",1
a,,bile ducts,5
a,,Hepatic tissue,1
a,,vulva,1
a,,portal and central venous regions,1
a,,cancer cells,1
a,,various organs,1
a,,liver histology,1
a,,hepatocytes around the central vein,1
a,,Glisson's sheath,1
a,,in the lobules,2
a,,around the central vein,1
a,,all over her body,1
a,,perivascular,1
a,,liver and skin,1
a,,"liver, skin, and bone marrow",1
a,,hepatocyte region,1
a,,pulmonary area,1
a,,peripheral blood smear,1
a,,bilateral globus pallidus,1
a,,left portal vein branch,1
a,,extrahepatic,1
a,,both lobes,2
a,,left branch of the portal vein,2
a,,urea cycle,1
a,,"stomach, spleen left renal vein",1
a,,right femoral vein,1
a,,portal vein,3
a,,splenic,1
a,,splenic artery,1
a,,gastric lumen,1
a,,spleen,2
a,,inferior polar branch of the splenic artery,1
a,,left adrenal vein,1
a,,S3,1
a,,umbilical vein,1
a,,anterior surface of the left lateral lobes,1
a,,anterior surface of the extrahepatic area,1
a,,middle hepatic vein,3
a,,"right lobe of the liver, gallbladder, and hepatic flexure of the colon",1
a,,thoracic cavity,2
a,,inside of the hepatic hilum of the right lobe of the liver,1
a,,right hepatic vein,1
a,,reflux area of the middle hepatic vein,1
a,,subhepatic vena cava,1
a,,at the bifurcation of the right and left hepatic ducts,1
a,,intrahepatic bile ducts,2
a,,right lobe of the liver,1
a,,esophagus or stomach,1
a,,partial hepatic,1
a,,right and middle hepatic veins,1
a,,mucosa of the lower small to large intestine,1
a,,inside,2
a,,lower gastrointestinal mucosa,1
a,,superior mesenteric vein,1
a,,vein,1
a,,lower gastrointestinal tract,1
a,,surface of the liver,1
a,,liver or bile ducts,1
a,,portal vein and sinusoids,1
a,,portal vein region,1
a,,Liver histology,1
a,,liver tissues,1
a,,sampling site,1
a,,intestine and liver blood,1
a,,along the fascia of both lower legs,1
a,,common bile duct,2
a,,at 1 cm from the papillary opening,1
a,,pancreatic head,1
a,,kidney,1
a,,brain,1
a,,right parietal lobe,1
a,,intestinal mucosa,1
a,,lungs,3
a,,left lower lobe,1
a,,lobulated structure,1
a,,parenchyma,2
a,,Glisson’s capsule,2
a,,interlobular bile ducts,1
a,,medium-sized bile ducts,1
a,,lobular structures,1
a,,interstitium,1
a,,residual bile duct epithelium,1
a,,duct lumen,1
a,,hepatocytes,1
a,,periphery of the nodule,1
a,,duct wall,1
a,,distal,1
a,,biliary,1
a,,pancreatic duct system,1
a,,right breast,2
a,,right first and third intercostal spaces,1
a,,intercostal space,1
a,,second,1
a,,first and third intercostal spaces,1
a,,just below the wall pleura along the right internal thoracic artery,1
a,,second and third intercostal spaces,1
a,,internal thoracic arterioles,1
a,,right internal thoracic arterioles,1
a,,esophagus,1
a,,right lower lobe pulmonary artery,1
a,,right middle lobe bronchial lumen,1
a,,right upper lobe bronchus,1
a,,bronchial,1
a,,anterolaterally at the level of the right fourth intercostal space,1
a,,chest wall,1
a,,the center of the right upper lobe,1
a,,the lung and the mediastinal pleura,1
a,,middle lobe,3
a,,cephalad down the mediastinal side of the upper lobe,1
a,,ventral side of middle lobe S5 and the cephalic side of lower lobe S6,1
a,,bilateral,3
a,,lung,2
a,,pneumonectomy,1
a,,in deep veins such as the femoral and common iliac veins,1
a,,deep veins of the lower extremities,1
a,,left common femoral vein,1
a,,soleal vein,2
a,,pelvic and lower extremity veins,1
a,,central side from the popliteal vein central,1
a,,peripheral side,1
a,,veins,1
a,,full body,2
a,,upper extremities,3
a,,lower limbs and trunk,1
a,,limbs,2
a,,Hemorrhagic site,1
a,,Roux-en-Y limb including the intestinal fistula,1
a,,"collateral vessels, such as coronary veins or a splenorenal shunt",1
a,,retroperitoneal,1
a,,Roux-en Y limb,1
a,,collateral blood vessels,1
a,,intestine,3
a,,left lobe of the liver,1
a,,B6,2
a,,liver M,1
a,,facial,1
a,,stomach,7
a,,small intestine,6
a,,mid-small bowel,1
a,,T cells,1
a,,blood,1
a,,field of gastroenterology,1
a,,trunk and extremities,5
a,,in horny cell layer,1
a,,epidermis,6
a,,fingers,5
a,,hands and feet,1
a,,extremities,4
a,,face,10
a,,areas other than the cold tolerance area,1
a,,dermal,2
a,,around the blood vessels,2
a,,torso and extremities,2
a,,joints,1
a,,back side of the fingers,1
a,,around the nails,1
a,,around the eyes,1
a,,upper eyelids,2
a,,torso,1
a,,extension side of the torso and joints,1
a,,pelvic cavity,1
a,,mainly in the appendix,1
a,,uterine body,1
a,,ovary,2
a,,"upper limbs, trunk, and thighs",1
a,,face and upper limbs,1
a,,from the shoulders to the extensor side of the upper extremities,1
a,,skin,8
a,,muscle,1
a,,around the eyelids,1
a,,around the ducts,1
a,,both forearms,2
a,,both fingers to the extensor aspect of the forearms and the dorsum of both feet,1
a,,"cheeks, preauricular region, and chin",1
a,,forearm,1
a,,all layers of the dermis,4
a,,basal lamina,1
a,,erythematous skin,1
a,,epidermal-dermal border,1
a,,left side of the neck,2
a,,"gastrointestinal tract, liver, kidney, and lungs",1
a,,mediastinum,1
a,,salivary gland tissue,1
a,,in the mouth and lips,1
a,,mouth and lips,1
a,,surface,1
a,,abdomen,4
a,,just above the basal epidermal layer,1
a,,between epidermal cells,1
a,,tibialis anterior,1
a,,mainly on the face and back,1
a,,back,3
a,,upper to lower dermal layers,1
a,,"head, ears and axilla",1
a,,the entire body,1
a,,neck and precordium,1
a,,"primarily on the face, neck and the precordium, but covered nearly the entire body",1
a,,shallow dermis,1
a,,upper and lower limbs,3
a,,right lateral margin of the tongue,1
a,,both lower limbs,2
a,,mainly on the extension side of both lower limbs,1
a,,centering,1
a,,right lung,2
a,,around the eye sockets of both eyes,1
a,,upper cheeks on both sides,1
a,,upper and lower eyelids and upper cheeks on both sides,1
a,,in the center,1
a,,skin and mucous membranes,1
a,,various places,1
a,,palmoplantar,1
a,,neck,1
a,,Liver,1
a,,Skin,1
a,,minor salivary glands of the lips,1
a,,both temples,1
a,,optic nerve or retina,1
a,,face and hands,1
a,,the central area for both upper and lower limbs,1
a,,Generalized,1
a,,back of the neck,1
a,,trunk and both upper limbs,1
a,,over nearly the entire body,1
a,,cardiac cavity,1
a,,forearm and back of the neck,1
a,,upper dermis,2
a,,right side of the tongue,1
a,,entire body,4
a,,Skin covering the extensor of the right forearm,1
a,,subpapillary layer,1
a,,papillary layer,1
a,,epidermal-dermal junction,1
a,,entire torso,2
a,,the upper back down to the lumbar region,1
a,,into the dermis,1
a,,palms and soles of both hands,1
a,,scalp and both ears,1
a,,scalp,3
a,,lumbar region,2
a,,palms and soles of the feet,1
a,,scalp hair,1
a,,dermis,1
a,,anterior chest,1
a,,right upper back,1
a,,part of the face and oral mucosa,1
a,,just above the basal cell layer of the epidermis,1
a,,between the epidermal cells,1
a,,face and dorsum of the hands,1
a,,dorsum of the hands and face,1
a,,positive area,1
a,,dorsum of both hands and forearms,1
a,,"areas exposed to direct sunlight, such as the nape of the neck, forearms, and dorsum of the hands",1
a,,skin of the torso and extremities,1
a,,lower back and buttocks,1
a,,both cheeks,1
a,,periphery,1
a,,lateral margins of both feet,1
a,,dorsum of the right hand,1
a,,scarred area,1
a,,"face, upper arm and lateral margin of the leg",1
a,,foot,1
a,,scars found over her son's entire body,1
a,,face and lower limbs,1
a,,"forehead, right third finger, both knees and the right sole of her foot",1
a,,forehead and extremities,1
a,,subcutaneous tissue,1
a,,lung fields,1
a,,subcutaneous,2
a,,extensor of her left thigh,1
a,,left thigh extensor,1
a,,left inguinal region,1
a,,center,1
a,,area of induration,1
a,,lesion,2
a,,both kneecaps,1
a,,both of her kneecaps,1
a,,Bilateral,1
a,,from the axilla down to the lateral abdomen,1
a,,"his trunk, buttocks, and upper and lower extremities",1
a,,upper to middle dermis between collagen fibers,1
a,,lens,1
a,,"both eyes, especially in the left eye",1
a,,both eyelids,1
a,,both of his eyes,1
a,,ocular conjunctiva,1
a,,cornea,1
a,,bronchiolar wall,1
a,,all lung fields,1
a,,airway,1
a,,right two fingers,1
a,,his trunk and extremities,1
a,,"trunk, extremities, and occiput",1
a,,"back, kidneys, and upper limbs",1
a,,lips,1
a,,appendix,9
a,,right lower abdomen,2
a,,appendiceal wall,2
a,,appendiceal orifice,1
a,,cecum and sigmoid colon,1
a,,cecum,4
a,,sigmoid colon,7
a,,Abdomen,1
a,,face and trunk,1
a,,perforation,1
a,,fascia,1
a,,neck and trunk,1
a,,oral,2
a,,maxillary,1
a,,mandibular,1
a,,teeth,3
a,,lip,1
a,,the entire jaw,1
a,,lower jaw,1
a,,upper and lower jaw,1
a,,right,3
a,,ascending colon,5
a,,mammary gland,2
a,,colon,2
a,,upper left upper breast,1
a,,U region,1
a,,left breast,1
a,,outside,1
a,,12 o'clock direction of the left breast,1
a,,at 6 and 9 o'clock of the left breast and 9 o'clock of the right breast,1
a,,AC region of the left breast,1
a,,other left and right mammary glands,1
a,,the entire,1
a,,bilateral upper outer breast,1
a,,slightly lateral to the upper left breast,1
a,,left,1
a,,CD region of the right breast,1
a,,mastectomy,1
a,,sentinel lymph nodes,1
a,,mastectomy margins,1
a,,remaining breast,1
a,,mammary gland tissue,1
a,,tumor occupies the area,1
a,,just below the areola and nipple,1
a,,small bowel stenosis,2
a,,mouth,1
a,,ileum,2
a,,gastrectomy,6
a,,small bowel resection specimen,1
a,,sub-SM,1
a,,sigmoid,1
a,,pelvic organ,1
a,,bladder and prostate,1
a,,sacral,1
a,,S4-5,1
a,,from the stricture to the mouth,1
a,,liver S7,1
a,,right lung S3,2
a,,hepatic S7,1
a,,left of the aorta,1
a,,upper abdomen,3
a,,rectal,2
a,,necrotic intestine,1
a,,blind end,1
a,,wall,1
a,,right-sided colon that was continuous to the transverse colon,1
a,,surrounding,2
a,,lumen,1
a,,submucosa,3
a,,"surrounding small intestine, transverse colon, and sigmoid colon",1
a,,large intestine,1
a,,near,2
a,,just below the mucosal muscle plate,1
a,,D3,1
a,,around McBurney's point,1
a,,up to the cecum,1
a,,ileocecum,1
a,,near the appendiceal orifice,1
a,,submucosal to subplasmalemmal tissues,1
a,,submucosa and appendiceal mesentery,1
a,,cecum to the appendix,1
a,,cecum and appendix,1
a,,left lower abdomen,1
a,,around the sigmoid colon,1
a,,perforation site,1
a,,colonic mucosa,1
a,,remaining intestine,1
a,,pancreatectomy,2
a,,in,1
a,,head of the pancreas,1
a,,pancreatic duct,2
a,,toward the tail,1
a,,pancreas,1
a,,pancreatic duct at the tail,1
a,,parasternal papillae,3
a,,in the pancreatic duct,1
a,,upstream,1
a,,parapapillary,1
a,,accessory pancreatic duct,1
a,,posterior wall,1
a,,anterior,1
a,,bile duct bile,2
a,,in the gallbladder and bile duct walls,1
a,,gallbladder,18
a,,P8-10 from the right descending pulmonary branch,1
a,,in the inferior vena cava from the left internal and external iliac veins,1
a,,right internal jugular vein,1
a,,"peritoneum, greater omentum, and mesentery",1
a,,surrounding tissues,1
a,,the sigmoid colon and in the Douglas fossa,1
a,,small bowel,2
a,,the duodenum,1
a,,Vater papilla,1
a,,gallbladder wall,3
a,,into the gallbladder,1
a,,hepatic surface,1
a,,in the gallbladder,2
a,,gallbladder body,1
a,,arteries,2
a,,base of the ulcer,1
a,,mid to left side of the lower abdomen,1
a,,abdominal,2
a,,coronary artery,1
a,,body network,2
a,,between the gallbladder and liver,1
a,,the liver and gallbladder,1
a,,gallbladder duct,1
a,,mucosal,1
a,,peripheral side of the confluence of the three ducts,1
a,,the vicinity,1
a,,lower abdomen,1
a,,in the gallbladder and intra-abdominal cavity,1
a,,from the bilateral subdiaphragm to the pelvic region,1
a,,intra-abdominal,2
a,,in the gallbladder and in the gallbladder wall,1
a,,gallbladder bed,1
a,,RS of the rectum,1
a,,abdominal wall muscle group,1
a,,lower right abdomen,2
a,,oblique abdominal muscle,1
a,,right lower quadrant,1
a,,Douglas fossa,1
a,,"external and internal oblique abdominal muscles, anterior and posterior fascia sheaths,",1
a,,preperitoneal fat,1
a,,peritoneal,1
a,,laparo,2
a,,internal and external oblique abdominal muscles,1
a,,lumbar or median sacral artery,1
a,,the mass,1
a,,mid-thoracic esophagus,1
a,,mid-esophagus,1
a,,upper and middle mediastinum,1
a,,rectal Rb,2
a,,left adrenal gland,1
a,,other organs,1
a,,just below the hilum to the gastric fundus,1
a,,hepatic artery,1
a,,common hepatic artery,3
a,,celiac artery,1
a,,dorsal caudal to the portal vein,1
a,,from the right side of the portal vein to the ventral side,1
a,,upper gastric lesser curvature,1
a,,dorsal and caudal to the portal vein,1
a,,hepatic arterial,1
a,,"basic mesenteric arterial groups (left gastric artery, hepatic artery, splenic artery, and superior mesenteric artery)",1
a,,longitudinally and transversely in the interarterial anastomotic branches,1
a,,gastrointestinal tract,1
a,,upper border of the pancreatic head,1
a,,No. 8a,1
a,,8p,1
a,,dorsal,1
a,,right gastroepiploic artery (RGEA),1
a,,RGEA,3
a,,"RA-LAD, LITA-D1, RGEA-PL, SV-4PD",1
a,,anterior wall of the gastric body by the lesser curvature,1
a,,RGEA graft,1
a,,perigraft organs,1
a,,RGEA grafts,1
a,,graft,1
a,,mainly in the upper abdomen,1
a,,lesser curvature side of the gastric body,1
a,,reticulum and inferior surface of the liver,1
a,,major blood vessels,1
a,,the gastric peduncle,1
a,,reticulum,1
a,,extensively touching the liver,1
a,,extramural,1
a,,advanced area,1
a,,gastric,1
a,,remaining stomach,3
a,,anastomotic,1
a,,the remaining stomach,1
a,,pyloric,3
a,,Abdominal,1
a,,around the anastomosis,1
a,,in the remaining stomach,1
a,,anastomosis,2
a,,epiploic blood vessel,1
a,,right femoral artery,1
a,,D2,1
a,,hysterectomy,2
a,,from the outer membrane of the rectum to the intrinsic muscle layer,1
a,,transverse colon,1
a,,rectum,2
a,,skeletal muscle and skin,1
a,,occupying the entire circumference of the pyloric vestibule,1
a,,pyloric vestibule,2
a,,same area and the large mesh,1
a,,"occipital head semispinalis, dorsal head semispinalis, left supraspinatus, right subxiphoid muscle, left triceps, left latissimus dorsi, left thigh subcutaneously, and right vastus medialis",1
a,,pylorus of the stomach,1
a,,large reticulum tumor,1
a,,abdominal cavity,1
a,,extremities and in the chest and abdomen,1
a,,splen,1
a,,"face, neck, trunk, and upper limbs",2
a,,bladder,3
a,,resection margin,1
a,,Lt region,2
a,,UtCe region,2
a,,19 cm from the upper incisor on the mouth side,1
a,,mouth resection margin,1
a,,remaining esophagus,1
a,,extent of resection,1
a,,posterior wall of the gastric vestibule,1
a,,vaginal margin,1
a,,bladder and vaginal margins,1
a,,Sigmoid colon cancer,1
a,,"bladder, vagina",1
a,,vagina,1
a,,"cystectomy,",1
a,,vaginal dissection,1
a,,lower rectum 3 cm from the anal verge,1
a,,rectum Rb-Ra,1
a,,in the mesorectum and along the left internal iliac artery,1
a,,bilateral ovarian arterioles and admixtures,1
a,,ovaries,1
a,,abdominal wall,1
a,,ovarian,2
a,,rectal wall,1
a,,rectum about 6 cm from the anal verge,1
a,,Ra,1
a,,mucosal surface,1
a,,surrounding jejunum,1
a,,150 cm from the Treitz ligament and 440 cm from the terminal ileum,1
a,,jejunal,1
a,,slightly oral part of the ileum,1
a,,intestinal,1
a,,ileum about 3 cm from the terminal ileum,1
a,,appendiceal,1
a,,between the liver and the right kidney,1
a,,the inferior vena cava ventrally,1
a,,right adrenal gland cephalad,1
a,,interior,1
a,,retroperitoneum,1
a,,upper urinary tract,1
a,,kidneys,1
a,,incision,1
a,,wound,1
a,,tip of the 12th rib,2
a,,nephrectomy position,1
a,,muscle layer,1
a,,retroperitoneal cavity,1
a,,posterior lobe of the Gerota fascia,1
a,,renal stalk,1
a,,renal artery and vein,1
a,,ureter,1
a,,cut end of the ureter,1
a,,renal mucosa,1
a,,upper pole,1
a,,renal fibrous capsule,1
a,,ureteric,1
a,,vascular intersection,1
a,,appendicectomy scar,1
a,,prostate,1
a,,3 mm distal to the bladder neck,1
a,,total,1
a,,in the bladder,2
a,,left internal iliac artery,1
a,,from the apex of the bladder to the posterior wall,1
d,suspicious,multiple liver abscesses or multiple liver metastases of the lung cancer,1
d,suspicious,suspicion of hepatotoxicity,1
d,suspicious,irAE,1
d,suspicious,cholangitis,1
d,suspicious,hepatic impairment,1
d,suspicious,ICIs might be the cause of the liver damage,1
d,suspicious,drug-induced hepatotoxicity,1
d,suspicious,tumor,1
d,suspicious,acute hepatitis,1
d,suspicious,infection,1
d,suspicious,skin eruption,1
d,suspicious,cholecystitis,1
d,suspicious,acquired metabolic imbalance,1
d,suspicious,portal hepatic vein shunt,1
d,suspicious,hepatic encephalopathy,1
d,suspicious,obstruction,1
d,suspicious,congestive hepatopathy,1
d,suspicious,upper gastrointestinal bleeding,1
d,suspicious,rupture of the esophageal varices,1
d,suspicious,portal hypertensive enteropathy,1
d,suspicious,lower gastrointestinal bleeding due to a diffuse hemorrhage,1
d,suspicious,primary biliary cholangitis,1
d,suspicious,Wilson's Disease,2
d,suspicious,Wilson's disease,3
d,suspicious,heterozygosity,1
d,suspicious,bleeding,2
d,suspicious,small intestine stenosis,1
d,suspicious,Gottron's sign,1
d,suspicious,recurrence and metastasis of cancer,1
d,suspicious,Sjogren's syndrome,1
d,suspicious,Epicarditis,1
d,suspicious,ectopic thyroid tissue,1
d,suspicious,malignant tumor,1
d,suspicious,drug rash,1
d,suspicious,ulcerative colitis,1
d,suspicious,malignant lymphoma,1
d,suspicious,atypical mycobacteriosis,1
d,suspicious,temporal arteritis,1
d,suspicious,collagen disease,1
d,suspicious,erosive pustular dermatosis of the scalp,1
d,suspicious,contact dermatitis or photocontact dermatitis,1
d,suspicious,sarcoidosis,2
d,suspicious,tuberculosis,2
d,suspicious,primary biliary cirrhosis (PBC),1
d,suspicious,angina pectoris,1
d,suspicious,acute myocardial infarction,1
d,suspicious,peripheral airway obstruction,1
d,suspicious,Erythema exsudativum multiforme due to viral infection and drug eruption due to over-the-counter medication,1
d,suspicious,appendiceal carcinoma or appendiceal mucous cystadenoma,1
d,suspicious,appendiceal cancer,1
d,suspicious,intraductal extension,1
d,suspicious,metastatic tumor,1
d,suspicious,advanced cancer,1
d,suspicious,intestinal obstruction,1
d,suspicious,acute appendicitis,1
d,suspicious,appendiceal or cecal cancer,1
d,suspicious,cellulitis appendicitis,1
d,suspicious,ulcers,1
d,suspicious,CMV enteritis,1
d,suspicious,Groove pancreatitis,1
d,suspicious,adhesions,1
d,suspicious,common bile duct stone,1
d,suspicious,phenomenon of pancreatic juice bile duct reflux,1
d,suspicious,"Peritoneal dissemination of sigmoid colon cancer, ovarian metastasis, concurrent ovarian cancer and its peritoneal dissemination, and Meigs syndrome caused by ovarian tumor",1
d,suspicious,gallbladder perforation,1
d,suspicious,intra-abdominal hemorrhage,1
d,suspicious,combination of esophageal cancer and malignant lymphoma,1
d,suspicious,lymph node metastasis,2
d,suspicious,invasion,1
d,suspicious,anastomotic stenosis,1
d,suspicious,recurrence of gastric cancer,1
d,suspicious,colonic ileus caused by rectal cancer,1
d,suspicious,adhesive ileus,1
d,negative,invasion of the lung cancer into the liver,1
d,negative,bacteria,1
d,negative,hepatic mass,1
d,negative,autoimmune,1
d,negative,hepatitis virus marker,1
d,negative,anti-mitochondrial antibody,2
d,negative,dilatation,1
d,negative,relapse,2
d,negative,subjective symptoms,1
d,negative,findings upon abdominal examination,1
d,negative,"various viral markers, i.e. ANA and AMA2,",1
d,negative,stenosis or neoplastic lesions,1
d,negative,inflammatory changes or necrosis of the hepatocytes,1
d,negative,cholangitis,1
d,negative,primary vulvar tumor,1
d,negative,"malignant hepatic lesions, hepatic infarction, portal vein thrombus or bile duct malignancy",1
d,negative,fibrous thickening,1
d,negative,Abdominal findings,1
d,negative,HCV antibody,3
d,negative,HBsAg,1
d,negative,"fatty liver, atrophy or ascites",1
d,negative,worsening of the skin rash,1
d,negative,a bacterial infection or malignancy,1
d,negative,liver injury or recurrence of fever,1
d,negative,recurrence of a skin rash or liver damage,1
d,negative,"infection, including parasites, blood flow disorders, autoimmune diseases, neoplastic lesions and hematological diseases",1
d,negative,vasculitis,2
d,negative,hepatic encephalopathy,1
d,negative,Various hepatitis viral markers,1
d,negative,anti-M2 antibody,1
d,negative,underlying,1
d,negative,HBs antigen,4
d,negative,shunt,2
d,negative,increase in the ammonia,1
d,negative,disease,1
d,negative,complications,7
d,negative,concurrent complication due to encephalopathy,1
d,negative,recurrence of encephalopathy,1
d,negative,hepatic coma,1
d,negative,ascites or hepatocellular carcinoma,1
d,negative,complication or incident,1
d,negative,splenorenal shunt,1
d,negative,thoracic ascites,1
d,negative,esophagogastric varices aggravated,1
d,negative,HCC,1
d,negative,point of origin for obstruction,1
d,negative,varices,1
d,negative,hematemesis,1
d,negative,evidence of organic disease,1
d,negative,Kayser-Fleischer corneal rings,1
d,negative,"Hepatitis virus markers, ANA and AMA-M2Ab were negative",1
d,negative,mutation,1
d,negative,genetic mutations,1
d,negative,sinus arrest,1
d,negative,active bleeding,1
d,negative,vomited,1
d,negative,enlargement or fibrosis,1
d,negative,anti-nuclear antibodies,1
d,negative,obstruction,1
d,negative,"gangrene, itchy skin",1
d,negative,Jaundice,1
d,negative,anti-smooth muscle antibody,1
d,negative,necrosis or destruction,1
d,negative,gangrene,1
d,negative,jaundice,2
d,negative,breast cancer,3
d,negative,cancer,2
d,negative,right breast cancer,2
d,negative,other lymph node metastasis or distant metastasis findings,1
d,negative,esophageal cancer,4
d,negative,torsion,1
d,negative,color deficiency,1
d,negative,vital changes or acidosis,1
d,negative,thrombi,1
d,negative,flexion,1
d,negative,portal hypertension,1
d,negative,leaking,1
d,negative,adhesive small bowel obstruction (ASBO),1
d,negative,ileus,1
d,negative,viral infection or other drug-induced hepatic injury,1
d,negative,liver function abnormalities,1
d,negative,Advanced symptoms,1
d,negative,Bacterial culture,2
d,negative,cryoprotein,1
d,negative,anti-Jo-1 antibodies,1
d,negative,Erythema around the nails,1
d,negative,"anti-nRNP, Jo-1, Ku, Sm, SSA/Ro, and SSB/La antibodies",1
d,negative,cancer lesions,1
d,negative,dryness,1
d,negative,Anti-SSA and anti-SSB antibodies,1
d,negative,antinuclear antibodies,2
d,negative,dryness symptoms,1
d,negative,anti-centromere,1
d,negative,anti-DNA,1
d,negative,anti-Sm,1
d,negative,anti-RNP,1
d,negative,Abscesses in the mouth,1
d,negative,side effects,1
d,negative,C-reactive protein (CRP),1
d,negative,urinary B-J protein,1
d,negative,rash,1
d,negative,skin rash,6
d,negative,seborrheic eczema and psoriasis,1
d,negative,tuberculosis,2
d,negative,T-cell receptor beta chain reconstitution (Tc beta),1
d,negative,ischemic lesions,1
d,negative,LE cells,1
d,negative,lung and esophageal lesions,1
d,negative,pustules,1
d,negative,deformity of the nail plate,1
d,negative,staphylococcus aureus,1
d,negative,fungi,1
d,negative,cutaneous malignancy,1
d,negative,skin malignancies,1
d,negative,infiltration,1
d,negative,BHL,2
d,negative,trauma,1
d,negative,itchy,1
d,negative,atopic dermatitis,2
d,negative,chest pain,2
d,negative,peripheral airway obstruction,1
d,negative,bronchiolitis,1
d,negative,allergic disease such as bronchial asthma,1
d,negative,Autologous serum intradermal reaction,1
d,negative,eosinophilic inflammation,1
d,negative,autoantibodies,1
d,negative,puffiness,1
d,negative,swelling rash,1
d,negative,cholinergic reed measles,1
d,negative,adrenergic reed measles,1
d,negative,Water reed measles,1
d,negative,cold reed measles,1
d,negative,Erythema,1
d,negative,erythema,1
d,negative,recurrence,10
d,negative,tenderness,1
d,negative,dysgeusia,1
d,negative,myoclonus,1
d,negative,left breast cancer,1
d,negative,gastrointestinal metastasis,1
d,negative,CK20,3
d,negative,MUC2,1
d,negative,accumulation,1
d,negative,vascular invasion,1
d,negative,metastasis,3
d,negative,malignant findings,1
d,negative,serous invasion,1
d,negative,E-cadherin,2
d,negative,recurrence or metastasis,1
d,negative,recurrent foci,2
d,negative,outflow,1
d,negative,lymph nodes,1
d,negative,peritoneal irritation symptoms,1
d,negative,portal vein tumor emboli,1
d,negative,complications such as suture failure,1
d,negative,IP,1
d,negative,muscular defenses,1
d,negative,pain,1
d,negative,pancreatic ductal angiography,1
d,negative,thymic carcinoma,1
d,negative,varicose vein,1
d,negative,atypical cells,1
d,negative,thoracicoabdominal fluid,1
d,negative,anemia,1
d,negative,contrast,1
d,negative,symptoms of peritoneal irritation,1
d,negative,wall thickening,1
d,negative,recoil pain,1
d,negative,perforation of the gastrointestinal tract,1
d,negative,antiplatelet antibodies,1
d,negative,bulging,1
d,negative,injury,1
d,negative,intra-abdominal hemorrhage,1
d,negative,recur,1
d,negative,abdominal symptoms,1
d,negative,beating mass,1
d,negative,recurrent metastasis,1
d,negative,distant metastasis,2
d,negative,metastases,1
d,negative,c-kit,1
d,negative,CD34,1
d,negative,S-100,1
d,negative,signs of recurrence,1
d,negative,early ascending colon cancer,1
d,negative,cardiovascular complications,1
d,negative,that could cause stenosis,1
d,negative,anastomotic stenosis,1
d,negative,food mass,1
d,negative,gastric cancer,1
d,negative,adverse events,2
d,negative,0-IIa+IIc lesions,1
d,negative,recurrent findings,1
d,negative,tumor invasion,1
d,negative,left lateral lymph node metastasis,1
d,negative,cancer tissue,1
d,negative,band,1
d,negative,malignant,1
d,negative,recurrence of ileus,1
d,negative,abdominal trauma,1
cc,executed,radiochemotherapy,1
cc,executed,consult,3
cc,executed,discharged,24
cc,executed,transferred to our department,1
cc,executed,follow-up,6
cc,executed,hospitalized,10
cc,executed,seen,5
cc,executed,emergency,1
cc,executed,discharge,1
cc,executed,readmitted,2
cc,executed,admitted to the hospital,7
cc,executed,our hospital for emergency treatment,1
cc,executed,outpatient,9
cc,executed,admitted upon referral,1
cc,executed,regularly scheduled follow-up visits,1
cc,executed,transferred to another hospital,1
cc,executed,transferred,6
cc,executed,transfer,1
cc,executed,treated,3
cc,executed,informed consent,1
cc,executed,follow up,1
cc,executed,outpatient clinic,1
cc,executed,observation,4
cc,executed,hospitalizations,1
cc,executed,referred,2
cc,executed,second opinion,1
cc,executed,admitted,19
cc,executed,patient,2
cc,executed,rushed,1
cc,executed,visited,20
cc,executed,examined for liver disorder,1
cc,executed,examined,6
cc,executed,additional tests,1
cc,executed,regular follow-up,1
cc,executed,inpatient management,1
cc,executed,long-term residents,1
cc,executed,prolonged bed rest,1
cc,executed,examination performed at the time of admission,1
cc,executed,out of doors,1
cc,executed,readmitted to the hospital,1
cc,executed,Initial examination,2
cc,executed,regularly visited,1
cc,executed,hospital,1
cc,executed,first visit,1
cc,executed,First Examination,2
cc,executed,treatment,3
cc,executed,discharged from the hospital,3
cc,executed,emergency admitted,1
cc,executed,First examination,5
cc,executed,initial examination,2
cc,executed,referred to,1
cc,executed,First examined,5
cc,executed,First Visit,1
cc,executed,admitted for further treatment,1
cc,executed,examination,4
cc,executed,examined and treated,1
cc,executed,our department,1
cc,executed,underwent a medical exam,1
cc,executed,First seen,1
cc,executed,first examination,1
cc,executed,seen at our outpatient clinic,1
cc,executed,visited our outpatient clinic,1
cc,executed,outpatient clinic for a 2nd examination,1
cc,executed,ER,4
cc,executed,visiting the ER,1
cc,executed,general practitioners,1
cc,executed,visited the ER,1
cc,executed,visiting our ER,1
cc,executed,visits,1
cc,executed,regular visits,1
cc,executed,visit the ER,1
cc,executed,visit,2
cc,executed,she visited,1
cc,executed,admission,1
cc,executed,admitted to the,1
cc,executed,initial diagnosis,2
cc,executed,able to be transferred,1
cc,executed,admitted to the hospital in an emergency,1
cc,executed,to,4
cc,executed,referred to the hospital,1
cc,executed,IC,1
cc,executed,brought,1
cc,executed,came to the hospital,1
cc,executed,in the hospital,1
cc,executed,was,1
cc,executed,visited the emergency room,1
cc,executed,ESWL,1
cc,executed,refused,1
cc,executed,to the,1
cc,executed,discharge from the hospital,1
cc,executed,returned to the clinic,1
cc,executed,transported to another hospital for emergency treatment,1
cc,executed,followed up,1
cc,executed,emergency treatment,1
cc,executed,visiting the hospital regularly,1
cc,executed,emergency hospitalization,1
cc,executed,attending outpatient clinic,1
cc,executed,brought to our emergency room,1
cc,executed,patient was discharged,1
cc,executed,referred to our hospital,1
cc,executed,came,1
cc,executed,requested,1
cc,executed,the hospital,1
cc,executed,emergency department,1
cc,executed,admitted to the hospital as an emergency,1
m-key,other,immune checkpoint inhibitors,4
m-key,other,anti-PD-L1 antibodies,1
m-key,other,Immune checkpoint inhibitors (ICIs),2
m-key,other,ICI,2
m-key,other,anti-PD-1 antibodies,1
m-key,other,ICIs,1
m-key,other,immune checkpoint inhibitors (ICIs),2
m-key,other,steroids,3
m-key,other,MMF,1
m-key,other,pazopanib,1
m-key,other,PSL,1
m-key,other,lactulose or branched-chain amino acid preparations,1
m-key,other,rifaximin and L-Carnitine preparations,1
m-key,other,rifaximin and L-Cartine,1
m-key,other,ethanolamine oleate (EO),1
m-key,other,haptoglobin,1
m-key,other,EO,2
m-key,other,sofosbuvir/velpatasvir (SOF/VEL),1
m-key,other,SOL/VEL,1
m-key,other,gelatinized nutrition,1
m-key,other,cyclosporine (CsA),1
m-key,other,tacrolimus (FK506),1
m-key,other,CsA,1
m-key,other,"Inchinkoto (Capillary Wormwood Decoction, hereinafter known as ICKT)",1
m-key,other,ICKT and Saireito (minor bupleurum decoction combined with poria powder with five herbs),1
m-key,other,INH,1
m-key,other,immunosuppressants,1
m-key,other,Chlorpyrifos,1
m-key,other,organophosphate,1
m-key,other,ICS,3
m-key,other,celecoxib,1
m-key,other,pregabalin,1
m-key,other,Pregabalin,1
m-key,other,panitumumab,1
m-key,other,molecular targeting agent,1
m-key,other,bevacizumab,1
m-key,other,anticancer drugs,1
m-key,other,NBCA,2
m-key,other,S-1/CDDP,1
d,general,various types of cancer,1
d,general,side effects,3
d,general,immune-related adverse events (irAEs),3
d,general,autoimmune hepatitis (AIH) like pathological findings,1
d,general,irAE,1
d,general,cholangitis,2
d,general,hepatotoxicity,1
d,general,histological features,1
d,general,visual was similar to that associated with primary bilious cholangitis,1
d,general,liver disorders,1
d,general,side effect (irAE),1
d,general,"irAEs, including those involving cholangitis",1
d,general,malignant melanoma,1
d,general,gastric cancer,5
d,general,Hepatotoxicity irAEs,1
d,general,IrAEs,1
d,general,"liver damage, hepatitis with elevated hepatobiliary enzymes, hepatitis and sclerosing cholangitis",1
d,general,drug induced hepatotoxicity,1
d,general,autoimmune response,1
d,general,cross-reactivity between neoantigen and autoantigen,1
d,general,malignant cancer,1
d,general,irAE induced liver disease,1
d,general,bile duct injury,1
d,general,liver related irAEs,1
d,general,"liver damage, including bile duct injury, which are irAEs related",1
d,general,liver damage due to irAEs,1
d,general,drug-induced hepatic impairment,1
d,general,immune-related Adverse Effects (irAEs),1
d,general,Hepatotoxicity,1
d,general,immune-related adverse effect,1
d,general,hepatotoxicity and hepatitis,1
d,general,autoimmune hepatitis like appearance,1
d,general,irAEs,1
d,general,Drug-induced hepatic impairment,1
d,general,liver disorder,1
d,general,hepatitis,1
d,general,Spur cell anemia,2
d,general,addition to spur cells,1
d,general,hemolytic change,1
d,general,cirrhosis,3
d,general,Hepatic encephalopathy caused by an intrahepatic portal hepatic vein shunt,1
d,general,liver cirrhosis and portal hypertension,1
d,general,Hepatic encephalopathy,1
d,general,"portal venous shunts associated with cirrhosis, portal hypertension",1
d,general,acquired metabolic imbalance,1
d,general,intrahepatic portal vein shunt,1
d,general,trauma,1
d,general,hepatic encephalopathy,4
d,general,uncompensated liver cirrhosis,1
d,general,portosystemic shunt,1
d,general,ascites and varicose vein exacerbation,1
d,general,hepatic comas,1
d,general,portal veins and large circulatory short circuits,1
d,general,hepatic coma,2
d,general,splenic-renal shunt,1
d,general,renal damage caused by intravascular hemolysis,1
d,general,pulmonary embolism,2
d,general,hepatic infarction,1
d,general,gastric varices associated with cirrhosis,1
d,general,splenic hyperplasia,1
d,general,gastric varices,1
d,general,decompensated cirrhosis,2
d,general,cirrhotic,1
d,general,portal-major circulatory shunts,1
d,general,shunted hepatic encephalopathy and decreased liver function,1
d,general,hematemesis and melena,1
d,general,Portal hypertensive enteropathy,1
d,general,thrombosis,3
d,general,portal hypertension,2
d,general,present blood,1
d,general,massive bloody discharge,1
d,general,diffuse bleeding,1
d,general,portal hypertensive disease,1
d,general,primary biliary cholangitis,2
d,general,primary cholangitis,1
d,general,elevated hepatobiliary enzymes,1
d,general,liver disorder or neuropsychiatric disease,1
d,general,genetic mutations,1
d,general,Wilson's disease,4
d,general,fatty liver or fatty hepatitis,1
d,general,fatty liver,1
d,general,disease,1
d,general,hepatic disorders and fatty liver disease,1
d,general,decompensated cirrhosis type C,1
d,general,adverse outcome,1
d,general,complications of the disease,1
d,general,underlying disease,1
d,general,H. cinaedi infection,1
d,general,cellulitis or proctitis,1
d,general,positive culture,1
d,general,recur,1
d,general,"jaundice, pain, and abdominal mass",1
d,general,cancer,2
d,general,type I allergy (immediate type allergy),1
d,general,chronic liver injury,1
d,general,immediate allergic,1
d,general,breast cancer,3
d,general,recurrence,1
d,general,Pulmonary axis torsion,1
d,general,complications,2
d,general,gastric tube injury,1
d,general,Deep vein thrombosis (DVT),1
d,general,blood clots form due to blood clotting,1
d,general,DVT,5
d,general,severe mental or physical disabilities,1
d,general,DVTs,1
d,general,underdeveloped,1
d,general,bedridden from birth,1
d,general,"physical changes, including muscle tension and epileptic seizures",1
d,general,muscle tension,2
d,general,abnormal muscle tension,1
d,general,"deformity, contracture and respiratory disorders",1
d,general,respiratory complications,1
d,general,biliary atresia,4
d,general,"gastrointestinal bleeding, including the rupture of gastroesophageal varices",1
d,general,gastrointestinal bleeding,1
d,general,liver failure,1
d,general,pathological dependency,1
d,general,aerophagia,1
d,general,flatulence,1
d,general,intellectually disabled,1
d,general,stress,1
d,general,"gastroesophageal reflux disease (GERD), diarrhea",1
d,general,ulcerative colitis,1
d,general,children fighting cancer,1
d,general,children with an excretory disorder,1
d,general,prolonged jaundice,1
d,general,liver fibrosis,2
d,general,psoriasis,1
d,general,psoriasis-like eczema and xerophilic skin rash,1
d,general,drug eruption in cases involving contagious mononucleosis,1
d,general,collagen disease,1
d,general,cirrhosis of the liver,1
d,general,malignant lymphoma,1
d,general,autism,1
d,general,lung cancer,2
d,general,hair loss,1
d,general,scarring,1
d,general,hepatic damage,1
d,general,skin damage,1
d,general,cutaneous malignancies,1
d,general,panniculitis,1
d,general,erythema nodosum,1
d,general,Necrosis,1
d,general,sarcoidosis,1
d,general,Cataracts and conical corneal-retinal detachment,1
d,general,complications of atopic dermatitis,1
d,general,asthmatic,1
d,general,severe drug eruptions,1
d,general,drug-induced hypersensitivity syndrome (DIHS),2
d,general,re-activation of HHV-6 concomitant with a drug allergy,1
d,general,viral infections,1
d,general,severe drug allergy,1
d,general,severe drug eruption,1
d,general,"toxic epidermal necrolysis, Stevens-Johnson syndrome and DIHS",1
d,general,multiple organ involvement,1
d,general,lymphadenopathy,1
d,general,skin symptoms,1
d,general,systemic organ involvement,1
d,general,reactivation of the herpesvirus family,1
d,general,DIHS,1
d,general,HS,2
d,general,viral reactivation,2
d,general,bronchial asthma attack,1
d,general,bronchial asthma,1
d,general,bronchial asthma attacks,1
d,general,peripheral airway inflammation,1
d,general,alveolitis,1
d,general,exercise-induced airway narrowing,1
d,general,cholinergic urticaria,1
d,general,soy milk allergy,1
d,general,OAS,1
d,general,drug eruptions,1
d,general,Psoriasis vulgaris,1
d,general,inflammatory keratosis disease,1
d,general,colorectal cancer,5
d,general,peripheral neuropathic pain,1
d,general,side effects such as floating dizziness and somnolence,1
d,general,stricture symptoms,1
d,general,invasive lobular carcinoma,1
d,general,breast cancer or ovarian cancer,1
d,general,Gastric cancer,1
d,general,male breast cancer,3
d,general,female breast cancer,1
d,general,inhibition of angiogenesis,1
d,general,MSI,3
d,general,non-MSI,2
d,general,BRAF mutations,1
d,general,High pancreatic-bile duct confluence,1
d,general,abnormal pancreatic-bile duct confluence,1
d,general,Deep vein thrombosis,1
d,general,Gallstones and colonic diverticula,1
d,general,Saint triad,1
d,general,obesity,1
d,general,Emphysematous cholecystitis,1
d,general,acute cholecystitis,2
d,general,gas picture,1
d,general,gangrenous cholecystitis,1
d,general,cholecystitis,1
d,general,perforates,1
d,general,ischemia,1
d,general,arteriosclerotic diseases such as,1
d,general,diabetes mellitus,1
d,general,infection by gas-producing bacteria,1
d,general,hydrocephalus,1
d,general,"dysfunction due to increased intra-abdominal pressure, intra-abdominal adhesions or infection",1
d,general,gastrointestinal cancer,1
d,general,myelodysplastic syndromes (MDS),1
d,general,Traumatic abdominal hernia,1
d,general,damage,1
d,general,Type 2 endoleak (EL ),1
d,general,abdominal aortic aneurysm (AAA),1
d,general,"cerebral aneurysms, arteriovenous thinness, hepatic hemorrhage, and renal hemorrhage",1
d,general,esophageal cancer complicated by sarcoidosis,1
d,general,enlarged lymph nodes,1
d,general,adrenal metastases,1
d,general,multiple organ metastases,1
d,general,multiple metastases,1
d,general,running abnormalities,1
d,general,travel abnormality,1
d,general,graft damage,1
d,general,spasm due to traction,1
d,general,food residues,1
d,general,anastomotic stenosis or gastric calculus,1
d,general,gastric tube cancer,1
d,general,Gastric cancer has been reported to metastasize to the colon,1
d,general,"lymph node metastasis, liver metastasis, and peritoneal dissemination metastasis",1
d,general,metastasis,1
d,general,skin metastasis of gastric cancer,1
d,general,primary tumors,1
d,general,metastatic skin cancer,1
d,general,cutaneous metastasis,1
d,general,Sister Mary Joseph node,1
d,general,Stage ll-III esophageal cancer,1
d,general,primary lesions and lymph node metastases,1
d,general,"IM, intraepithelial extension, and multiple lesions",1
d,general,unresectable advanced gastric cancer,1
d,general,highly advanced colorectal cancer,1
d,general,rectal cancer,1
d,general,direct invasion or metastasis,1
d,general,advanced recurrent colorectal cancer,1
d,general,Small bowel hemorrhage,1
d,general,paralytic ileus,1
d,general,adhesive ileus,1
d,general,tumors,1
d,general,stones,1
d,general,stone adhesion,1
d,general,bladder cancer,1
d,general,malignant tumors,1
d,general,Bladder cancer,1
timex3,time,Concomitantly,1
timex3,time,As of this writing,1
timex3,time,In recent years,1
timex3,time,Thereafter,1
timex3,time,was,1
timex3,time,is now,1
timex3,time,As of now,1
timex3,time,At this juncture,1
timex3,time,recently,3
timex3,time,currently,7
timex3,time,Recently,4
timex3,time,is currently,2
timex3,time,At present,1
timex3,time,past three years,1
timex3,time,Approximately 2 months prior,1
timex3,time,10 a.m,1
timex3,time,now,2
timex3,time,early morning,1
timex3,time,early in the morning,1
timex3,time,9:30 a.m.,1
timex3,time,the present,1
timex3,time,after 5 minutes,1
timex3,time,immediately after,1
timex3,time,immediately,2
timex3,time,few hours later,1
timex3,time,Currently,3
timex3,time,still,1
timex3,time,same time,1
timex3,time,morning,1
timex3,time,the afternoon,1
timex3,time,at around 5:00 a.m.,1
timex3,time,x,1
timex3,time,So far,1
timex3,time,is,1
timex3,time,Immediately afterwards,1
timex3,time,date,1
timex3,time,Now,1
t-key,,hepatobiliary enzymes,5
t-key,,AST,16
t-key,,ALT,16
t-key,,ALP,12
t-key,,γGTP,4
t-key,,anti-nuclear antibody,3
t-key,,IgG,8
t-key,,IgG4,1
t-key,,IgM,8
t-key,,hepatobiliary enzyme,1
t-key,,T-bil,1
t-key,,γGT,1
t-key,,biliary enzymes,1
t-key,,IgG and IgG4,1
t-key,,Hepatobiliary enzymes,1
t-key,,liver function,8
t-key,,T-Bil,4
t-key,,γ-GTP,9
t-key,,PT,8
t-key,,white blood cell count,4
t-key,,CRP,12
t-key,,T-Bil ,2
t-key,,D-Bil,2
t-key,,LDH,14
t-key,,Autoantibodies,1
t-key,,viral markers,1
t-key,,DLST,1
t-key,,total score,1
t-key,,days since onset,1
t-key,,existence of non-drug related causes (Y/N),1
t-key,,previous liver disorder reported,1
t-key,,Height,2
t-key,,Weight,1
t-key,,M2BPGi,2
t-key,,ANA,2
t-key,,AST/ALT,1
t-key,,Liver function,1
t-key,,eosinophils,2
t-key,,eosinophil,1
t-key,,neutrophils,2
t-key,,no abnormalities in the hematopoiesis,1
t-key,,ChE,1
t-key,,T-bill,1
t-key,,D-bill,1
t-key,,Cu,1
t-key,,CMV and EBV related antigen-antibody reactions,1
t-key,,antinuclear antibody,1
t-key,,WBC,8
t-key,,RBC,2
t-key,,Hb,9
t-key,,Ht,2
t-key,,MCV,1
t-key,,MCHC,1
t-key,,Plt,5
t-key,,history of drinking,1
t-key,,ammonia,2
t-key,,Fisher ratio,1
t-key,,blood citrulline,1
t-key,,hepatic reserve,1
t-key,,blood ammonia level,1
t-key,,Alb,8
t-key,,T.Bil,1
t-key,,NH3,2
t-key,,PLT,3
t-key,,PT-INR,2
t-key,,portal pressure,1
t-key,,hepatic function,2
t-key,,platelet count,2
t-key,,platelet,1
t-key,,ammonia level,1
t-key,,TB,2
t-key,,INR,2
t-key,,Ammonia,2
t-key,,Cre,2
t-key,,Na,2
t-key,,portal venous blood flow,1
t-key,,splenic venous blood flow,1
t-key,,liver hardness,2
t-key,,Child-Pugh score,3
t-key,,MELD-Na score,2
t-key,,liver volume,1
t-key,,serum ammonia levels,1
t-key,,hepatic venous wedge pressure,1
t-key,,level of consciousness,1
t-key,,anti-mitochondrial antibody,2
t-key,,anti-mitochondrial M2 index,1
t-key,,BMI,2
t-key,,CHE ,1
t-key,,serum ceruloplasmin ,1
t-key,,serum copper,1
t-key,,Urinary copper,1
t-key,,urinary copper,1
t-key,,copper level in the liver tissue,1
t-key,,copper,1
t-key,,copper level,1
t-key,,serum ceruloplasmin and serum copper,1
t-key,,Child-Pugh Criteria (CPS),1
t-key,,CPS,3
t-key,,eGFR,3
t-key,,erythrocyte sedimentation,1
t-key,,total bilirubin,1
t-key,,GOT,10
t-key,,GPT,9
t-key,,Al-P,2
t-key,,yGTP,1
t-key,, BSP,1
t-key,,ICG,1
t-key,,yG,1
t-key,,IgA,1
t-key,,T. bilirubin,1
t-key,,D. bilirubin,1
t-key,,LAP,1
t-key,,T. cholesterol,1
t-key,,Triglyceride,1
t-key,,"GOT, GPT, Al-P, and LAP",1
t-key,,ATPase,1
t-key,,serum IgE levels,2
t-key,,alcohol intake,1
t-key,,blood loss,1
t-key,,Oshima classification,1
t-key,,D-dimer,1
t-key,,SpO2 and single ventilatory volume,1
t-key,,heart and respiratory rate,1
t-key,,SpO2,1
t-key,,TP,2
t-key,,chE,1
t-key,,stool frequency/hematochezia score,1
t-key,,score,2
t-key,,liver fibrosis markers,1
t-key,,elasticity values,1
t-key,,Serum cytokines,2
t-key,,CPK,5
t-key,,antinuclear antibodies,4
t-key,,erythrocyte sedimentation rate,1
t-key,,sialic acid,1
t-key,,IgG and M,1
t-key,,Antinuclear antibodies,2
t-key,,CEA,13
t-key,,CA19-9,7
t-key,,aldolase,2
t-key,,γ-globulin,2
t-key,,anti intercellular substance antibody titer,1
t-key,,intercellular substance antibody titer,1
t-key,,IgA kappa monoclone,1
t-key,,white blood cell,3
t-key,,T-BIL,1
t-key,,TC,2
t-key,,TG,4
t-key,,P-L,1
t-key,,anti-SS-B antibodies,1
t-key,,ATL antibody titer,2
t-key,,HTLV-1 proviral DNA,1
t-key,,γ-gl,1
t-key,,CH50,1
t-key,,Lung capacity,1
t-key,,1 second rate,1
t-key,,Blood gas pO2,1
t-key,,EMG,1
t-key,,pO2,1
t-key,,T.P,1
t-key,,γ-Gl,1
t-key,,TTT,1
t-key,,ZTT,1
t-key,,CHE,1
t-key,,PL,1
t-key,,β-LP,1
t-key,,anti-centromere antibody,1
t-key,,Alp,1
t-key,,1gG,1
t-key,,400x dilution,1
t-key,,ACE,3
t-key,,sake (Japanese rice wine),1
t-key,,smoking,1
t-key,,serum lipids,1
t-key,,T. chol,2
t-key,,Obesity,1
t-key,,FBS,1
t-key,,glucose tolerance,1
t-key,,riboprotein lipase activity,1
t-key,,PaO2,2
t-key,,BH,1
t-key,,BW,1
t-key,,BT,1
t-key,,BP,1
t-key,,PR,1
t-key,,both inspiration and expiration,1
t-key,,VCAIgM,1
t-key,,EBNA,1
t-key,,pH,1
t-key,,PaCO2,1
t-key,,arterial blood gas,1
t-key,,respiratory function,1
t-key,,slL-2R,1
t-key,,2-5AS ,1
t-key,,HHV-61gG antibodies,1
t-key,,Real-time PCR,1
t-key,,peripheral whole blood HHV-6,1
t-key,,serum cytokines,1
t-key,,"IL-5, IL-6, and IFN-g",1
t-key,,Eosinophil count,1
t-key,,IgE,1
t-key,,milk,1
t-key,,soybean,1
t-key,,eosinophil count,1
t-key,,alveolar NO levels (aNO),1
t-key,,KL-6,1
t-key,,SP-D,2
t-key,,exhaled NO concentration,1
t-key,,aNO,4
t-key,,bronchial NO flux (bNO ),1
t-key,,BAL cell fraction,1
t-key,,CD4/8 ratio,1
t-key,,Serum Trichosporon antibody,1
t-key,,NO levels,2
t-key,,IgE-RIST,1
t-key,,ticks,1
t-key,,HD,1
t-key,,FeNO (ppb),1
t-key,,lowering rate of the forced respiratory volume in one second (△FEV1),1
t-key,,△FEV1,6
t-key,,FeNO,6
t-key,,Specific IgE,1
t-key,,Peripheral blood,1
t-key,,immunoglobulin,1
t-key,,serum complement titer,1
t-key,,Serum total IgE,1
t-key,,specific IgE,1
t-key,,weight,1
t-key,,body temperature,3
t-key,,blood pressure,2
t-key,,pulse,1
t-key,,tall,1
t-key,,in weight,1
t-key,,eating rate,1
t-key,,blood concentration,1
t-key,,HER2,1
t-key,,Ki67 index,1
t-key,,Tumor markers,2
t-key,,T-Bi 1,1
t-key,,D-Bi 1,1
t-key,,PS,1
t-key,,platelets,1
t-key,,tumor shrinkage rate,1
t-key,,Blood pressure,1
t-key,,pulse rate was,1
t-key,,surrounding lipid tissue concentration,1
t-key,,HR,1
t-key,,pancreatitis markers,1
t-key,,Drinking history,1
t-key,,amylase,1
t-key,,lipase,1
t-key,,body mass index,1
t-key,,Hct,1
t-key,,tumor markers,1
t-key,,AFP,2
t-key,,tumor marker,1
t-key,,uric acid levels,1
t-key,,urinary biochemistry,1
t-key,,Serum uric acid level,1
t-key,,daily uric acid excretion,1
t-key,,Urinary Mg excretion,1
t-key,,serum uric acid level,1
t-key,,uric acid clearance,1
t-key,,FEurate,1
t-key,,Uric acid excretion function,1
t-key,,PSA,1
t-key,,estimated volume,1
t-key,,MFR,1
t-key,,IPSS,1
t-key,,history of smoking,1
t-val,,93 U/L,1
t-val,,94 U/L,1
t-val,,1341 U/L,1
t-val,,149 U/L,1
t-val,,80X,1
t-val,,1645.6 mg/dL,1
t-val,,20.5 mg/dL,1
t-val,,45.1 mg/dL,1
t-val,,11 U/L,1
t-val,,26 U/L,1
t-val,,566 U/L,1
t-val,,73 U/L,2
t-val,,100 U/L,1
t-val,,104 U/L,1
t-val,,1215 U/L,1
t-val,,328 U/L,1
t-val,,0.81 mg/dl,1
t-val,,91 U/l,1
t-val,,144 U/l,1
t-val,,1478 U/l,1
t-val,,426 U/l,1
t-val,,0.7 mg/dL,1
t-val,,6781 U/L,1
t-val,,5381 U/L,1
t-val,,211 U/L,1
t-val,,481 U/L,1
t-val,,87.2%,1
t-val,,"7,950/μL",1
t-val,,3.97 mg/dL,1
t-val,,negative,19
t-val,,7.85 mg/dl,1
t-val,,5.07 mg/dl,1
t-val,,559 IU/L,1
t-val,,515 IU/L,1
t-val,,747 IU/L,1
t-val,,1490 IU/L,1
t-val,,5 points,1
t-val,,2 points,2
t-val,,1 point,1
t-val,,22.37 mg/dl,1
t-val,,15.02 mg/dl,1
t-val,,447 IU/L,1
t-val,,348 IU/L,1
t-val,,499 IU/L,1
t-val,,2360 IU/L,1
t-val,,44 IU/L,1
t-val,,63 IU/L,1
t-val,,120 IU/L,1
t-val,,176 IU/L,1
t-val,,163 cm,1
t-val,,66 kg,1
t-val,,1361 IU/L,1
t-val,,1593 IU/L,1
t-val,,1.1 mg/dL,2
t-val,,1027 mg/dl,1
t-val,,81%,1
t-val,,1.06,1
t-val,,40x,2
t-val,,270 IU/L,1
t-val,,822 IU/L,1
t-val,,74%,1
t-val,,100/ul,1
t-val,,58IU/l,1
t-val,,l8IU/l,1
t-val,,175IU/l,1
t-val,,208IU/l,1
t-val,,449U/1,1
t-val,,102U/1,1
t-val,,12.7mg/dl,1
t-val,,5.4mg/dl,1
t-val,,30%,2
t-val,,90μg/dl,1
t-val,,12.16COI,1
t-val,,negative pattern,1
t-val,,1569 mg/dl,1
t-val,,less than 40-fold,1
t-val,,4900/μl,1
t-val,,410×104/μl,1
t-val,,2.1 g/dl,1
t-val,,6.2%,1
t-val,,151.2 fl,1
t-val,,51.2 Pg,1
t-val,, 10.7x104/ul,1
t-val,,193 μg/dL,1
t-val,,No,1
t-val,,176 μg/dL,1
t-val,,1.4,1
t-val,,27.8 nmol/mL,1
t-val,,42 μg/dL,1
t-val,,Child Pugh grade A (6 points),1
t-val,,3.0 g/dL,1
t-val,,138 μg/dL,1
t-val,,11.8x10^4/μL,1
t-val,,63.6%,1
t-val,,1.30,1
t-val,,47 μg/dL,1
t-val,,"50,000-70,000/μl",1
t-val,,around 100 mg/dl,1
t-val,,"73,000/μl",1
t-val,,"158,000/μl",1
t-val,,"150,000/μl",1
t-val,,32 mg/dl,1
t-val,,2.1 mg/dL,1
t-val,,2.7 g/dL,1
t-val,,36.6%,1
t-val,,1.80,1
t-val,,199 μg/dL,1
t-val,,0.59 mg/dL,1
t-val,,140 mmol/L,2
t-val,,21.5 kPa,1
t-val,,11,1
t-val,,16,1
t-val,,5,1
t-val,,8,1
t-val,,0.9 mg/dL,1
t-val,,3.7 g/dL,1
t-val,,79.3%,1
t-val,,1.13,1
t-val,,29 ug/dL,1
t-val,,0.66 mg/dL,1
t-val,,8B,1
t-val,,Child A,1
t-val,,good,1
t-val,,79 IU/L,1
t-val,,10 mmHg,1
t-val,,E4V5M6,1
t-val,,66 U/L,1
t-val,,50 U/L,1
t-val,,1025 U/L,1
t-val,,335 U/L,1
t-val,,1.4 mg/dl,1
t-val,,20.6x104/ul,1
t-val,,103%,1
t-val,,×160,1
t-val,,×80,1
t-val,,88.5,1
t-val,,1923 mg/dl,1
t-val,,523 mg/dl,1
t-val,,42 U/L,1
t-val,,36 U/L,1
t-val,,27.7,1
t-val,,51 U/L,1
t-val,,109 U/L,1
t-val,,34,2
t-val,,447 U/L,1
t-val,,13 mg/dl,1
t-val,, 55 μg/dl,1
t-val,,72.8 μg/day,1
t-val,,1474.2 μg/day,1
t-val,,70.5 μg/g,1
t-val,,7 points,1
t-val,,10 points,3
t-val,,11 points,1
t-val,,15 points,2
t-val,,29.03,1
t-val,,19.3,1
t-val,,7.4 g/dl,1
t-val,,rate 49/h,1
t-val,,1.2 mg/dl,1
t-val,,64,1
t-val,,30,2
t-val,,19.8 B.L.,1
t-val,,391,1
t-val,,19%,2
t-val,,13%,2
t-val,,12.7 g/dl,2
t-val,,2760 mg/dl,1
t-val,,550 mg/dl,1
t-val,,286 mg/dl,1
t-val,,640x,1
t-val,,15.0 mg/dl,1
t-val,,8.4 mg/dl,1
t-val,,31.7K.A.U.,1
t-val,,480G.R.U,1
t-val,,52K.U.,1
t-val,,34K.U.,1
t-val,,259 mg/dl,1
t-val,,374 mg/dl,1
t-val,,positive,6
t-val,,305 ml,1
t-val,,1,1
t-val,,7.3 g/dl,1
t-val,,4.5 g/dl,1
t-val,,301 IU/l,1
t-val,,6,2
t-val,,3 to 4 points,1
t-val,,0 points,1
t-val,,105 IU/l,1
t-val,,110 IU/l,1
t-val,,20-fold increase in,1
t-val,,"1,280-fold",1
t-val,,++,1
t-val,,32.2%,1
t-val,,x320,1
t-val,,640-fold,1
t-val,,40-fold,1
t-val,,147,1
t-val,,1028,1
t-val,,strongly positive,2
t-val,,Pseudo-positive,1
t-val,,1280-fold,1
t-val,,32-fold,1
t-val,,more than 256 times,1
t-val,,"5,500",1
t-val,,73,1
t-val,,35,3
t-val,,"1,138",1
t-val,,161,1
t-val,,17%,1
t-val,,36.5,1
t-val,,71.2%,1
t-val,,73.8%,1
t-val,,80%,1
t-val,,Low voltage,1
t-val,,50%,1
t-val,,392,1
t-val,,123,1
t-val,,1803,1
t-val,,9400,1
t-val,,8.6,1
t-val,,1280X,1
t-val,,320X,1
t-val,,Positive,2
t-val,,negative to weakly positive,1
t-val,,weakly positive,1
t-val,,42.3 U/ml,1
t-val,,Negative,1
t-val,,10.41 U/l/37°C,1
t-val,,more than 5 cups (>900 ml) per day,1
t-val,,40 cigarettes/day,1
t-val,,6050 mg/d1,1
t-val,,697 mg/dl,1
t-val,,106 mg/dl,1
t-val,,77 Torr,1
t-val,,170 cm,1
t-val,,84 kg,1
t-val,,38.5°C,1
t-val,,124/74 mmHg,1
t-val,,102/min,1
t-val,,"21,400/μl (St1, Sg23, E7, M6, L57, A-L 6%)",1
t-val,,16.9 g/dl,1
t-val,,"152,000",1
t-val,,6.4,1
t-val,,0.15 (-),1
t-val,,30.8 (+),1
t-val,,10<,2
t-val,,x20,1
t-val,,0.26 (-),1
t-val,,7.4 (+),1
t-val,,10,1
t-val,,1911 U/L,1
t-val,,2481 U/L,1
t-val,,16581 U/L,1
t-val,,1801 U/L,1
t-val,,7.4,1
t-val,,57.0,1
t-val,,36.1,1
t-val,,"31,700/μL (eosinol%, A-ly 12.5% )",1
t-val,,"169,000/μL",1
t-val,,5.2 g/dL,1
t-val,,I371 U/L,1
t-val,,2021 U/L,1
t-val,,7141 U/L,1
t-val,,1.8 mg/dL,1
t-val,,"13,100 U/mL",1
t-val,,213 pMol/dL,1
t-val,,"from 20 to 10, 240x",1
t-val,,from 3.5 × 105 to 6.3 × 103 copies/106 cells,1
t-val,,3663/μ1,1
t-val,,12.38 U/ml,1
t-val,,24.30 U/ml,1
t-val,,1.22 U/ml,1
t-val,,1456 U/m1,1
t-val,,116 ng/ml,1
t-val,,50.1 ppb,1
t-val,,9.9 ppb,1
t-val,,3.0 nl/s,1
t-val,,0.4,1
t-val,,5171U/ml,1
t-val,,38,1
t-val,,12%,1
t-val,,10%,1
t-val,,1%,2
t-val,,class 5,1
t-val,,class 3,1
t-val,,class 2,2
t-val,,class 1,1
t-val,,3+,1
t-val,,2+,1
t-val,,88.41 U/ml,1
t-val,,negative result,1
t-val,,positive result,1
t-val,,"10,000/ul",1
t-val,,0.28 mg/ml,1
t-val,,159.5 cm,1
t-val,,66.1 kg,1
t-val,,35.6°C,1
t-val,,149/99 mmHg,1
t-val,,68 beats/min,1
t-val,,173 cm,1
t-val,,46 kg,1
t-val,,2.7 g/dl,1
t-val,,8.1 g/dl,1
t-val,,16.6 kg/m2,1
t-val,,53 points,1
t-val,,2.2 g/dL,1
t-val,,score of 62,1
t-val,,2.3 g/dL,1
t-val,,about 10-30%,1
t-val,,score 0,1
t-val,,18.6,1
t-val,,4.6,1
t-val,,791.1 ng/m1,1
t-val,,29432 U/ml,1
t-val,,1.6 mg/dl,1
t-val,,1.0 mg/dl,1
t-val,,160 U/l,1
t-val,,104 U/l,1
t-val,,338 U/l,1
t-val,,1720 U/l,1
t-val,,416 U/l,1
t-val,,169 U/l,1
t-val,,0,1
t-val,,8.4 ng/ml,1
t-val,,5 6.7 U/ml,1
t-val,,Group 1,1
t-val,,44%,1
t-val,,126/76 mm Hg,1
t-val,,77 beats/min,1
t-val,,36.9°C,2
t-val,,"11,000 mm3",1
t-val,,75%,1
t-val,,2.08 mg/dl,1
t-val,,80/51 mmHg,1
t-val,,122 beats per minute,1
t-val,,4.8 g/dl,1
t-val,,9600,1
t-val,,"150,000",1
t-val,,2.58 g/dl,1
t-val,,4.19,1
t-val,,7-8 cans of beer (1 350m can)/day,1
t-val,,15000 IU/L,1
t-val,,96000 IU/L,1
t-val,,30.8,1
t-val,,"9,900/μl",1
t-val,,4.6 mg/dl,1
t-val,,2.87,1
t-val,,"10,480/μl",1
t-val,,5.44 mg/dl,1
t-val,,1.50 mg/dl,1
t-val,,3000/μl,1
t-val,,167×104/μl,1
t-val,,6.4 ml/dl,1
t-val,,20.1%,1
t-val,,1.6×104/μl,1
t-val,,20.3 ng/ml,1
t-val,,6.6 g/dl,1
t-val,,1798 ng/mL,1
t-val,,157 ng/mL,1
t-val,,Class 1,1
t-val,,3.5 ng/ml,1
t-val,,less than 6 U/ml,1
t-val,,10.3,1
t-val,,less than 0.6,1
t-val,,0.0 mg/dl,1
t-val,,"5,400",1
t-val,,"285,000",1
t-val,,11.1 ng/ml,1
t-val,,Class 5,1
t-val,,3.7 mg/dl,1
t-val,,61 ng/ml,1
t-val,,15 ng/ml,1
t-val,,7500/μl,1
t-val,,18.0 mg/dl,1
t-val,,from 2.2 to 20 ng/ml,1
t-val,,7.3 ng/ml,1
t-val,,4.0 ng/ml,1
t-val,,ranged from 36.4 to 124.6 ml,1
t-val,,74.1 ml,1
t-val,,18.9 ml/sec,1
t-val,,had,1
t-val,,in the 20% range,1
m-val,,0.5 mg/kg,1
m-val,,0.4 mg/kg,1
m-val,,1 mg/kg,1
m-val,,0.2 mg/kg,1
m-val,,150 mg,1
m-val,,30 mg,1
m-val,,15 mg,1
m-val,,600 mg,1
m-val,,45 mg/day (1 mg/kg/day),1
m-val,,60 mg,2
m-val,,800 mg,1
m-val,,200 mg,1
m-val,,1000 mg,1
m-val,,1 mg/kg/day,2
m-val,,6 mg/day,1
m-val,,same dosage,1
m-val,,total of 7 ml,1
m-val,,600 mg/day,1
m-val,,3.75 mg/day,1
m-val,,2 g/day,1
m-val,,200 mg/day,2
m-val,,8 mmHg,1
m-val,, 0.45 g/kg/day,1
m-val,,30 mg/day,2
m-val,,750 mg/day,1
m-val,,250 mg,1
m-val,,1500 mg,1
m-val,,60 mg/day,1
m-val,,(20 mg),1
m-val,,20 mg/day (1 mg/kg),1
m-val,,5 mg/day,1
m-val,,240 mg/day,1
m-val,,25 mg,1
m-val,,50 mg,1
m-val,,50 mg/day,1
m-val,,"35 mg/day,",1
m-val,,"1 to 6,718 J/cm2",1
m-val,,459,1
m-val,,200 J/cm2,1
m-val,,6.8-14.3 J/cm2,1
m-val,,O.3-0.9 J/cm2,1
m-val,,8 mg/day,1
m-val,,200 μg/day,1
m-val,,10 mg/day,1
m-val,,15 mg/day,1
m-val,,150 mg/day,1
m-val,,20 mg/day,1
m-val,,40 Gy in total,1
m-val,,15-20 mg/day,1
m-val,,2 mg/day,1
m-val,,100 mg/day,1
m-val,,70 mg/m2,2
m-val,,700 mg/m2,1
m-val,,120 mg/body/day,1
m-val,,60 mg/m2,1
m-val,,50.4 Gy/28 Fr,1
m-val,,8 units,1
timex3,duration,every 2 weeks,1
timex3,duration,while undergoing the cancer therapy,1
timex3,duration,More than 8 months later,1
timex3,duration,every 3 weeks,1
timex3,duration,for 3 days,2
timex3,duration,approximately one month,1
timex3,duration,48 hours,1
timex3,duration,113 to 150 hours,1
timex3,duration,5 to 7 days,1
timex3,duration,more than 10 days,1
timex3,duration,per day,1
timex3,duration,2 years,1
timex3,duration,the past 13 years,1
timex3,duration,"10 hours, 2 minutes",1
timex3,duration,"4 hours, 39 minutes",1
timex3,duration,15 minutes,1
timex3,duration,24 hours,1
timex3,duration,within one month,2
timex3,duration,over the course of the year,1
timex3,duration,7 months,2
timex3,duration,a day,1
timex3,duration,1 week,1
timex3,duration,a week,2
timex3,duration,within 24 hours,1
timex3,duration,10 days,1
timex3,duration,within a month,1
timex3,duration,about 2 months,1
timex3,duration,about 10 days,2
timex3,duration,"within 2, 3 days",1
timex3,duration,approximately 7 weeks,1
timex3,duration,for a short time,1
timex3,duration,6 years,1
timex3,duration,for 1 month,1
timex3,duration,for 13 years,1
timex3,duration,3 week,1
timex3,duration,10 years,1
timex3,duration,90 minutes,1
timex3,duration,recent past 10 years,1
timex3,duration,For about 20 years,1
timex3,duration,3 days,1
timex3,duration,9 days,1
timex3,duration,in,1
timex3,duration,1 month,1
timex3,duration,70-year-old,1
timex3,duration,for the past 3 years,1
timex3,duration,several years,1
timex3,duration,5 minutes,1
timex3,duration,15 min,2
timex3,duration,for 4 h,1
timex3,duration,about 1 week,1
timex3,duration,5 hours 49 minutes,1
timex3,duration,for about 5 years,1
timex3,duration,for 4 months,1
timex3,duration,8 months,2
timex3,duration,2 years after,1
timex3,duration,about 10 months,1
timex3,duration,for 3 weeks,1
timex3,duration,for a time,1
timex3,duration,a year,1
timex3,duration,4 hours and 10 minutes,1
timex3,duration,for 2 days,2
timex3,duration,approximately 9 months,1
timex3,duration,4 years and 3 months,1
timex3,duration,1 year,1
timex3,duration,5 months,1
timex3,duration,3 months,1
timex3,duration,for 1 year,1
timex3,duration,about 13 months,1
timex3,duration,period of about six months,1
timex3,duration,4-week,1
timex3,duration,250 min,1
timex3,duration,2-3 minutes,1
timex3,duration,over 10 years,1
m-key,negated,nivolumab,1
m-key,negated,PSL,3
m-key,negated,ICI (nivolumab and ipilimumab),1
m-key,negated,pazopanib,2
m-key,negated,antibacterial medication,1
m-key,negated,lactitol,1
m-key,negated,SOF/VEL,1
m-key,negated,Daikenchuto,1
m-key,negated,Acetazolamide,1
m-key,negated,INH,1
m-key,negated,medications,1
m-key,negated,antiepileptic drug CBZ,1
m-key,negated,fatty preparations,1
m-key,negated,ICS,3
m-key,negated,EN,1
m-key,negated,pregabalin,2
m-key,negated,oxaliplatin,1
m-key,negated,FOLFOX,1
m-key,negated,insulin,1
m-key,negated,tegafur-uracil combination,1
m-key,negated,blood transfusion,1
p,,"The score, in accordance with the diagnostic criteria for drug-induced liver injury revised by the DDW-J 2004 Workshop, for",1
p,,8 points,1
p,,9 points,1
p,,their efficacy against the tumor,1
p,,"due to nosocomial infection or horizontal transmission,",1
p,,Cell-mediated immunity,1
p,,"With the patient lying on her left side, ",1
p,,if the portal vein main blood flow,1
p,,blood flow,1
p,,blood flow of the portal vein,1
p,,"with their own liver,",1
p,,.,1
p,,homogeneous and speckled,1
p,,the MED test result,1
p,,CTL,1
p,,"C, type0-IIa, pM, tubl in adenoma, pN0, sH0, sP0, M0, fStage0 and S, type1, tub1, pSS, sN0, sP0, cM0, fStage II",1
p,,Category 4,1
p,,negative margin.,1
p,,"tub2 > tub1 > muc, pTla(M), ly0, v0, pN0.",1
p,,"Ra-Rb, Type 3, cA1 (prostate), cH2, cStagelV)",1
p,,"tub2 > muc, pA1 (prostate), ly2, v1, pPMX, pDMX, pRM0, N (2/38)",1
p,,"pMP, pNO (0/29)",1
p,,Rb,1
p,,"tub2a, ly1, v3, N1, H0, P0, M0, Stage llIa, Radicality A",1
p,,"CK(A), Type 2",1
p,,"tub2, pS1, N3, H3, P0, M1 (LM3), fStage lV",1
p,,"SE, N2, H0, P0, M0: Stage lllb",1
p,,C4-type pSE pN3 H0 pP1M1 (LYM) fStage lV,1
p,,Grade lV,1
p,,IPSS-Int-1). ,1
p,,mp N(-),1
p,,"Mt, Type2+0-2b, 45×30 mm, pT3, INFb, 1y3, v1, IM1, N1 (1/22), MO, PMO, DMO, RMO, stage3",1
p,,"type2, tub2 > muc, pT3, int, INFb, ly0, v2, pN0, pPM0, pDM0, pRM0, sP0, sH0, cM0, fStage 2",1
p,,Histological evaluation of treatment response was grade1b,1
p,,"H0, CY0, M0, Stage IIB",1
p,,tub1,1
p,,"UM, Less, type3",1
p,,pTlb (SM2),1
p,,pStagelA,1
p,,"si (panc.
coating), ly2, v2, n2 (12/76), stage3b",1
p,,"(SKI, OTH) PIHO StagelV",1
p,,"ML, AntLess, type3, por, pT3, ly1, vO and M, Post, 0-Ilc, tub1, pTlb2, ly0, v0, pN2M0P0H0, pStage3A",1
p,,"H0, M1 (LYM), P0, CYX, H0 stage lV",1
p,,"L, Less, yType3, ypT2, int, INFb, v1, ly3, ypN2, M0, P0, CY0, H0, ypStage IIB, pPM0, pDM0, pR0, Grade2",1
p,,cSI,2
p,,"cN3, cH0, cP0, cM1 (#283), cStage lV",1
p,,"cH0, cP0, cM0, cStage ll",1
p,,cStage3b,1
p,,"pA, pN1 (2/18), fStage 3a",1
p,,"HO, PO",1
p,,cStageIIIb,1
p,,grade 3,1
p,,Bleeding volume: 100 ml,1
p,,"TCC, G1, pTa,",1
timex3,set,4 times,1
timex3,set,frequently,3
timex3,set,3X/week,1
timex3,set,Periodic,1
timex3,set,multiple,1
timex3,set,every 3 to 4 months,1
timex3,set,"11th, 13th, and 15th days, counting from the onset of the illness",1
timex3,set,two,1
timex3,set,5 times,1
timex3,set,frequent,2
timex3,set,several times,2
timex3,set,five times,2
timex3,set,1 to 621,1
timex3,set,106,1
timex3,set,96,1
timex3,set,three to five times a week,1
timex3,set,two to three times a year,1
timex3,set,18 cycles,1
timex3,set,7 cycles,1
timex3,set,6,1
timex3,set,12 times,1
timex3,set,21 times,1
timex3,set,eight times,1
timex3,set,daily,1
timex3,set,2 courses,1
timex3,set,5 courses,1
timex3,set,weekly,1
timex3,set,6 courses,1
timex3,set,Eight,1
r,other,immunosuppressive therapy,1
r,other,liver transplant,3
r,other,"retrograde transvenous embolization under balloon occlusion, portal vein diversion or percutaneous transhepatic obliteration",1
r,other,BRTO,4
r,other,balloon,1
r,other,balloon-occluded retrogade transvenous obliteration (BRTO),1
r,other,"partial splenic artery embolization, hereinafter known as PSE",1
r,other,embolizing,1
r,other,balloon occlusion retrograde transvenous obliteration (BRTO),1
r,other,IVR treatment,1
r,other,shunt occlusion,1
r,other,localized therapy,1
r,other,antiviral therapy,1
r,other,Shunt occlusion,1
r,other,transcatheter therapy,1
r,other,laparotomy,1
r,other,shunt ligation,1
r,other,chemotherapy,4
r,other,surgery,4
r,other,"chemotherapy, radiotherapy, and hormone therapy",1
r,other,hepatoportoenterostomy,1
r,other,transplant,3
r,other,living donor transplants,1
r,other,living donor liver transplant,1
r,other,gastric sleeve fixation,1
r,other,nutrition is infused,1
r,other,gastrostomy tube,1
r,other,infusion,2
r,other,one-shot infusion,1
r,other,oral steroids,1
r,other,steroid pulse therapy and high-dose intravenous immunoglobulin therapy,1
r,other,dental approaches,1
r,other,oral care,1
r,other,denture adjustment,1
r,other,pectoral muscle-sparing mastectomy,1
r,other,partial mastectomy,1
r,other,cancer chemotherapy,1
r,other,anticancer therapy,1
r,other,ventriculoperitoneal shunting,1
r,other,endovascular therapy,1
r,other,dissection,3
r,other,resection,2
r,other,resectable,2
r,other,chemotherapy and radiotherapy,1
r,other,Cardiac coronary artery bypass grafting (CABG),1
r,other,surgical manipulation,1
r,other,radical resection,1
r,other,radiation therapy,1
r,other,Ovarian mobilization and fixation,1
r,other,laparoscopic,1
r,other,mobilization and fixation,1
r,other,Chemotherapy,1
r,other,FOLFOX therapy,1
r,other,mFOLFOX6 and Xelox therapy,1
r,other,adjuvant therapy,1
r,other,removal,1
r,other,laparoscopic excision,1
r,other,Stents,1
r,other,catheter reinsertion,1
t-test,other,liver biopsy,3
t-test,other,upper and lower endoscopy,1
t-test,other,screening,1
t-test,other,blood culture,1
t-test,other,ERCP and PTC,1
t-test,other,PET-Mammography (PEM),1
t-test,other,MMG,1
t-test,other,FDG-PET,1
t-test,other,contrast-enhanced MRI,1
t-test,other,sentinel lymph node biopsy,1
t-test,other,rapid pathological,1
t-test,other,PET-CT,1
t-test,other,rapid pathology,1
t-test,other,imaging studies,1
t-test,other,biopsy,1
t-test,other,chest CT scan,1
r,negated,administration,1
r,negated,ventilator,1
r,negated,liver transplant,2
r,negated,percutaneous localized therapy,1
r,negated,transcatheter approach,2
r,negated,DAA treatment,1
r,negated,taking any medications,1
r,negated,drug use,1
r,negated,removal,1
r,negated,lobar fixation,1
r,negated,steroid treatment,1
r,negated,tube feeding,1
r,negated,medication,1
r,negated,total pancreatectomy,1
r,negated,shunting surgery,1
r,negated,resection,1
r,negated,drainage,1
r,negated,closed with simple sutures,1
r,negated,drain,2
r,negated,mesh,1
r,negated,dissected,1
r,negated,pylorus-preserving gastrectomy,1
r,negated,curative resection,1
r,negated,catheters,1
r,negated,temporary urethral stent,2
r,negated,inoperability,1
r,scheduled,percutaneous transhepatic obliteration,1
r,scheduled,PSE,1
r,scheduled,BRTO,1
r,scheduled,shunt occlusion,1
r,scheduled,percutaneous transsplenic umbilical vein occlusion,1
r,scheduled,splenic artery embolization,1
r,scheduled,surgical repair of the diaphragm,1
r,scheduled,control the ascites,1
r,scheduled,living donor liver transplant,1
r,scheduled,electron beam irradiation,1
r,scheduled,surgery,8
r,scheduled,evaluation,1
r,scheduled,NST intervention,1
r,scheduled,chemotherapy,1
r,scheduled,radical surgery,1
r,scheduled,total,1
r,scheduled,autologous pancreas transplantation,1
r,scheduled,autologous islet transplantation,1
r,scheduled,cholecystectomy,1
r,scheduled,temporary inferior vena cava filter,1
r,scheduled,perform surgery,1
timex3,misc,after the traffic accident,1
timex3,misc,early stages of the disease and in the chronic hepatitis stage,1
timex3,misc,After resumption of food intake,1
timex3,misc,entering high school,1
timex3,misc,worsened,1
timex3,misc,1 year and 2 months after the onset of illness,1
timex3,misc,during serious bouts,1
timex3,misc,period of exacerbation,1
timex3,misc,post chicken pox,1
timex3,misc,after a bout of wheezing,1
timex3,misc,After returning home,1
timex3,misc,Since birth,1
timex3,misc,during exercise,1
timex3,misc,after ingestion of fruits,1
timex3,misc,when consuming,1
timex3,misc,since the onset of symptoms,1
timex3,misc,when taking,1
timex3,misc,while taking a bath,1
timex3,misc,after taking,1
timex3,misc,after normal stool,1
timex3,misc,when renal function deteriorates,1
timex3,misc,After drinking,1
timex3,misc,While riding her bicycle,1
timex3,misc,23 weeks' gestation,1
timex3,misc,40 weeks' gestation,1
timex3,misc,during pregnancy,1
timex3,misc,after dinner,1
timex3,misc,before every meal,1
cc,other,following,1
cc,other,inpatient management,1
cc,other,confined to bed for a long period of time,1
cc,other,short-term care facilities,1
cc,other,restrained,1
cc,other,restraint,1
cc,other,regular ophthalmologic examinations,1
cc,other,visiting ,1
cc,other,emergency room (ER),2
cc,other,regular visits to the hospital,1
cc,other,visited,1
cc,other,visiting,1
cc,other,regular visits,1
cc,other,outpatient,1
cc,other,follow-up,2
t-test,negated,biopsy,1
t-test,negated,pustules,2
t-test,negated,erythema,2
t-test,negated,CMV antigenemia,1
t-test,negated,chest CT scan,1
d,,cT2NOMO,1
d,,"MP, N0, M0,",1
d,,T2NIMO,1
d,,pTlb,1
d,,"T3, N1, P0",1
d,,T4a,2
d,,N3a,1
d,,M0,2
d,,N1,1
d,,NOMO,1
d,,T4bN3bM1,1
d,,cT3N2,1
d,,T1bSM1,1
d,,T3,2
d,,N2,1
d,,MO,1
d,,"pTa, N0, and M0",1
cc,negated,referred to our department for a psychiatric consult,1
cc,negated,family doctor,1
cc,negated,visit the hospital,1
m-val,negated,radiation,1
m-val,negated,arsenic,1
cc,scheduled,thorough examination and treatment,1
